GO:0022625 cytosolic large
ribosomal subunit
|
40
|
1.11e-22
|
-8.95e-01
|
6.53e-20
|
GO:0002181 cytoplasmic translation
|
27
|
4.68e-14
|
-8.38e-01
|
6.32e-12
|
GO:0045116 protein neddylation
|
10
|
1.25e-05
|
-7.98e-01
|
4.22e-04
|
GO:0022627 cytosolic small
ribosomal subunit
|
25
|
9.06e-12
|
-7.88e-01
|
8.85e-10
|
GO:0007076 mitotic chromosome
condensation
|
10
|
2.24e-05
|
7.74e-01
|
6.56e-04
|
GO:0036121 double-stranded DNA
helicase activity
|
11
|
2.37e-05
|
7.36e-01
|
6.71e-04
|
GO:0035145 exon-exon junction
complex
|
10
|
5.88e-05
|
7.34e-01
|
1.31e-03
|
GO:0003735 structural constituent
of ribosome
|
118
|
8.25e-41
|
-7.12e-01
|
1.45e-37
|
GO:0021915 neural tube development
|
15
|
3.23e-06
|
6.94e-01
|
1.45e-04
|
GO:1902774 late endosome to
lysosome transport
|
10
|
1.44e-04
|
-6.94e-01
|
2.76e-03
|
GO:0000228 nuclear chromosome
|
13
|
3.26e-05
|
6.65e-01
|
8.18e-04
|
GO:0070034 telomerase RNA binding
|
12
|
8.35e-05
|
6.56e-01
|
1.77e-03
|
GO:0005049 nuclear export signal
receptor activity
|
10
|
3.75e-04
|
6.50e-01
|
5.49e-03
|
GO:1990518 single-stranded 3’-5’
DNA helicase activity
|
11
|
1.98e-04
|
6.48e-01
|
3.45e-03
|
GO:0000793 condensed chromosome
|
13
|
5.50e-05
|
6.46e-01
|
1.26e-03
|
GO:2000737 negative regulation of
stem cell differentiation
|
12
|
1.12e-04
|
6.44e-01
|
2.24e-03
|
GO:0140658 ATP-dependent chromatin
remodeler activity
|
11
|
2.32e-04
|
6.41e-01
|
3.92e-03
|
GO:0061749 forked DNA-dependent
helicase activity
|
10
|
4.56e-04
|
6.40e-01
|
6.27e-03
|
GO:1990023 mitotic spindle midzone
|
10
|
6.90e-04
|
6.20e-01
|
8.54e-03
|
GO:0017056 structural constituent
of nuclear pore
|
19
|
5.23e-06
|
6.04e-01
|
2.14e-04
|
GO:0070064 proline-rich region
binding
|
10
|
9.51e-04
|
6.04e-01
|
1.06e-02
|
GO:0006412 translation
|
96
|
3.49e-24
|
-5.99e-01
|
3.06e-21
|
GO:0004364 glutathione transferase
activity
|
10
|
1.06e-03
|
-5.98e-01
|
1.17e-02
|
GO:0006120 mitochondrial electron
transport, NADH to ubiquinone
|
19
|
6.85e-06
|
-5.96e-01
|
2.56e-04
|
GO:0071806 protein transmembrane
transport
|
12
|
3.89e-04
|
-5.91e-01
|
5.65e-03
|
GO:0000380 alternative mRNA
splicing, via spliceosome
|
16
|
4.58e-05
|
5.89e-01
|
1.07e-03
|
GO:0032585 multivesicular body
membrane
|
12
|
4.95e-04
|
-5.81e-01
|
6.70e-03
|
GO:0070577 lysine-acetylated
histone binding
|
16
|
6.19e-05
|
5.78e-01
|
1.36e-03
|
GO:0006337 nucleosome disassembly
|
10
|
1.70e-03
|
5.73e-01
|
1.73e-02
|
GO:0000245 spliceosomal complex
assembly
|
10
|
1.77e-03
|
5.71e-01
|
1.77e-02
|
GO:0003678 DNA helicase activity
|
20
|
1.11e-05
|
5.68e-01
|
3.90e-04
|
GO:0016581 NuRD complex
|
10
|
2.03e-03
|
5.63e-01
|
1.93e-02
|
GO:0035371 microtubule plus-end
|
12
|
9.44e-04
|
5.51e-01
|
1.06e-02
|
GO:0051010 microtubule plus-end
binding
|
11
|
1.58e-03
|
5.50e-01
|
1.64e-02
|
GO:0007249 canonical NF-kappaB
signal transduction
|
18
|
5.43e-05
|
5.50e-01
|
1.26e-03
|
GO:0033116 endoplasmic
reticulum-Golgi intermediate compartment membrane
|
18
|
5.75e-05
|
-5.48e-01
|
1.30e-03
|
GO:0051536 iron-sulfur cluster
binding
|
12
|
1.10e-03
|
-5.44e-01
|
1.20e-02
|
GO:1990391 DNA repair complex
|
10
|
3.19e-03
|
5.39e-01
|
2.59e-02
|
GO:0008233 peptidase activity
|
10
|
3.50e-03
|
-5.33e-01
|
2.77e-02
|
GO:0006749 glutathione metabolic
process
|
15
|
3.65e-04
|
-5.31e-01
|
5.40e-03
|
GO:0045271 respiratory chain
complex I
|
31
|
3.33e-07
|
-5.30e-01
|
1.83e-05
|
GO:0005840 ribosome
|
43
|
2.98e-09
|
-5.23e-01
|
2.18e-07
|
GO:0051315 attachment of mitotic
spindle microtubules to kinetochore
|
10
|
4.49e-03
|
5.19e-01
|
3.23e-02
|
GO:0016442 RISC complex
|
11
|
2.91e-03
|
5.18e-01
|
2.45e-02
|
GO:0035855 megakaryocyte
development
|
10
|
4.65e-03
|
5.17e-01
|
3.31e-02
|
GO:0003151 outflow tract
morphogenesis
|
19
|
1.04e-04
|
5.14e-01
|
2.13e-03
|
GO:0032968 positive regulation of
transcription elongation by RNA polymerase II
|
15
|
5.89e-04
|
5.13e-01
|
7.47e-03
|
GO:0043296 apical junction complex
|
10
|
5.21e-03
|
5.10e-01
|
3.55e-02
|
GO:0031468 nuclear membrane
reassembly
|
11
|
3.58e-03
|
-5.07e-01
|
2.82e-02
|
GO:0031466 Cul5-RING ubiquitin
ligase complex
|
11
|
3.81e-03
|
-5.04e-01
|
2.94e-02
|
GO:0001578 microtubule bundle
formation
|
15
|
8.76e-04
|
4.96e-01
|
1.01e-02
|
GO:0007042 lysosomal lumen
acidification
|
10
|
6.70e-03
|
-4.95e-01
|
4.30e-02
|
GO:0016226 iron-sulfur cluster
assembly
|
17
|
4.10e-04
|
-4.95e-01
|
5.85e-03
|
GO:0007026 negative regulation of
microtubule depolymerization
|
17
|
4.13e-04
|
4.95e-01
|
5.85e-03
|
GO:0003777 microtubule motor
activity
|
23
|
4.24e-05
|
4.93e-01
|
1.01e-03
|
GO:0071816 tail-anchored membrane
protein insertion into ER membrane
|
10
|
6.94e-03
|
-4.93e-01
|
4.39e-02
|
GO:0003148 outflow tract septum
morphogenesis
|
12
|
3.16e-03
|
4.92e-01
|
2.59e-02
|
GO:1900181 negative regulation of
protein localization to nucleus
|
11
|
4.95e-03
|
4.89e-01
|
3.42e-02
|
GO:0051537 2 iron, 2 sulfur cluster
binding
|
17
|
5.44e-04
|
-4.84e-01
|
7.14e-03
|
GO:0004857 enzyme inhibitor
activity
|
12
|
3.70e-03
|
4.84e-01
|
2.89e-02
|
GO:0030331 nuclear estrogen
receptor binding
|
19
|
2.76e-04
|
4.82e-01
|
4.43e-03
|
GO:0006334 nucleosome assembly
|
27
|
1.51e-05
|
4.81e-01
|
4.73e-04
|
GO:0005763 mitochondrial small
ribosomal subunit
|
21
|
1.38e-04
|
-4.80e-01
|
2.70e-03
|
GO:0035278 miRNA-mediated gene
silencing by inhibition of translation
|
12
|
4.02e-03
|
4.80e-01
|
3.01e-02
|
GO:0042277 peptide binding
|
10
|
8.69e-03
|
4.79e-01
|
5.08e-02
|
GO:0000987 cis-regulatory region
sequence-specific DNA binding
|
21
|
1.47e-04
|
4.79e-01
|
2.78e-03
|
GO:0005484 SNAP receptor activity
|
26
|
2.43e-05
|
-4.78e-01
|
6.77e-04
|
GO:0015035 protein-disulfide
reductase activity
|
14
|
2.01e-03
|
-4.77e-01
|
1.92e-02
|
GO:0051881 regulation of
mitochondrial membrane potential
|
15
|
1.42e-03
|
-4.76e-01
|
1.48e-02
|
GO:0033962 P-body assembly
|
14
|
2.09e-03
|
4.75e-01
|
1.95e-02
|
GO:2000648 positive regulation of
stem cell proliferation
|
12
|
4.54e-03
|
4.73e-01
|
3.24e-02
|
GO:0034727 piecemeal microautophagy
of the nucleus
|
13
|
3.18e-03
|
-4.73e-01
|
2.59e-02
|
GO:0050905 neuromuscular process
|
10
|
9.78e-03
|
-4.72e-01
|
5.39e-02
|
GO:0032981 mitochondrial
respiratory chain complex I assembly
|
38
|
5.20e-07
|
-4.71e-01
|
2.77e-05
|
GO:0048041 focal adhesion assembly
|
14
|
2.33e-03
|
4.70e-01
|
2.07e-02
|
GO:0007097 nuclear migration
|
15
|
1.82e-03
|
4.65e-01
|
1.80e-02
|
GO:0070182 DNA polymerase binding
|
13
|
3.73e-03
|
4.65e-01
|
2.90e-02
|
GO:0008137 NADH dehydrogenase
(ubiquinone) activity
|
10
|
1.14e-02
|
-4.62e-01
|
6.07e-02
|
GO:0048010 vascular endothelial
growth factor receptor signaling pathway
|
13
|
3.97e-03
|
4.61e-01
|
3.01e-02
|
GO:0060045 positive regulation of
cardiac muscle cell proliferation
|
13
|
4.47e-03
|
4.55e-01
|
3.23e-02
|
GO:0006906 vesicle fusion
|
15
|
2.31e-03
|
-4.54e-01
|
2.06e-02
|
GO:0002040 sprouting angiogenesis
|
18
|
9.02e-04
|
4.52e-01
|
1.03e-02
|
GO:0060236 regulation of mitotic
spindle organization
|
12
|
6.76e-03
|
4.52e-01
|
4.31e-02
|
GO:0031201 SNARE complex
|
33
|
7.74e-06
|
-4.50e-01
|
2.84e-04
|
GO:0034314 Arp2/3 complex-mediated
actin nucleation
|
11
|
9.79e-03
|
-4.50e-01
|
5.39e-02
|
GO:1990247
N6-methyladenosine-containing RNA reader activity
|
10
|
1.39e-02
|
4.49e-01
|
7.02e-02
|
GO:2001222 regulation of neuron
migration
|
10
|
1.42e-02
|
4.48e-01
|
7.16e-02
|
GO:0005871 kinesin complex
|
22
|
2.82e-04
|
4.47e-01
|
4.43e-03
|
GO:0070059 intrinsic apoptotic
signaling pathway in response to endoplasmic reticulum stress
|
15
|
2.75e-03
|
4.47e-01
|
2.35e-02
|
GO:0061631 ubiquitin conjugating
enzyme activity
|
24
|
1.55e-04
|
-4.46e-01
|
2.86e-03
|
GO:0006346 DNA
methylation-dependent constitutive heterochromatin formation
|
10
|
1.52e-02
|
4.43e-01
|
7.53e-02
|
GO:0140416 transcription regulator
inhibitor activity
|
12
|
8.23e-03
|
4.41e-01
|
4.91e-02
|
GO:0009378 four-way junction
helicase activity
|
13
|
6.08e-03
|
4.40e-01
|
3.96e-02
|
GO:0033617 mitochondrial cytochrome
c oxidase assembly
|
13
|
7.24e-03
|
-4.30e-01
|
4.55e-02
|
GO:0140588 chromatin looping
|
27
|
1.11e-04
|
4.30e-01
|
2.24e-03
|
GO:0038061 non-canonical NF-kappaB
signal transduction
|
11
|
1.36e-02
|
4.30e-01
|
6.96e-02
|
GO:0002102 podosome
|
17
|
2.41e-03
|
4.25e-01
|
2.11e-02
|
GO:0051480 regulation of cytosolic
calcium ion concentration
|
13
|
8.10e-03
|
-4.24e-01
|
4.90e-02
|
GO:0140693 molecular condensate
scaffold activity
|
24
|
3.42e-04
|
4.22e-01
|
5.13e-03
|
GO:0051603 proteolysis involved in
protein catabolic process
|
23
|
4.55e-04
|
-4.22e-01
|
6.27e-03
|
GO:0016180 snRNA processing
|
10
|
2.17e-02
|
4.19e-01
|
9.47e-02
|
GO:0060349 bone morphogenesis
|
12
|
1.22e-02
|
4.18e-01
|
6.34e-02
|
GO:0097602 cullin family protein
binding
|
16
|
3.83e-03
|
-4.18e-01
|
2.94e-02
|
GO:0035329 hippo signaling
|
17
|
2.90e-03
|
4.17e-01
|
2.45e-02
|
GO:0045815 transcription
initiation-coupled chromatin remodeling
|
20
|
1.26e-03
|
4.17e-01
|
1.34e-02
|
GO:0010592 positive regulation of
lamellipodium assembly
|
10
|
2.27e-02
|
4.16e-01
|
9.82e-02
|
GO:0007492 endoderm development
|
10
|
2.27e-02
|
4.16e-01
|
9.82e-02
|
GO:0097718 disordered domain
specific binding
|
15
|
5.40e-03
|
4.15e-01
|
3.64e-02
|
GO:0001046 core promoter
sequence-specific DNA binding
|
11
|
1.73e-02
|
4.14e-01
|
8.18e-02
|
GO:0031929 TOR signaling
|
13
|
9.75e-03
|
-4.14e-01
|
5.39e-02
|
GO:0140584 chromatin extrusion
motor activity
|
23
|
5.95e-04
|
4.14e-01
|
7.47e-03
|
GO:0140665 ATP-dependent H3-H4
histone complex chaperone activity
|
23
|
5.95e-04
|
4.14e-01
|
7.47e-03
|
GO:0140849 ATP-dependent H2AZ
histone chaperone activity
|
23
|
5.95e-04
|
4.14e-01
|
7.47e-03
|
GO:0035613 RNA stem-loop binding
|
11
|
1.82e-02
|
4.11e-01
|
8.54e-02
|
GO:0005762 mitochondrial large
ribosomal subunit
|
38
|
1.28e-05
|
-4.09e-01
|
4.25e-04
|
GO:0030150 protein import into
mitochondrial matrix
|
12
|
1.45e-02
|
-4.08e-01
|
7.27e-02
|
GO:0061775 cohesin loader activity
|
24
|
5.48e-04
|
4.08e-01
|
7.14e-03
|
GO:0048873 homeostasis of number of
cells within a tissue
|
14
|
8.55e-03
|
4.06e-01
|
5.03e-02
|
GO:0002218 activation of innate
immune response
|
17
|
4.06e-03
|
4.03e-01
|
3.01e-02
|
GO:0052689 carboxylic ester
hydrolase activity
|
11
|
2.11e-02
|
-4.02e-01
|
9.34e-02
|
GO:1902894 negative regulation of
miRNA transcription
|
12
|
1.62e-02
|
4.01e-01
|
7.80e-02
|
GO:0006351 DNA-templated
transcription
|
36
|
3.14e-05
|
4.01e-01
|
8.00e-04
|
GO:0030992 intraciliary transport
particle B
|
15
|
7.32e-03
|
-4.00e-01
|
4.58e-02
|
GO:0046907 intracellular transport
|
14
|
9.66e-03
|
-4.00e-01
|
5.37e-02
|
GO:1903077 negative regulation of
protein localization to plasma membrane
|
14
|
9.83e-03
|
-3.99e-01
|
5.40e-02
|
GO:0031526 brush border membrane
|
12
|
1.72e-02
|
3.97e-01
|
8.15e-02
|
GO:0006488 dolichol-linked
oligosaccharide biosynthetic process
|
14
|
1.01e-02
|
-3.97e-01
|
5.52e-02
|
GO:0010976 positive regulation of
neuron projection development
|
28
|
2.81e-04
|
3.97e-01
|
4.43e-03
|
GO:0070403 NAD+ binding
|
11
|
2.28e-02
|
-3.97e-01
|
9.82e-02
|
GO:0061709 reticulophagy
|
15
|
7.85e-03
|
-3.96e-01
|
4.79e-02
|
GO:0016363 nuclear matrix
|
46
|
3.33e-06
|
3.96e-01
|
1.46e-04
|
GO:0031252 cell leading edge
|
19
|
2.88e-03
|
3.95e-01
|
2.45e-02
|
GO:0070530 K63-linked polyubiquitin
modification-dependent protein binding
|
17
|
4.89e-03
|
3.94e-01
|
3.41e-02
|
GO:0071168 protein localization to
chromatin
|
17
|
4.91e-03
|
3.94e-01
|
3.41e-02
|
GO:0120163 negative regulation of
cold-induced thermogenesis
|
22
|
1.39e-03
|
3.94e-01
|
1.47e-02
|
GO:0060379 cardiac muscle cell
myoblast differentiation
|
10
|
3.14e-02
|
3.93e-01
|
1.25e-01
|
GO:0051019 mitogen-activated
protein kinase binding
|
11
|
2.40e-02
|
3.93e-01
|
1.02e-01
|
GO:0070888 E-box binding
|
21
|
1.93e-03
|
3.91e-01
|
1.89e-02
|
GO:0031490 chromatin DNA binding
|
40
|
1.98e-05
|
3.90e-01
|
5.91e-04
|
GO:0005758 mitochondrial
intermembrane space
|
47
|
3.88e-06
|
-3.89e-01
|
1.66e-04
|
GO:0005828 kinetochore microtubule
|
10
|
3.30e-02
|
-3.89e-01
|
1.29e-01
|
GO:0030900 forebrain development
|
20
|
2.60e-03
|
3.89e-01
|
2.24e-02
|
GO:0007416 synapse assembly
|
24
|
9.74e-04
|
3.89e-01
|
1.08e-02
|
GO:0050808 synapse organization
|
17
|
5.55e-03
|
3.89e-01
|
3.72e-02
|
GO:0000422 autophagy of
mitochondrion
|
14
|
1.20e-02
|
-3.88e-01
|
6.25e-02
|
GO:0005782 peroxisomal matrix
|
10
|
3.44e-02
|
-3.86e-01
|
1.33e-01
|
GO:0003281 ventricular septum
development
|
15
|
9.61e-03
|
3.86e-01
|
5.37e-02
|
GO:0106222 lncRNA binding
|
17
|
6.08e-03
|
3.84e-01
|
3.96e-02
|
GO:0006913 nucleocytoplasmic
transport
|
18
|
4.89e-03
|
3.83e-01
|
3.41e-02
|
GO:0005743 mitochondrial inner
membrane
|
180
|
9.48e-19
|
-3.82e-01
|
2.78e-16
|
GO:0050661 NADP binding
|
15
|
1.08e-02
|
-3.80e-01
|
5.80e-02
|
GO:0045454 cell redox homeostasis
|
20
|
3.27e-03
|
-3.80e-01
|
2.63e-02
|
GO:0001708 cell fate specification
|
12
|
2.27e-02
|
3.80e-01
|
9.82e-02
|
GO:0006635 fatty acid
beta-oxidation
|
26
|
8.18e-04
|
-3.79e-01
|
9.65e-03
|
GO:0030513 positive regulation of
BMP signaling pathway
|
19
|
4.23e-03
|
3.79e-01
|
3.10e-02
|
GO:0032508 DNA duplex unwinding
|
44
|
1.44e-05
|
3.78e-01
|
4.59e-04
|
GO:0048278 vesicle docking
|
13
|
1.83e-02
|
-3.78e-01
|
8.54e-02
|
GO:0003724 RNA helicase activity
|
37
|
7.10e-05
|
3.78e-01
|
1.54e-03
|
GO:0016235 aggresome
|
16
|
9.17e-03
|
3.76e-01
|
5.27e-02
|
GO:0071222 cellular response to
lipopolysaccharide
|
46
|
1.07e-05
|
3.75e-01
|
3.84e-04
|
GO:0048015
phosphatidylinositol-mediated signaling
|
17
|
7.47e-03
|
3.75e-01
|
4.66e-02
|
GO:0046961 proton-transporting
ATPase activity, rotational mechanism
|
14
|
1.53e-02
|
-3.75e-01
|
7.53e-02
|
GO:0070498 interleukin-1-mediated
signaling pathway
|
11
|
3.22e-02
|
-3.73e-01
|
1.27e-01
|
GO:0002039 p53 binding
|
44
|
1.89e-05
|
3.73e-01
|
5.74e-04
|
GO:0005882 intermediate filament
|
20
|
4.13e-03
|
3.71e-01
|
3.05e-02
|
GO:0045292 mRNA cis splicing, via
spliceosome
|
13
|
2.09e-02
|
3.70e-01
|
9.31e-02
|
GO:0016514 SWI/SNF complex
|
20
|
4.20e-03
|
3.70e-01
|
3.09e-02
|
GO:0001570 vasculogenesis
|
26
|
1.14e-03
|
3.69e-01
|
1.23e-02
|
GO:0098869 cellular oxidant
detoxification
|
28
|
7.55e-04
|
-3.68e-01
|
9.09e-03
|
GO:0000281 mitotic cytokinesis
|
34
|
2.08e-04
|
3.68e-01
|
3.58e-03
|
GO:0048026 positive regulation of
mRNA splicing, via spliceosome
|
12
|
2.78e-02
|
3.67e-01
|
1.13e-01
|
GO:0043627 response to estrogen
|
10
|
4.46e-02
|
3.67e-01
|
1.59e-01
|
GO:0050772 positive regulation of
axonogenesis
|
12
|
2.82e-02
|
3.66e-01
|
1.14e-01
|
GO:0150052 regulation of
postsynapse assembly
|
12
|
2.91e-02
|
3.64e-01
|
1.17e-01
|
GO:0071889 14-3-3 protein binding
|
15
|
1.48e-02
|
3.64e-01
|
7.36e-02
|
GO:0022604 regulation of cell
morphogenesis
|
14
|
1.87e-02
|
3.63e-01
|
8.54e-02
|
GO:0006260 DNA replication
|
34
|
2.57e-04
|
3.62e-01
|
4.22e-03
|
GO:0001221 transcription
coregulator binding
|
16
|
1.21e-02
|
3.62e-01
|
6.33e-02
|
GO:0042393 histone binding
|
94
|
1.39e-09
|
3.62e-01
|
1.06e-07
|
GO:0004435 phosphatidylinositol
phospholipase C activity
|
11
|
3.80e-02
|
3.61e-01
|
1.43e-01
|
GO:0032206 positive regulation of
telomere maintenance
|
14
|
1.93e-02
|
3.61e-01
|
8.76e-02
|
GO:0002053 positive regulation of
mesenchymal cell proliferation
|
11
|
3.89e-02
|
3.60e-01
|
1.45e-01
|
GO:1900182 positive regulation of
protein localization to nucleus
|
25
|
1.95e-03
|
3.58e-01
|
1.90e-02
|
GO:0046966 nuclear thyroid hormone
receptor binding
|
15
|
1.67e-02
|
3.57e-01
|
8.03e-02
|
GO:0051290 protein
heterotetramerization
|
10
|
5.09e-02
|
3.57e-01
|
1.76e-01
|
GO:0071108 protein K48-linked
deubiquitination
|
15
|
1.70e-02
|
3.56e-01
|
8.12e-02
|
GO:0006695 cholesterol biosynthetic
process
|
16
|
1.37e-02
|
3.56e-01
|
7.00e-02
|
GO:0045943 positive regulation of
transcription by RNA polymerase I
|
11
|
4.12e-02
|
3.56e-01
|
1.51e-01
|
GO:0008320 protein transmembrane
transporter activity
|
11
|
4.17e-02
|
-3.55e-01
|
1.51e-01
|
GO:0004386 helicase activity
|
40
|
1.20e-04
|
3.52e-01
|
2.36e-03
|
GO:0003682 chromatin binding
|
237
|
1.43e-20
|
3.51e-01
|
6.09e-18
|
GO:0007095 mitotic G2 DNA damage
checkpoint signaling
|
30
|
8.82e-04
|
3.51e-01
|
1.01e-02
|
GO:0048812 neuron projection
morphogenesis
|
29
|
1.08e-03
|
3.51e-01
|
1.19e-02
|
GO:0000381 regulation of
alternative mRNA splicing, via spliceosome
|
31
|
7.33e-04
|
3.51e-01
|
8.95e-03
|
GO:0051393 alpha-actinin binding
|
10
|
5.55e-02
|
3.50e-01
|
1.84e-01
|
GO:0009888 tissue development
|
18
|
1.03e-02
|
3.49e-01
|
5.61e-02
|
GO:0000045 autophagosome assembly
|
52
|
1.35e-05
|
-3.49e-01
|
4.40e-04
|
GO:0005518 collagen binding
|
35
|
3.61e-04
|
-3.49e-01
|
5.38e-03
|
GO:0030020 extracellular matrix
structural constituent conferring tensile strength
|
16
|
1.59e-02
|
-3.48e-01
|
7.75e-02
|
GO:0031507 heterochromatin
formation
|
27
|
1.74e-03
|
3.48e-01
|
1.75e-02
|
GO:0035979 histone H2AXS139 kinase
activity
|
32
|
7.22e-04
|
3.45e-01
|
8.87e-03
|
GO:0051028 mRNA transport
|
27
|
1.92e-03
|
3.45e-01
|
1.89e-02
|
GO:0003689 DNA clamp loader
activity
|
32
|
7.43e-04
|
3.45e-01
|
9.01e-03
|
GO:0061484 hematopoietic stem cell
homeostasis
|
12
|
3.89e-02
|
3.44e-01
|
1.45e-01
|
GO:0006396 RNA processing
|
21
|
6.35e-03
|
3.44e-01
|
4.12e-02
|
GO:1990841 promoter-specific
chromatin binding
|
34
|
5.19e-04
|
3.44e-01
|
6.87e-03
|
GO:0043409 negative regulation of
MAPK cascade
|
20
|
7.76e-03
|
3.44e-01
|
4.77e-02
|
GO:0071013 catalytic step 2
spliceosome
|
52
|
1.81e-05
|
3.44e-01
|
5.58e-04
|
GO:0005721 pericentric
heterochromatin
|
18
|
1.17e-02
|
3.43e-01
|
6.17e-02
|
GO:0042100 B cell proliferation
|
14
|
2.63e-02
|
3.43e-01
|
1.09e-01
|
GO:0032720 negative regulation of
tumor necrosis factor production
|
18
|
1.18e-02
|
3.43e-01
|
6.20e-02
|
GO:0045669 positive regulation of
osteoblast differentiation
|
37
|
3.11e-04
|
3.43e-01
|
4.76e-03
|
GO:0004602 glutathione peroxidase
activity
|
12
|
4.01e-02
|
-3.42e-01
|
1.48e-01
|
GO:0000794 condensed nuclear
chromosome
|
20
|
8.18e-03
|
3.42e-01
|
4.91e-02
|
GO:0019843 rRNA binding
|
22
|
5.64e-03
|
-3.41e-01
|
3.76e-02
|
GO:0032467 positive regulation of
cytokinesis
|
14
|
2.76e-02
|
3.40e-01
|
1.13e-01
|
GO:0008033 tRNA processing
|
15
|
2.26e-02
|
-3.40e-01
|
9.82e-02
|
GO:0070085 glycosylation
|
14
|
2.77e-02
|
-3.40e-01
|
1.13e-01
|
GO:0001618 virus receptor activity
|
10
|
6.29e-02
|
3.40e-01
|
2.02e-01
|
GO:0072518 Rho-dependent protein
serine/threonine kinase activity
|
32
|
9.04e-04
|
3.39e-01
|
1.03e-02
|
GO:1990244 histone H2AT120 kinase
activity
|
31
|
1.14e-03
|
3.38e-01
|
1.23e-02
|
GO:0097431 mitotic spindle pole
|
27
|
2.41e-03
|
3.38e-01
|
2.11e-02
|
GO:0021987 cerebral cortex
development
|
24
|
4.27e-03
|
3.37e-01
|
3.11e-02
|
GO:0004676
3-phosphoinositide-dependent protein kinase activity
|
31
|
1.20e-03
|
3.36e-01
|
1.29e-02
|
GO:0031491 nucleosome binding
|
25
|
3.65e-03
|
3.36e-01
|
2.86e-02
|
GO:0002230 positive regulation of
defense response to virus by host
|
11
|
5.45e-02
|
3.35e-01
|
1.83e-01
|
GO:0003725 double-stranded RNA
binding
|
43
|
1.49e-04
|
3.34e-01
|
2.79e-03
|
GO:0045666 positive regulation of
neuron differentiation
|
26
|
3.20e-03
|
3.34e-01
|
2.59e-02
|
GO:0050839 cell adhesion molecule
binding
|
21
|
8.18e-03
|
3.33e-01
|
4.91e-02
|
GO:0042813 Wnt receptor activity
|
12
|
4.56e-02
|
3.33e-01
|
1.61e-01
|
GO:0007017 microtubule-based
process
|
11
|
5.60e-02
|
-3.33e-01
|
1.85e-01
|
GO:0017053 transcription repressor
complex
|
34
|
8.25e-04
|
3.31e-01
|
9.66e-03
|
GO:0007018 microtubule-based
movement
|
40
|
3.07e-04
|
3.30e-01
|
4.73e-03
|
GO:1905564 positive regulation of
vascular endothelial cell proliferation
|
10
|
7.26e-02
|
3.28e-01
|
2.24e-01
|
GO:0006641 triglyceride metabolic
process
|
10
|
7.31e-02
|
-3.27e-01
|
2.24e-01
|
GO:0005667 transcription regulator
complex
|
90
|
8.40e-08
|
3.27e-01
|
5.28e-06
|
GO:0060038 cardiac muscle cell
proliferation
|
12
|
5.00e-02
|
3.27e-01
|
1.75e-01
|
GO:0008139 nuclear localization
sequence binding
|
13
|
4.14e-02
|
3.27e-01
|
1.51e-01
|
GO:0007259 cell surface receptor
signaling pathway via JAK-STAT
|
21
|
9.59e-03
|
3.27e-01
|
5.37e-02
|
GO:0008094 ATP-dependent activity,
acting on DNA
|
11
|
6.09e-02
|
3.26e-01
|
1.97e-01
|
GO:0004677 DNA-dependent protein
kinase activity
|
31
|
1.67e-03
|
3.26e-01
|
1.72e-02
|
GO:0010718 positive regulation of
epithelial to mesenchymal transition
|
26
|
4.04e-03
|
3.26e-01
|
3.01e-02
|
GO:0035175 histone H3S10 kinase
activity
|
31
|
1.71e-03
|
3.26e-01
|
1.73e-02
|
GO:0072354 histone H3T3 kinase
activity
|
31
|
1.71e-03
|
3.26e-01
|
1.73e-02
|
GO:0030133 transport vesicle
|
23
|
6.94e-03
|
-3.25e-01
|
4.39e-02
|
GO:0005771 multivesicular body
|
21
|
1.02e-02
|
-3.24e-01
|
5.58e-02
|
GO:0051896 regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
12
|
5.22e-02
|
3.24e-01
|
1.79e-01
|
GO:0035402 histone H3T11 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0044022 histone H3S28 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0044023 histone H4S1 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0044024 histone H2AS1 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0044025 histone H2BS14 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0072371 histone H2AS121 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0140855 histone H3S57 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0140857 histone H3T45 kinase
activity
|
30
|
2.18e-03
|
3.23e-01
|
1.95e-02
|
GO:0098686 hippocampal mossy fiber
to CA3 synapse
|
18
|
1.76e-02
|
-3.23e-01
|
8.29e-02
|
GO:0000184 nuclear-transcribed mRNA
catabolic process, nonsense-mediated decay
|
21
|
1.04e-02
|
3.23e-01
|
5.62e-02
|
GO:0050767 regulation of
neurogenesis
|
14
|
3.69e-02
|
3.22e-01
|
1.40e-01
|
GO:0030276 clathrin binding
|
17
|
2.15e-02
|
3.22e-01
|
9.44e-02
|
GO:0003713 transcription
coactivator activity
|
127
|
3.87e-10
|
3.22e-01
|
3.09e-08
|
GO:0005044 scavenger receptor
activity
|
10
|
7.83e-02
|
-3.22e-01
|
2.34e-01
|
GO:0031902 late endosome membrane
|
67
|
5.56e-06
|
-3.21e-01
|
2.22e-04
|
GO:0006879 intracellular iron ion
homeostasis
|
31
|
1.99e-03
|
-3.21e-01
|
1.91e-02
|
GO:0030057 desmosome
|
12
|
5.48e-02
|
3.20e-01
|
1.83e-01
|
GO:0010494 cytoplasmic stress
granule
|
58
|
2.59e-05
|
3.20e-01
|
7.11e-04
|
GO:0009792 embryo development
ending in birth or egg hatching
|
10
|
8.08e-02
|
3.19e-01
|
2.36e-01
|
GO:0000792 heterochromatin
|
19
|
1.70e-02
|
3.16e-01
|
8.12e-02
|
GO:2000042 negative regulation of
double-strand break repair via homologous recombination
|
16
|
2.85e-02
|
3.16e-01
|
1.16e-01
|
GO:0030330 DNA damage response,
signal transduction by p53 class mediator
|
12
|
5.80e-02
|
3.16e-01
|
1.90e-01
|
GO:0050829 defense response to
Gram-negative bacterium
|
12
|
5.82e-02
|
3.16e-01
|
1.90e-01
|
GO:0006406 mRNA export from nucleus
|
28
|
3.83e-03
|
3.16e-01
|
2.94e-02
|
GO:0034237 protein kinase A
regulatory subunit binding
|
14
|
4.09e-02
|
3.16e-01
|
1.50e-01
|
GO:0030855 epithelial cell
differentiation
|
29
|
3.32e-03
|
-3.15e-01
|
2.65e-02
|
GO:0030866 cortical actin
cytoskeleton organization
|
20
|
1.47e-02
|
3.15e-01
|
7.36e-02
|
GO:0043536 positive regulation of
blood vessel endothelial cell migration
|
18
|
2.08e-02
|
3.15e-01
|
9.26e-02
|
GO:0030216 keratinocyte
differentiation
|
28
|
3.97e-03
|
3.15e-01
|
3.01e-02
|
GO:0051560 mitochondrial calcium
ion homeostasis
|
13
|
5.02e-02
|
-3.14e-01
|
1.75e-01
|
GO:0003714 transcription
corepressor activity
|
101
|
5.46e-08
|
3.13e-01
|
3.59e-06
|
GO:0097038 perinuclear endoplasmic
reticulum
|
10
|
8.65e-02
|
-3.13e-01
|
2.46e-01
|
GO:0019827 stem cell population
maintenance
|
21
|
1.31e-02
|
3.13e-01
|
6.70e-02
|
GO:1902600 proton transmembrane
transport
|
59
|
3.47e-05
|
-3.12e-01
|
8.59e-04
|
GO:0045773 positive regulation of
axon extension
|
10
|
8.84e-02
|
3.11e-01
|
2.50e-01
|
GO:0006979 response to oxidative
stress
|
50
|
1.44e-04
|
-3.11e-01
|
2.76e-03
|
GO:0046488 phosphatidylinositol
metabolic process
|
12
|
6.29e-02
|
3.10e-01
|
2.02e-01
|
GO:0000956 nuclear-transcribed mRNA
catabolic process
|
12
|
6.34e-02
|
3.10e-01
|
2.03e-01
|
GO:0050673 epithelial cell
proliferation
|
19
|
1.97e-02
|
3.09e-01
|
8.92e-02
|
GO:0000791 euchromatin
|
29
|
4.00e-03
|
3.09e-01
|
3.01e-02
|
GO:0008625 extrinsic apoptotic
signaling pathway via death domain receptors
|
18
|
2.35e-02
|
3.08e-01
|
1.00e-01
|
GO:0050850 positive regulation of
calcium-mediated signaling
|
10
|
9.18e-02
|
3.08e-01
|
2.58e-01
|
GO:0007010 cytoskeleton
organization
|
50
|
1.75e-04
|
3.07e-01
|
3.11e-03
|
GO:0000786 nucleosome
|
16
|
3.36e-02
|
3.07e-01
|
1.31e-01
|
GO:0007417 central nervous system
development
|
40
|
8.11e-04
|
3.06e-01
|
9.63e-03
|
GO:0032543 mitochondrial
translation
|
22
|
1.30e-02
|
-3.06e-01
|
6.69e-02
|
GO:0140823 histone H2BS36 kinase
activity
|
31
|
3.27e-03
|
3.05e-01
|
2.63e-02
|
GO:0008089 anterograde axonal
transport
|
10
|
9.54e-02
|
-3.05e-01
|
2.64e-01
|
GO:0043995 histone H4K5
acetyltransferase activity
|
10
|
9.57e-02
|
3.04e-01
|
2.64e-01
|
GO:0043996 histone H4K8
acetyltransferase activity
|
10
|
9.57e-02
|
3.04e-01
|
2.64e-01
|
GO:1904115 axon cytoplasm
|
25
|
8.60e-03
|
-3.04e-01
|
5.04e-02
|
GO:0051056 regulation of small
GTPase mediated signal transduction
|
16
|
3.55e-02
|
3.04e-01
|
1.36e-01
|
GO:0022626 cytosolic ribosome
|
13
|
5.81e-02
|
3.04e-01
|
1.90e-01
|
GO:0034497 protein localization to
phagophore assembly site
|
11
|
8.15e-02
|
-3.03e-01
|
2.37e-01
|
GO:0031669 cellular response to
nutrient levels
|
12
|
6.92e-02
|
3.03e-01
|
2.16e-01
|
GO:1903076 regulation of protein
localization to plasma membrane
|
18
|
2.65e-02
|
-3.02e-01
|
1.10e-01
|
GO:0034142 toll-like receptor 4
signaling pathway
|
15
|
4.28e-02
|
-3.02e-01
|
1.54e-01
|
GO:0035615 clathrin adaptor
activity
|
10
|
9.91e-02
|
-3.01e-01
|
2.69e-01
|
GO:0004694 eukaryotic translation
initiation factor 2alpha kinase activity
|
34
|
2.38e-03
|
3.01e-01
|
2.10e-02
|
GO:0060047 heart contraction
|
10
|
1.00e-01
|
-3.00e-01
|
2.72e-01
|
GO:0072593 reactive oxygen species
metabolic process
|
15
|
4.43e-02
|
-3.00e-01
|
1.58e-01
|
GO:0097352 autophagosome maturation
|
23
|
1.29e-02
|
-3.00e-01
|
6.65e-02
|
GO:0001671 ATPase activator
activity
|
18
|
2.78e-02
|
-3.00e-01
|
1.13e-01
|
GO:0016446 somatic hypermutation of
immunoglobulin genes
|
10
|
1.01e-01
|
2.99e-01
|
2.73e-01
|
GO:0009954 proximal/distal pattern
formation
|
14
|
5.30e-02
|
2.99e-01
|
1.80e-01
|
GO:0022904 respiratory electron
transport chain
|
14
|
5.30e-02
|
-2.99e-01
|
1.80e-01
|
GO:0035116 embryonic hindlimb
morphogenesis
|
11
|
8.63e-02
|
2.99e-01
|
2.46e-01
|
GO:0071005 U2-type precatalytic
spliceosome
|
31
|
4.04e-03
|
2.98e-01
|
3.01e-02
|
GO:0042407 cristae formation
|
11
|
8.68e-02
|
-2.98e-01
|
2.47e-01
|
GO:0035064 methylated histone
binding
|
42
|
8.30e-04
|
2.98e-01
|
9.66e-03
|
GO:0045494 photoreceptor cell
maintenance
|
24
|
1.15e-02
|
-2.98e-01
|
6.08e-02
|
GO:0043923 positive regulation by
host of viral transcription
|
12
|
7.43e-02
|
2.98e-01
|
2.27e-01
|
GO:0008143 poly(A) binding
|
13
|
6.33e-02
|
2.97e-01
|
2.03e-01
|
GO:0042127 regulation of cell
population proliferation
|
46
|
4.95e-04
|
2.97e-01
|
6.70e-03
|
GO:0001837 epithelial to
mesenchymal transition
|
17
|
3.46e-02
|
2.96e-01
|
1.33e-01
|
GO:0036092
phosphatidylinositol-3-phosphate biosynthetic process
|
14
|
5.52e-02
|
2.96e-01
|
1.84e-01
|
GO:0005125 cytokine activity
|
28
|
6.74e-03
|
2.96e-01
|
4.31e-02
|
GO:0005544 calcium-dependent
phospholipid binding
|
21
|
1.92e-02
|
-2.95e-01
|
8.74e-02
|
GO:0034614 cellular response to
reactive oxygen species
|
16
|
4.13e-02
|
-2.95e-01
|
1.51e-01
|
GO:0000785 chromatin
|
243
|
3.39e-15
|
2.94e-01
|
4.97e-13
|
GO:0035019 somatic stem cell
population maintenance
|
31
|
4.70e-03
|
2.93e-01
|
3.32e-02
|
GO:0000463 maturation of LSU-rRNA
from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
12
|
7.87e-02
|
-2.93e-01
|
2.35e-01
|
GO:0032757 positive regulation of
interleukin-8 production
|
17
|
3.64e-02
|
-2.93e-01
|
1.39e-01
|
GO:0001917 photoreceptor inner
segment
|
23
|
1.54e-02
|
-2.92e-01
|
7.54e-02
|
GO:0034045 phagophore assembly site
membrane
|
12
|
8.00e-02
|
-2.92e-01
|
2.35e-01
|
GO:0005777 peroxisome
|
49
|
4.18e-04
|
-2.91e-01
|
5.88e-03
|
GO:0032039 integrator complex
|
15
|
5.08e-02
|
2.91e-01
|
1.76e-01
|
GO:0030182 neuron differentiation
|
56
|
1.64e-04
|
2.91e-01
|
2.97e-03
|
GO:0048538 thymus development
|
22
|
1.81e-02
|
2.91e-01
|
8.53e-02
|
GO:0000118 histone deacetylase
complex
|
22
|
1.85e-02
|
2.90e-01
|
8.54e-02
|
GO:0042073 intraciliary transport
|
16
|
4.46e-02
|
-2.90e-01
|
1.59e-01
|
GO:0045765 regulation of
angiogenesis
|
10
|
1.13e-01
|
2.90e-01
|
2.89e-01
|
GO:1905168 positive regulation of
double-strand break repair via homologous recombination
|
25
|
1.23e-02
|
2.89e-01
|
6.38e-02
|
GO:0042789 mRNA transcription by
RNA polymerase II
|
27
|
9.41e-03
|
2.89e-01
|
5.34e-02
|
GO:0001673 male germ cell nucleus
|
27
|
9.47e-03
|
2.89e-01
|
5.35e-02
|
GO:0031124 mRNA 3’-end processing
|
13
|
7.17e-02
|
2.89e-01
|
2.22e-01
|
GO:0042981 regulation of apoptotic
process
|
54
|
2.51e-04
|
2.88e-01
|
4.16e-03
|
GO:0140374 antiviral innate immune
response
|
19
|
2.99e-02
|
-2.88e-01
|
1.20e-01
|
GO:0043531 ADP binding
|
20
|
2.61e-02
|
2.87e-01
|
1.09e-01
|
GO:0001657 ureteric bud development
|
13
|
7.32e-02
|
2.87e-01
|
2.24e-01
|
GO:0035403 histone H3T6 kinase
activity
|
32
|
5.07e-03
|
2.86e-01
|
3.47e-02
|
GO:0004402 histone
acetyltransferase activity
|
11
|
1.00e-01
|
2.86e-01
|
2.72e-01
|
GO:0008593 regulation of Notch
signaling pathway
|
10
|
1.18e-01
|
-2.86e-01
|
2.97e-01
|
GO:0031210 phosphatidylcholine
binding
|
18
|
3.64e-02
|
-2.85e-01
|
1.39e-01
|
GO:0031624 ubiquitin conjugating
enzyme binding
|
17
|
4.20e-02
|
-2.85e-01
|
1.52e-01
|
GO:0007004 telomere maintenance via
telomerase
|
11
|
1.02e-01
|
2.85e-01
|
2.74e-01
|
GO:0000242 pericentriolar material
|
14
|
6.58e-02
|
2.84e-01
|
2.09e-01
|
GO:0140662 ATP-dependent protein
folding chaperone
|
23
|
1.85e-02
|
2.84e-01
|
8.54e-02
|
GO:0003712 transcription
coregulator activity
|
75
|
2.28e-05
|
2.83e-01
|
6.57e-04
|
GO:0046849 bone remodeling
|
10
|
1.22e-01
|
2.83e-01
|
3.03e-01
|
GO:0001569 branching involved in
blood vessel morphogenesis
|
15
|
5.83e-02
|
2.82e-01
|
1.90e-01
|
GO:0006744 ubiquinone biosynthetic
process
|
11
|
1.05e-01
|
-2.82e-01
|
2.77e-01
|
GO:0004711 ribosomal protein S6
kinase activity
|
32
|
5.72e-03
|
2.82e-01
|
3.79e-02
|
GO:0032391 photoreceptor connecting
cilium
|
18
|
3.89e-02
|
-2.81e-01
|
1.45e-01
|
GO:0032993 protein-DNA complex
|
21
|
2.57e-02
|
2.81e-01
|
1.08e-01
|
GO:0005852 eukaryotic translation
initiation factor 3 complex
|
10
|
1.24e-01
|
-2.81e-01
|
3.07e-01
|
GO:0001894 tissue homeostasis
|
13
|
7.96e-02
|
2.81e-01
|
2.35e-01
|
GO:0043488 regulation of mRNA
stability
|
16
|
5.18e-02
|
2.81e-01
|
1.78e-01
|
GO:0022857 transmembrane
transporter activity
|
37
|
3.14e-03
|
-2.81e-01
|
2.59e-02
|
GO:0000070 mitotic sister chromatid
segregation
|
18
|
3.94e-02
|
2.80e-01
|
1.46e-01
|
GO:0097546 ciliary base
|
17
|
4.53e-02
|
-2.80e-01
|
1.61e-01
|
GO:0004679 AMP-activated protein
kinase activity
|
32
|
6.06e-03
|
2.80e-01
|
3.96e-02
|
GO:0042060 wound healing
|
29
|
8.98e-03
|
2.80e-01
|
5.21e-02
|
GO:0042273 ribosomal large subunit
biogenesis
|
22
|
2.28e-02
|
-2.80e-01
|
9.82e-02
|
GO:0044458 motile cilium assembly
|
12
|
9.30e-02
|
-2.80e-01
|
2.60e-01
|
GO:0006891 intra-Golgi
vesicle-mediated transport
|
19
|
3.53e-02
|
-2.79e-01
|
1.35e-01
|
GO:0014704 intercalated disc
|
14
|
7.13e-02
|
2.78e-01
|
2.21e-01
|
GO:0030286 dynein complex
|
10
|
1.28e-01
|
-2.78e-01
|
3.10e-01
|
GO:0050660 flavin adenine
dinucleotide binding
|
33
|
5.84e-03
|
-2.77e-01
|
3.86e-02
|
GO:0045214 sarcomere organization
|
11
|
1.12e-01
|
-2.77e-01
|
2.89e-01
|
GO:0035198 miRNA binding
|
20
|
3.22e-02
|
2.77e-01
|
1.27e-01
|
GO:0006865 amino acid transport
|
11
|
1.13e-01
|
2.76e-01
|
2.89e-01
|
GO:0043997 histone H4K12
acetyltransferase activity
|
10
|
1.31e-01
|
2.76e-01
|
3.16e-01
|
GO:0015297 antiporter activity
|
18
|
4.28e-02
|
-2.76e-01
|
1.54e-01
|
GO:0070161 anchoring junction
|
16
|
5.69e-02
|
2.75e-01
|
1.88e-01
|
GO:0003700 DNA-binding
transcription factor activity
|
78
|
2.74e-05
|
2.75e-01
|
7.41e-04
|
GO:0031116 positive regulation of
microtubule polymerization
|
11
|
1.15e-01
|
2.74e-01
|
2.92e-01
|
GO:0005815 microtubule organizing
center
|
36
|
4.51e-03
|
2.74e-01
|
3.24e-02
|
GO:0032266
phosphatidylinositol-3-phosphate binding
|
32
|
7.53e-03
|
-2.73e-01
|
4.68e-02
|
GO:0000932 P-body
|
60
|
2.79e-04
|
2.71e-01
|
4.43e-03
|
GO:0061025 membrane fusion
|
21
|
3.14e-02
|
-2.71e-01
|
1.25e-01
|
GO:0000976 transcription
cis-regulatory region binding
|
54
|
5.68e-04
|
2.71e-01
|
7.34e-03
|
GO:1902895 positive regulation of
miRNA transcription
|
24
|
2.16e-02
|
2.71e-01
|
9.44e-02
|
GO:0051302 regulation of cell
division
|
11
|
1.20e-01
|
2.71e-01
|
3.00e-01
|
GO:0051018 protein kinase A binding
|
12
|
1.05e-01
|
2.71e-01
|
2.77e-01
|
GO:0009749 response to glucose
|
14
|
7.97e-02
|
2.71e-01
|
2.35e-01
|
GO:0051209 release of sequestered
calcium ion into cytosol
|
19
|
4.16e-02
|
2.70e-01
|
1.51e-01
|
GO:0042169 SH2 domain binding
|
20
|
3.69e-02
|
2.70e-01
|
1.40e-01
|
GO:0042826 histone deacetylase
binding
|
66
|
1.57e-04
|
2.69e-01
|
2.88e-03
|
GO:0050770 regulation of
axonogenesis
|
13
|
9.31e-02
|
2.69e-01
|
2.60e-01
|
GO:0001889 liver development
|
30
|
1.09e-02
|
2.69e-01
|
5.80e-02
|
GO:0071526 semaphorin-plexin
signaling pathway
|
22
|
2.97e-02
|
2.68e-01
|
1.19e-01
|
GO:0005977 glycogen metabolic
process
|
14
|
8.29e-02
|
-2.68e-01
|
2.40e-01
|
GO:0031647 regulation of protein
stability
|
57
|
5.00e-04
|
2.67e-01
|
6.70e-03
|
GO:0042307 positive regulation of
protein import into nucleus
|
25
|
2.11e-02
|
2.66e-01
|
9.34e-02
|
GO:0045665 negative regulation of
neuron differentiation
|
24
|
2.40e-02
|
2.66e-01
|
1.02e-01
|
GO:0000981 DNA-binding
transcription factor activity, RNA polymerase II-specific
|
345
|
2.43e-17
|
2.66e-01
|
5.33e-15
|
GO:0090303 positive regulation of
wound healing
|
11
|
1.28e-01
|
-2.65e-01
|
3.10e-01
|
GO:0005978 glycogen biosynthetic
process
|
11
|
1.29e-01
|
-2.65e-01
|
3.11e-01
|
GO:0006631 fatty acid metabolic
process
|
34
|
7.61e-03
|
-2.65e-01
|
4.70e-02
|
GO:0015485 cholesterol binding
|
29
|
1.38e-02
|
-2.64e-01
|
7.02e-02
|
GO:1903543 positive regulation of
exosomal secretion
|
10
|
1.50e-01
|
-2.63e-01
|
3.48e-01
|
GO:0072332 intrinsic apoptotic
signaling pathway by p53 class mediator
|
11
|
1.32e-01
|
2.63e-01
|
3.17e-01
|
GO:0098761 cellular response to
interleukin-7
|
10
|
1.50e-01
|
2.63e-01
|
3.49e-01
|
GO:0006974 DNA damage response
|
120
|
7.02e-07
|
2.62e-01
|
3.52e-05
|
GO:0060412 ventricular septum
morphogenesis
|
18
|
5.40e-02
|
2.62e-01
|
1.82e-01
|
GO:0030134 COPII-coated ER to Golgi
transport vesicle
|
21
|
3.77e-02
|
-2.62e-01
|
1.42e-01
|
GO:0032922 circadian regulation of
gene expression
|
34
|
8.24e-03
|
2.62e-01
|
4.91e-02
|
GO:0006890 retrograde
vesicle-mediated transport, Golgi to endoplasmic reticulum
|
32
|
1.04e-02
|
-2.62e-01
|
5.62e-02
|
GO:0043138 3’-5’ DNA helicase
activity
|
10
|
1.53e-01
|
2.61e-01
|
3.50e-01
|
GO:0010575 positive regulation of
vascular endothelial growth factor production
|
13
|
1.04e-01
|
2.61e-01
|
2.76e-01
|
GO:0043024 ribosomal small subunit
binding
|
13
|
1.04e-01
|
2.61e-01
|
2.76e-01
|
GO:0000460 maturation of 5.8S rRNA
|
11
|
1.35e-01
|
-2.61e-01
|
3.22e-01
|
GO:0033290 eukaryotic 48S
preinitiation complex
|
13
|
1.04e-01
|
-2.61e-01
|
2.76e-01
|
GO:0015459 potassium channel
regulator activity
|
12
|
1.18e-01
|
-2.60e-01
|
2.97e-01
|
GO:0005912 adherens junction
|
69
|
1.86e-04
|
2.60e-01
|
3.27e-03
|
GO:0051491 positive regulation of
filopodium assembly
|
14
|
9.22e-02
|
2.60e-01
|
2.59e-01
|
GO:0006888 endoplasmic reticulum to
Golgi vesicle-mediated transport
|
67
|
2.36e-04
|
-2.60e-01
|
3.95e-03
|
GO:0038066 p38MAPK cascade
|
12
|
1.19e-01
|
2.60e-01
|
2.99e-01
|
GO:0006338 chromatin remodeling
|
249
|
1.87e-12
|
2.60e-01
|
2.19e-10
|
GO:0019003 GDP binding
|
44
|
2.91e-03
|
-2.60e-01
|
2.45e-02
|
GO:0005764 lysosome
|
132
|
2.71e-07
|
-2.60e-01
|
1.54e-05
|
GO:0045165 cell fate commitment
|
21
|
3.98e-02
|
2.59e-01
|
1.47e-01
|
GO:0000407 phagophore assembly site
|
20
|
4.49e-02
|
-2.59e-01
|
1.60e-01
|
GO:0016607 nuclear speck
|
240
|
5.68e-12
|
2.59e-01
|
5.88e-10
|
GO:0061952 midbody abscission
|
14
|
9.49e-02
|
-2.58e-01
|
2.63e-01
|
GO:0031663
lipopolysaccharide-mediated signaling pathway
|
11
|
1.39e-01
|
-2.58e-01
|
3.30e-01
|
GO:0015914 phospholipid transport
|
26
|
2.31e-02
|
-2.57e-01
|
9.89e-02
|
GO:0071560 cellular response to
transforming growth factor beta stimulus
|
16
|
7.49e-02
|
2.57e-01
|
2.28e-01
|
GO:0000421 autophagosome membrane
|
23
|
3.32e-02
|
-2.57e-01
|
1.29e-01
|
GO:0045599 negative regulation of
fat cell differentiation
|
21
|
4.20e-02
|
2.56e-01
|
1.52e-01
|
GO:0030177 positive regulation of
Wnt signaling pathway
|
17
|
6.75e-02
|
2.56e-01
|
2.12e-01
|
GO:0005540 hyaluronic acid binding
|
14
|
9.72e-02
|
2.56e-01
|
2.67e-01
|
GO:0045595 regulation of cell
differentiation
|
13
|
1.10e-01
|
2.56e-01
|
2.88e-01
|
GO:0000978 RNA polymerase II
cis-regulatory region sequence-specific DNA binding
|
391
|
5.24e-18
|
2.56e-01
|
1.32e-15
|
GO:0007156 homophilic cell adhesion
via plasma membrane adhesion molecules
|
36
|
7.98e-03
|
2.56e-01
|
4.84e-02
|
GO:0035023 regulation of Rho
protein signal transduction
|
16
|
7.73e-02
|
2.55e-01
|
2.32e-01
|
GO:0030514 negative regulation of
BMP signaling pathway
|
26
|
2.44e-02
|
2.55e-01
|
1.03e-01
|
GO:0010824 regulation of centrosome
duplication
|
15
|
8.78e-02
|
-2.55e-01
|
2.49e-01
|
GO:0030426 growth cone
|
41
|
4.86e-03
|
2.54e-01
|
3.41e-02
|
GO:0003824 catalytic activity
|
10
|
1.65e-01
|
-2.53e-01
|
3.66e-01
|
GO:0008584 male gonad development
|
28
|
2.04e-02
|
2.53e-01
|
9.14e-02
|
GO:0004693 cyclin-dependent protein
serine/threonine kinase activity
|
10
|
1.66e-01
|
2.53e-01
|
3.66e-01
|
GO:0042162 telomeric DNA binding
|
20
|
5.04e-02
|
2.53e-01
|
1.75e-01
|
GO:0050768 negative regulation of
neurogenesis
|
10
|
1.67e-01
|
2.52e-01
|
3.69e-01
|
GO:0010719 negative regulation of
epithelial to mesenchymal transition
|
16
|
8.14e-02
|
2.52e-01
|
2.37e-01
|
GO:0006099 tricarboxylic acid cycle
|
19
|
5.80e-02
|
-2.51e-01
|
1.90e-01
|
GO:0008327 methyl-CpG binding
|
16
|
8.21e-02
|
2.51e-01
|
2.39e-01
|
GO:0051233 spindle midzone
|
17
|
7.36e-02
|
2.51e-01
|
2.25e-01
|
GO:0072089 stem cell proliferation
|
21
|
4.70e-02
|
2.50e-01
|
1.65e-01
|
GO:0072686 mitotic spindle
|
70
|
2.94e-04
|
2.50e-01
|
4.58e-03
|
GO:0001756 somitogenesis
|
24
|
3.40e-02
|
2.50e-01
|
1.32e-01
|
GO:0030863 cortical cytoskeleton
|
10
|
1.72e-01
|
-2.50e-01
|
3.76e-01
|
GO:0001732 formation of cytoplasmic
translation initiation complex
|
12
|
1.34e-01
|
-2.50e-01
|
3.22e-01
|
GO:0006487 protein N-linked
glycosylation
|
29
|
2.14e-02
|
-2.47e-01
|
9.40e-02
|
GO:0032728 positive regulation of
interferon-beta production
|
15
|
9.88e-02
|
2.46e-01
|
2.69e-01
|
GO:0030139 endocytic vesicle
|
37
|
9.59e-03
|
2.46e-01
|
5.37e-02
|
GO:0003333 amino acid transmembrane
transport
|
10
|
1.78e-01
|
2.46e-01
|
3.84e-01
|
GO:0016491 oxidoreductase activity
|
46
|
3.94e-03
|
-2.46e-01
|
3.01e-02
|
GO:0001726 ruffle
|
43
|
5.31e-03
|
2.46e-01
|
3.61e-02
|
GO:0030897 HOPS complex
|
10
|
1.79e-01
|
-2.46e-01
|
3.85e-01
|
GO:0003697 single-stranded DNA
binding
|
67
|
5.17e-04
|
2.45e-01
|
6.87e-03
|
GO:0060216 definitive hemopoiesis
|
10
|
1.80e-01
|
2.45e-01
|
3.88e-01
|
GO:0050890 cognition
|
18
|
7.24e-02
|
2.45e-01
|
2.23e-01
|
GO:0001664 G protein-coupled
receptor binding
|
22
|
4.73e-02
|
2.44e-01
|
1.66e-01
|
GO:0010314
phosphatidylinositol-5-phosphate binding
|
11
|
1.62e-01
|
-2.44e-01
|
3.63e-01
|
GO:0006355 regulation of
DNA-templated transcription
|
158
|
1.45e-07
|
2.43e-01
|
8.81e-06
|
GO:0045648 positive regulation of
erythrocyte differentiation
|
18
|
7.48e-02
|
2.43e-01
|
2.28e-01
|
GO:0045995 regulation of embryonic
development
|
27
|
2.93e-02
|
2.42e-01
|
1.18e-01
|
GO:0004715 non-membrane spanning
protein tyrosine kinase activity
|
20
|
6.06e-02
|
2.42e-01
|
1.97e-01
|
GO:0046427 positive regulation of
receptor signaling pathway via JAK-STAT
|
13
|
1.31e-01
|
2.42e-01
|
3.16e-01
|
GO:0070840 dynein complex binding
|
11
|
1.65e-01
|
2.42e-01
|
3.66e-01
|
GO:0007405 neuroblast proliferation
|
21
|
5.51e-02
|
2.42e-01
|
1.84e-01
|
GO:0055074 calcium ion homeostasis
|
18
|
7.62e-02
|
-2.41e-01
|
2.30e-01
|
GO:0097110 scaffold protein binding
|
28
|
2.71e-02
|
2.41e-01
|
1.12e-01
|
GO:0008654 phospholipid
biosynthetic process
|
12
|
1.48e-01
|
-2.41e-01
|
3.45e-01
|
GO:0045190 isotype switching
|
13
|
1.32e-01
|
2.41e-01
|
3.17e-01
|
GO:0014009 glial cell proliferation
|
10
|
1.87e-01
|
2.41e-01
|
3.96e-01
|
GO:0030864 cortical actin
cytoskeleton
|
32
|
1.85e-02
|
2.41e-01
|
8.54e-02
|
GO:0017022 myosin binding
|
11
|
1.67e-01
|
2.41e-01
|
3.69e-01
|
GO:0000122 negative regulation of
transcription by RNA polymerase II
|
395
|
3.13e-16
|
2.40e-01
|
5.50e-14
|
GO:0016192 vesicle-mediated
transport
|
101
|
3.06e-05
|
-2.40e-01
|
7.92e-04
|
GO:0001227 DNA-binding
transcription repressor activity, RNA polymerase II-specific
|
112
|
1.16e-05
|
2.40e-01
|
3.99e-04
|
GO:0048675 axon extension
|
15
|
1.07e-01
|
2.40e-01
|
2.83e-01
|
GO:0070373 negative regulation of
ERK1 and ERK2 cascade
|
30
|
2.32e-02
|
2.40e-01
|
9.89e-02
|
GO:0016829 lyase activity
|
15
|
1.08e-01
|
-2.40e-01
|
2.84e-01
|
GO:0001750 photoreceptor outer
segment
|
23
|
4.71e-02
|
-2.39e-01
|
1.66e-01
|
GO:0003677 DNA binding
|
335
|
6.37e-14
|
2.39e-01
|
7.99e-12
|
GO:0003887 DNA-directed DNA
polymerase activity
|
16
|
9.78e-02
|
2.39e-01
|
2.68e-01
|
GO:0003729 mRNA binding
|
146
|
6.44e-07
|
2.39e-01
|
3.33e-05
|
GO:0007601 visual perception
|
38
|
1.09e-02
|
-2.39e-01
|
5.80e-02
|
GO:0007052 mitotic spindle
organization
|
34
|
1.60e-02
|
2.39e-01
|
7.77e-02
|
GO:0048255 mRNA stabilization
|
16
|
9.84e-02
|
2.39e-01
|
2.69e-01
|
GO:0061512 protein localization to
cilium
|
22
|
5.28e-02
|
-2.39e-01
|
1.80e-01
|
GO:0048839 inner ear development
|
12
|
1.53e-01
|
2.38e-01
|
3.50e-01
|
GO:0000462 maturation of SSU-rRNA
from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
13
|
1.37e-01
|
2.38e-01
|
3.27e-01
|
GO:0048477 oogenesis
|
14
|
1.23e-01
|
2.38e-01
|
3.05e-01
|
GO:0032465 regulation of
cytokinesis
|
23
|
4.83e-02
|
2.38e-01
|
1.69e-01
|
GO:0140672 ATAC complex
|
11
|
1.72e-01
|
2.38e-01
|
3.77e-01
|
GO:0016791 phosphatase activity
|
15
|
1.12e-01
|
-2.37e-01
|
2.89e-01
|
GO:0001675 acrosome assembly
|
11
|
1.73e-01
|
-2.37e-01
|
3.78e-01
|
GO:0000781 chromosome, telomeric
region
|
75
|
3.93e-04
|
2.37e-01
|
5.67e-03
|
GO:0030904 retromer complex
|
15
|
1.12e-01
|
-2.37e-01
|
2.89e-01
|
GO:0030027 lamellipodium
|
91
|
9.60e-05
|
2.37e-01
|
2.01e-03
|
GO:0051721 protein phosphatase 2A
binding
|
14
|
1.25e-01
|
2.37e-01
|
3.09e-01
|
GO:0090128 regulation of synapse
maturation
|
10
|
1.96e-01
|
2.36e-01
|
4.05e-01
|
GO:0030500 regulation of bone
mineralization
|
12
|
1.57e-01
|
-2.36e-01
|
3.56e-01
|
GO:0010634 positive regulation of
epithelial cell migration
|
19
|
7.48e-02
|
2.36e-01
|
2.28e-01
|
GO:0034704 calcium channel complex
|
10
|
1.96e-01
|
-2.36e-01
|
4.05e-01
|
GO:0008360 regulation of cell shape
|
60
|
1.59e-03
|
2.36e-01
|
1.64e-02
|
GO:0030159 signaling receptor
complex adaptor activity
|
13
|
1.42e-01
|
2.35e-01
|
3.37e-01
|
GO:0061462 protein localization to
lysosome
|
10
|
2.00e-01
|
-2.34e-01
|
4.09e-01
|
GO:0006805 xenobiotic metabolic
process
|
17
|
9.54e-02
|
-2.34e-01
|
2.64e-01
|
GO:0045216 cell-cell junction
organization
|
13
|
1.45e-01
|
2.33e-01
|
3.42e-01
|
GO:0007094 mitotic spindle assembly
checkpoint signaling
|
19
|
7.88e-02
|
2.33e-01
|
2.35e-01
|
GO:0035115 embryonic forelimb
morphogenesis
|
16
|
1.07e-01
|
2.33e-01
|
2.83e-01
|
GO:0005876 spindle microtubule
|
20
|
7.32e-02
|
2.31e-01
|
2.24e-01
|
GO:0046875 ephrin receptor binding
|
17
|
9.92e-02
|
2.31e-01
|
2.69e-01
|
GO:0045746 negative regulation of
Notch signaling pathway
|
15
|
1.22e-01
|
2.31e-01
|
3.03e-01
|
GO:0034063 stress granule assembly
|
21
|
6.73e-02
|
2.31e-01
|
2.12e-01
|
GO:0001223 transcription
coactivator binding
|
22
|
6.22e-02
|
2.30e-01
|
2.01e-01
|
GO:0043122 regulation of canonical
NF-kappaB signal transduction
|
18
|
9.17e-02
|
2.30e-01
|
2.58e-01
|
GO:0005179 hormone activity
|
12
|
1.69e-01
|
-2.29e-01
|
3.72e-01
|
GO:0070412 R-SMAD binding
|
13
|
1.52e-01
|
2.29e-01
|
3.50e-01
|
GO:0044233 mitochondria-associated
endoplasmic reticulum membrane contact site
|
16
|
1.13e-01
|
-2.29e-01
|
2.89e-01
|
GO:0043240 Fanconi anaemia nuclear
complex
|
11
|
1.88e-01
|
-2.29e-01
|
3.98e-01
|
GO:0001707 mesoderm formation
|
15
|
1.25e-01
|
-2.29e-01
|
3.08e-01
|
GO:0003730 mRNA 3’-UTR binding
|
51
|
4.70e-03
|
2.29e-01
|
3.32e-02
|
GO:1900026 positive regulation of
substrate adhesion-dependent cell spreading
|
24
|
5.25e-02
|
2.29e-01
|
1.79e-01
|
GO:0034220 monoatomic ion
transmembrane transport
|
20
|
7.73e-02
|
-2.28e-01
|
2.32e-01
|
GO:0071333 cellular response to
glucose stimulus
|
12
|
1.72e-01
|
2.28e-01
|
3.76e-01
|
GO:0005923 bicellular tight
junction
|
50
|
5.39e-03
|
2.28e-01
|
3.64e-02
|
GO:0003688 DNA replication origin
binding
|
12
|
1.72e-01
|
2.27e-01
|
3.77e-01
|
GO:0031966 mitochondrial membrane
|
38
|
1.56e-02
|
-2.27e-01
|
7.63e-02
|
GO:0000166 nucleotide binding
|
36
|
1.86e-02
|
-2.27e-01
|
8.54e-02
|
GO:0009306 protein secretion
|
20
|
7.96e-02
|
-2.26e-01
|
2.35e-01
|
GO:0005581 collagen trimer
|
18
|
9.73e-02
|
-2.26e-01
|
2.67e-01
|
GO:0007129 homologous chromosome
pairing at meiosis
|
14
|
1.44e-01
|
2.26e-01
|
3.40e-01
|
GO:0005765 lysosomal membrane
|
137
|
5.90e-06
|
-2.24e-01
|
2.28e-04
|
GO:0007369 gastrulation
|
10
|
2.19e-01
|
-2.24e-01
|
4.31e-01
|
GO:0043542 endothelial cell
migration
|
13
|
1.62e-01
|
2.24e-01
|
3.63e-01
|
GO:1990782 protein tyrosine kinase
binding
|
14
|
1.47e-01
|
2.24e-01
|
3.44e-01
|
GO:0032570 response to progesterone
|
13
|
1.63e-01
|
2.24e-01
|
3.64e-01
|
GO:0035267 NuA4 histone
acetyltransferase complex
|
18
|
1.01e-01
|
2.23e-01
|
2.73e-01
|
GO:0050852 T cell receptor
signaling pathway
|
50
|
6.40e-03
|
2.23e-01
|
4.12e-02
|
GO:0003785 actin monomer binding
|
13
|
1.64e-01
|
-2.23e-01
|
3.65e-01
|
GO:0016973 poly(A)+ mRNA export
from nucleus
|
13
|
1.65e-01
|
2.22e-01
|
3.66e-01
|
GO:0042130 negative regulation of T
cell proliferation
|
12
|
1.83e-01
|
2.22e-01
|
3.92e-01
|
GO:0009791 post-embryonic
development
|
36
|
2.12e-02
|
2.22e-01
|
9.34e-02
|
GO:0042572 retinol metabolic
process
|
12
|
1.84e-01
|
-2.22e-01
|
3.92e-01
|
GO:0006506 GPI anchor biosynthetic
process
|
25
|
5.54e-02
|
-2.21e-01
|
1.84e-01
|
GO:0005819 spindle
|
54
|
4.98e-03
|
2.21e-01
|
3.43e-02
|
GO:0031032 actomyosin structure
organization
|
17
|
1.15e-01
|
2.21e-01
|
2.91e-01
|
GO:0061077 chaperone-mediated
protein folding
|
17
|
1.15e-01
|
-2.21e-01
|
2.92e-01
|
GO:0017116 single-stranded DNA
helicase activity
|
16
|
1.27e-01
|
2.20e-01
|
3.10e-01
|
GO:0038084 vascular endothelial
growth factor signaling pathway
|
23
|
6.82e-02
|
2.20e-01
|
2.13e-01
|
GO:0008305 integrin complex
|
17
|
1.17e-01
|
-2.20e-01
|
2.96e-01
|
GO:0000723 telomere maintenance
|
29
|
4.12e-02
|
2.19e-01
|
1.51e-01
|
GO:0032008 positive regulation of
TOR signaling
|
11
|
2.09e-01
|
-2.19e-01
|
4.20e-01
|
GO:0006886 intracellular protein
transport
|
158
|
2.14e-06
|
-2.19e-01
|
9.92e-05
|
GO:0051382 kinetochore assembly
|
11
|
2.10e-01
|
2.18e-01
|
4.22e-01
|
GO:0018279 protein N-linked
glycosylation via asparagine
|
11
|
2.11e-01
|
-2.18e-01
|
4.22e-01
|
GO:0043010 camera-type eye
development
|
22
|
7.70e-02
|
2.18e-01
|
2.32e-01
|
GO:0008380 RNA splicing
|
48
|
9.07e-03
|
2.18e-01
|
5.23e-02
|
GO:0035924 cellular response to
vascular endothelial growth factor stimulus
|
16
|
1.32e-01
|
2.17e-01
|
3.18e-01
|
GO:2000377 regulation of reactive
oxygen species metabolic process
|
10
|
2.34e-01
|
-2.17e-01
|
4.46e-01
|
GO:0031681 G-protein beta-subunit
binding
|
10
|
2.35e-01
|
-2.17e-01
|
4.46e-01
|
GO:0016887 ATP hydrolysis activity
|
213
|
5.51e-08
|
2.17e-01
|
3.59e-06
|
GO:0048306 calcium-dependent
protein binding
|
20
|
9.39e-02
|
-2.16e-01
|
2.61e-01
|
GO:0048821 erythrocyte development
|
15
|
1.47e-01
|
2.16e-01
|
3.44e-01
|
GO:0050918 positive chemotaxis
|
13
|
1.77e-01
|
2.16e-01
|
3.83e-01
|
GO:0045944 positive regulation of
transcription by RNA polymerase II
|
525
|
3.69e-17
|
2.16e-01
|
7.20e-15
|
GO:0046718 symbiont entry into host
cell
|
22
|
7.99e-02
|
2.16e-01
|
2.35e-01
|
GO:0032211 negative regulation of
telomere maintenance via telomerase
|
10
|
2.38e-01
|
2.15e-01
|
4.49e-01
|
GO:0006376 mRNA splice site
recognition
|
12
|
1.99e-01
|
2.14e-01
|
4.09e-01
|
GO:0000149 SNARE binding
|
31
|
3.89e-02
|
-2.14e-01
|
1.45e-01
|
GO:0045335 phagocytic vesicle
|
36
|
2.63e-02
|
-2.14e-01
|
1.09e-01
|
GO:0031334 positive regulation of
protein-containing complex assembly
|
17
|
1.27e-01
|
-2.14e-01
|
3.10e-01
|
GO:0050679 positive regulation of
epithelial cell proliferation
|
20
|
9.80e-02
|
2.14e-01
|
2.68e-01
|
GO:0051726 regulation of cell cycle
|
104
|
1.69e-04
|
2.14e-01
|
3.02e-03
|
GO:0010569 regulation of
double-strand break repair via homologous recombination
|
10
|
2.42e-01
|
2.14e-01
|
4.53e-01
|
GO:0031122 cytoplasmic microtubule
organization
|
28
|
5.05e-02
|
2.14e-01
|
1.75e-01
|
GO:0003743 translation initiation
factor activity
|
39
|
2.12e-02
|
-2.13e-01
|
9.34e-02
|
GO:0006275 regulation of DNA
replication
|
24
|
7.05e-02
|
2.13e-01
|
2.19e-01
|
GO:2001244 positive regulation of
intrinsic apoptotic signaling pathway
|
11
|
2.22e-01
|
-2.13e-01
|
4.34e-01
|
GO:0009952 anterior/posterior
pattern specification
|
41
|
1.87e-02
|
2.12e-01
|
8.54e-02
|
GO:0005778 peroxisomal membrane
|
28
|
5.19e-02
|
-2.12e-01
|
1.78e-01
|
GO:0043124 negative regulation of
canonical NF-kappaB signal transduction
|
36
|
2.77e-02
|
2.12e-01
|
1.13e-01
|
GO:0009653 anatomical structure
morphogenesis
|
22
|
8.54e-02
|
2.12e-01
|
2.44e-01
|
GO:0008013 beta-catenin binding
|
46
|
1.29e-02
|
2.12e-01
|
6.67e-02
|
GO:0006672 ceramide metabolic
process
|
10
|
2.47e-01
|
-2.12e-01
|
4.58e-01
|
GO:0030833 regulation of actin
filament polymerization
|
21
|
9.34e-02
|
2.12e-01
|
2.60e-01
|
GO:0030670 phagocytic vesicle
membrane
|
19
|
1.11e-01
|
-2.11e-01
|
2.89e-01
|
GO:0071320 cellular response to
cAMP
|
19
|
1.12e-01
|
2.11e-01
|
2.89e-01
|
GO:0060382 regulation of DNA strand
elongation
|
10
|
2.49e-01
|
2.10e-01
|
4.60e-01
|
GO:0006887 exocytosis
|
42
|
1.87e-02
|
-2.10e-01
|
8.54e-02
|
GO:0016604 nuclear body
|
175
|
1.77e-06
|
2.10e-01
|
8.41e-05
|
GO:0051489 regulation of filopodium
assembly
|
10
|
2.51e-01
|
-2.10e-01
|
4.61e-01
|
GO:0030100 regulation of
endocytosis
|
12
|
2.09e-01
|
-2.09e-01
|
4.20e-01
|
GO:0005665 RNA polymerase II, core
complex
|
10
|
2.52e-01
|
-2.09e-01
|
4.61e-01
|
GO:0007596 blood coagulation
|
25
|
7.04e-02
|
-2.09e-01
|
2.19e-01
|
GO:0090575 RNA polymerase II
transcription regulator complex
|
53
|
8.52e-03
|
2.09e-01
|
5.03e-02
|
GO:0004519 endonuclease activity
|
14
|
1.76e-01
|
2.09e-01
|
3.82e-01
|
GO:0001678 intracellular glucose
homeostasis
|
17
|
1.36e-01
|
2.09e-01
|
3.25e-01
|
GO:0061157 mRNA destabilization
|
12
|
2.13e-01
|
2.08e-01
|
4.24e-01
|
GO:0030141 secretory granule
|
18
|
1.28e-01
|
-2.07e-01
|
3.10e-01
|
GO:0071339 MLL1 complex
|
18
|
1.28e-01
|
2.07e-01
|
3.10e-01
|
GO:0030334 regulation of cell
migration
|
35
|
3.38e-02
|
2.07e-01
|
1.31e-01
|
GO:0016236 macroautophagy
|
16
|
1.51e-01
|
-2.07e-01
|
3.49e-01
|
GO:0003925 G protein activity
|
18
|
1.28e-01
|
-2.07e-01
|
3.10e-01
|
GO:0043162 ubiquitin-dependent
protein catabolic process via the multivesicular body sorting pathway
|
16
|
1.52e-01
|
-2.07e-01
|
3.50e-01
|
GO:0051787 misfolded protein
binding
|
12
|
2.15e-01
|
-2.07e-01
|
4.27e-01
|
GO:0060976 coronary vasculature
development
|
17
|
1.40e-01
|
2.07e-01
|
3.33e-01
|
GO:0106310 protein serine kinase
activity
|
38
|
2.77e-02
|
2.06e-01
|
1.13e-01
|
GO:0090102 cochlea development
|
12
|
2.16e-01
|
2.06e-01
|
4.28e-01
|
GO:0000165 MAPK cascade
|
46
|
1.57e-02
|
2.06e-01
|
7.65e-02
|
GO:0006402 mRNA catabolic process
|
14
|
1.83e-01
|
2.06e-01
|
3.92e-01
|
GO:0030968 endoplasmic reticulum
unfolded protein response
|
30
|
5.17e-02
|
-2.05e-01
|
1.78e-01
|
GO:0030032 lamellipodium assembly
|
20
|
1.12e-01
|
2.05e-01
|
2.89e-01
|
GO:0065003 protein-containing
complex assembly
|
38
|
2.88e-02
|
2.05e-01
|
1.16e-01
|
GO:0048872 homeostasis of number of
cells
|
14
|
1.84e-01
|
2.05e-01
|
3.92e-01
|
GO:0042026 protein refolding
|
12
|
2.19e-01
|
2.05e-01
|
4.31e-01
|
GO:0060070 canonical Wnt signaling
pathway
|
57
|
7.59e-03
|
2.05e-01
|
4.70e-02
|
GO:0032874 positive regulation of
stress-activated MAPK cascade
|
11
|
2.41e-01
|
2.04e-01
|
4.52e-01
|
GO:0005158 insulin receptor binding
|
13
|
2.04e-01
|
2.04e-01
|
4.15e-01
|
GO:0051287 NAD binding
|
18
|
1.37e-01
|
-2.03e-01
|
3.26e-01
|
GO:0031333 negative regulation of
protein-containing complex assembly
|
16
|
1.60e-01
|
2.03e-01
|
3.63e-01
|
GO:0070402 NADPH binding
|
10
|
2.68e-01
|
-2.02e-01
|
4.82e-01
|
GO:0030946 protein tyrosine
phosphatase activity, metal-dependent
|
15
|
1.75e-01
|
2.02e-01
|
3.80e-01
|
GO:0140793 histone H2AXY142
phosphatase activity
|
15
|
1.75e-01
|
2.02e-01
|
3.80e-01
|
GO:0005868 cytoplasmic dynein
complex
|
14
|
1.90e-01
|
-2.02e-01
|
4.00e-01
|
GO:0043408 regulation of MAPK
cascade
|
21
|
1.09e-01
|
2.02e-01
|
2.86e-01
|
GO:0016579 protein deubiquitination
|
28
|
6.49e-02
|
2.02e-01
|
2.06e-01
|
GO:0003899 DNA-directed 5’-3’ RNA
polymerase activity
|
10
|
2.70e-01
|
2.02e-01
|
4.84e-01
|
GO:0009060 aerobic respiration
|
10
|
2.70e-01
|
-2.01e-01
|
4.84e-01
|
GO:0000423 mitophagy
|
31
|
5.25e-02
|
-2.01e-01
|
1.79e-01
|
GO:0001818 negative regulation of
cytokine production
|
11
|
2.49e-01
|
-2.01e-01
|
4.60e-01
|
GO:0046856 phosphatidylinositol
dephosphorylation
|
26
|
7.67e-02
|
-2.01e-01
|
2.31e-01
|
GO:0071347 cellular response to
interleukin-1
|
17
|
1.52e-01
|
2.01e-01
|
3.50e-01
|
GO:0006606 protein import into
nucleus
|
62
|
6.39e-03
|
2.00e-01
|
4.12e-02
|
GO:0043495 protein-membrane adaptor
activity
|
17
|
1.53e-01
|
-2.00e-01
|
3.51e-01
|
GO:0006357 regulation of
transcription by RNA polymerase II
|
549
|
2.50e-15
|
1.99e-01
|
3.99e-13
|
GO:0060348 bone development
|
26
|
7.97e-02
|
-1.99e-01
|
2.35e-01
|
GO:0017147 Wnt-protein binding
|
17
|
1.57e-01
|
1.98e-01
|
3.56e-01
|
GO:0071577 zinc ion transmembrane
transport
|
10
|
2.78e-01
|
-1.98e-01
|
4.93e-01
|
GO:0070507 regulation of
microtubule cytoskeleton organization
|
14
|
1.99e-01
|
1.98e-01
|
4.09e-01
|
GO:0120020 cholesterol transfer
activity
|
12
|
2.35e-01
|
-1.98e-01
|
4.46e-01
|
GO:0030488 tRNA methylation
|
20
|
1.25e-01
|
-1.98e-01
|
3.09e-01
|
GO:0048511 rhythmic process
|
25
|
8.71e-02
|
1.98e-01
|
2.47e-01
|
GO:0038202 TORC1 signaling
|
12
|
2.36e-01
|
1.98e-01
|
4.47e-01
|
GO:0004842 ubiquitin-protein
transferase activity
|
65
|
5.92e-03
|
1.98e-01
|
3.90e-02
|
GO:0006325 chromatin organization
|
66
|
5.58e-03
|
1.97e-01
|
3.73e-02
|
GO:0010507 negative regulation of
autophagy
|
23
|
1.02e-01
|
1.97e-01
|
2.74e-01
|
GO:0070131 positive regulation of
mitochondrial translation
|
10
|
2.81e-01
|
-1.97e-01
|
4.95e-01
|
GO:0030017 sarcomere
|
13
|
2.19e-01
|
-1.97e-01
|
4.31e-01
|
GO:0008017 microtubule binding
|
152
|
2.94e-05
|
1.97e-01
|
7.71e-04
|
GO:0032729 positive regulation of
type II interferon production
|
23
|
1.03e-01
|
1.96e-01
|
2.75e-01
|
GO:0098685 Schaffer collateral -
CA1 synapse
|
45
|
2.36e-02
|
1.95e-01
|
1.00e-01
|
GO:0042771 intrinsic apoptotic
signaling pathway in response to DNA damage by p53 class mediator
|
17
|
1.64e-01
|
1.95e-01
|
3.65e-01
|
GO:0001228 DNA-binding
transcription activator activity, RNA polymerase II-specific
|
182
|
5.95e-06
|
1.95e-01
|
2.28e-04
|
GO:0030890 positive regulation of B
cell proliferation
|
21
|
1.22e-01
|
1.95e-01
|
3.03e-01
|
GO:0005783 endoplasmic reticulum
|
433
|
4.65e-12
|
-1.95e-01
|
5.11e-10
|
GO:0046329 negative regulation of
JNK cascade
|
12
|
2.44e-01
|
1.94e-01
|
4.54e-01
|
GO:0010811 positive regulation of
cell-substrate adhesion
|
13
|
2.25e-01
|
-1.94e-01
|
4.39e-01
|
GO:0008203 cholesterol metabolic
process
|
30
|
6.61e-02
|
1.94e-01
|
2.09e-01
|
GO:0006898 receptor-mediated
endocytosis
|
24
|
1.00e-01
|
1.94e-01
|
2.72e-01
|
GO:0098839 postsynaptic density
membrane
|
34
|
5.07e-02
|
1.94e-01
|
1.76e-01
|
GO:0016342 catenin complex
|
13
|
2.27e-01
|
1.94e-01
|
4.39e-01
|
GO:0044291 cell-cell contact zone
|
14
|
2.11e-01
|
1.93e-01
|
4.22e-01
|
GO:0051539 4 iron, 4 sulfur cluster
binding
|
33
|
5.51e-02
|
-1.93e-01
|
1.84e-01
|
GO:0007267 cell-cell signaling
|
13
|
2.28e-01
|
1.93e-01
|
4.39e-01
|
GO:0017018 myosin phosphatase
activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0140791 histone H2AXS140
phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0180004 RNA polymerase II CTD
heptapeptide repeat Y1 phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0180005 RNA polymerase II CTD
heptapeptide repeat T4 phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0180006 RNA polymerase II CTD
heptapeptide repeat S2 phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0180007 RNA polymerase II CTD
heptapeptide repeat S5 phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0180008 RNA polymerase II CTD
heptapeptide repeat S7 phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:1990439 MAP kinase
serine/threonine phosphatase activity
|
13
|
2.28e-01
|
-1.93e-01
|
4.39e-01
|
GO:0005881 cytoplasmic microtubule
|
30
|
6.77e-02
|
1.93e-01
|
2.12e-01
|
GO:0015030 Cajal body
|
26
|
8.90e-02
|
1.93e-01
|
2.51e-01
|
GO:0042995 cell projection
|
53
|
1.53e-02
|
1.93e-01
|
7.53e-02
|
GO:0071466 cellular response to
xenobiotic stimulus
|
25
|
9.55e-02
|
1.93e-01
|
2.64e-01
|
GO:0005200 structural constituent
of cytoskeleton
|
27
|
8.36e-02
|
1.92e-01
|
2.41e-01
|
GO:0080008 Cul4-RING E3 ubiquitin
ligase complex
|
13
|
2.30e-01
|
1.92e-01
|
4.41e-01
|
GO:0016605 PML body
|
61
|
9.50e-03
|
1.92e-01
|
5.35e-02
|
GO:0061629 RNA polymerase
II-specific DNA-binding transcription factor binding
|
83
|
2.53e-03
|
1.92e-01
|
2.19e-02
|
GO:0035098 ESC/E(Z) complex
|
12
|
2.50e-01
|
1.92e-01
|
4.60e-01
|
GO:0035035 histone
acetyltransferase binding
|
12
|
2.50e-01
|
1.92e-01
|
4.60e-01
|
GO:0033627 cell adhesion mediated
by integrin
|
22
|
1.20e-01
|
-1.91e-01
|
3.00e-01
|
GO:0042149 cellular response to
glucose starvation
|
28
|
8.02e-02
|
1.91e-01
|
2.35e-01
|
GO:0032012 regulation of ARF
protein signal transduction
|
14
|
2.16e-01
|
1.91e-01
|
4.28e-01
|
GO:0005112 Notch binding
|
13
|
2.34e-01
|
1.91e-01
|
4.46e-01
|
GO:0010761 fibroblast migration
|
10
|
2.97e-01
|
1.90e-01
|
5.09e-01
|
GO:0043197 dendritic spine
|
45
|
2.73e-02
|
1.90e-01
|
1.13e-01
|
GO:0001725 stress fiber
|
42
|
3.31e-02
|
1.90e-01
|
1.29e-01
|
GO:0007131 reciprocal meiotic
recombination
|
13
|
2.35e-01
|
1.90e-01
|
4.47e-01
|
GO:0045787 positive regulation of
cell cycle
|
13
|
2.36e-01
|
1.90e-01
|
4.47e-01
|
GO:0040029 epigenetic regulation of
gene expression
|
18
|
1.63e-01
|
1.90e-01
|
3.65e-01
|
GO:0016787 hydrolase activity
|
108
|
6.80e-04
|
1.89e-01
|
8.48e-03
|
GO:0005694 chromosome
|
76
|
4.34e-03
|
1.89e-01
|
3.15e-02
|
GO:0045893 positive regulation of
DNA-templated transcription
|
223
|
1.28e-06
|
1.89e-01
|
6.25e-05
|
GO:0042742 defense response to
bacterium
|
28
|
8.41e-02
|
1.89e-01
|
2.42e-01
|
GO:0000139 Golgi membrane
|
260
|
1.82e-07
|
-1.88e-01
|
1.07e-05
|
GO:0090734 site of DNA damage
|
22
|
1.26e-01
|
1.88e-01
|
3.10e-01
|
GO:0008047 enzyme activator
activity
|
15
|
2.07e-01
|
1.88e-01
|
4.19e-01
|
GO:1901981 phosphatidylinositol
phosphate binding
|
16
|
1.93e-01
|
-1.88e-01
|
4.03e-01
|
GO:0007163 establishment or
maintenance of cell polarity
|
13
|
2.40e-01
|
-1.88e-01
|
4.52e-01
|
GO:0048167 regulation of synaptic
plasticity
|
15
|
2.07e-01
|
1.88e-01
|
4.19e-01
|
GO:0012505 endomembrane system
|
97
|
1.41e-03
|
-1.88e-01
|
1.48e-02
|
GO:0055013 cardiac muscle cell
development
|
11
|
2.81e-01
|
1.88e-01
|
4.95e-01
|
GO:0051403 stress-activated MAPK
cascade
|
12
|
2.61e-01
|
1.87e-01
|
4.72e-01
|
GO:0006413 translational initiation
|
30
|
7.64e-02
|
-1.87e-01
|
2.31e-01
|
GO:0034446 substrate
adhesion-dependent cell spreading
|
33
|
6.38e-02
|
1.87e-01
|
2.03e-01
|
GO:0030511 positive regulation of
transforming growth factor beta receptor signaling pathway
|
19
|
1.59e-01
|
1.87e-01
|
3.61e-01
|
GO:0008053 mitochondrial fusion
|
17
|
1.84e-01
|
-1.86e-01
|
3.92e-01
|
GO:2000045 regulation of G1/S
transition of mitotic cell cycle
|
19
|
1.61e-01
|
1.86e-01
|
3.63e-01
|
GO:0031267 small GTPase binding
|
164
|
4.24e-05
|
1.86e-01
|
1.01e-03
|
GO:0061024 membrane organization
|
13
|
2.47e-01
|
-1.85e-01
|
4.58e-01
|
GO:0043565 sequence-specific DNA
binding
|
56
|
1.65e-02
|
1.85e-01
|
7.96e-02
|
GO:0060021 roof of mouth
development
|
36
|
5.45e-02
|
1.85e-01
|
1.83e-01
|
GO:0030175 filopodium
|
29
|
8.44e-02
|
1.85e-01
|
2.43e-01
|
GO:0030901 midbrain development
|
11
|
2.88e-01
|
1.85e-01
|
5.00e-01
|
GO:0007162 negative regulation of
cell adhesion
|
16
|
2.00e-01
|
1.85e-01
|
4.10e-01
|
GO:0045892 negative regulation of
DNA-templated transcription
|
173
|
2.88e-05
|
1.85e-01
|
7.67e-04
|
GO:0005096 GTPase activator
activity
|
150
|
9.75e-05
|
1.85e-01
|
2.02e-03
|
GO:0010595 positive regulation of
endothelial cell migration
|
26
|
1.04e-01
|
1.84e-01
|
2.76e-01
|
GO:0030054 cell junction
|
53
|
2.04e-02
|
1.84e-01
|
9.14e-02
|
GO:0000977 RNA polymerase II
transcription regulatory region sequence-specific DNA binding
|
85
|
3.37e-03
|
1.84e-01
|
2.68e-02
|
GO:0060173 limb development
|
23
|
1.27e-01
|
1.84e-01
|
3.10e-01
|
GO:0005682 U5 snRNP
|
10
|
3.14e-01
|
1.84e-01
|
5.27e-01
|
GO:0007266 Rho protein signal
transduction
|
33
|
6.77e-02
|
1.84e-01
|
2.12e-01
|
GO:0032420 stereocilium
|
14
|
2.34e-01
|
-1.84e-01
|
4.46e-01
|
GO:0005741 mitochondrial outer
membrane
|
95
|
1.99e-03
|
-1.84e-01
|
1.91e-02
|
GO:0050885 neuromuscular process
controlling balance
|
23
|
1.27e-01
|
1.84e-01
|
3.10e-01
|
GO:0031594 neuromuscular junction
|
34
|
6.40e-02
|
1.84e-01
|
2.04e-01
|
GO:0010212 response to ionizing
radiation
|
24
|
1.20e-01
|
1.83e-01
|
3.00e-01
|
GO:0005201 extracellular matrix
structural constituent
|
12
|
2.73e-01
|
1.83e-01
|
4.88e-01
|
GO:0007399 nervous system
development
|
89
|
2.93e-03
|
1.83e-01
|
2.45e-02
|
GO:0060261 positive regulation of
transcription initiation by RNA polymerase II
|
30
|
8.37e-02
|
1.83e-01
|
2.41e-01
|
GO:0030490 maturation of SSU-rRNA
|
12
|
2.74e-01
|
-1.82e-01
|
4.89e-01
|
GO:0008104 protein localization
|
69
|
8.92e-03
|
1.82e-01
|
5.19e-02
|
GO:1902018 negative regulation of
cilium assembly
|
13
|
2.56e-01
|
1.82e-01
|
4.65e-01
|
GO:0006298 mismatch repair
|
16
|
2.08e-01
|
1.82e-01
|
4.19e-01
|
GO:0016601 Rac protein signal
transduction
|
17
|
1.95e-01
|
1.82e-01
|
4.05e-01
|
GO:0051219 phosphoprotein binding
|
20
|
1.62e-01
|
1.81e-01
|
3.63e-01
|
GO:0042752 regulation of circadian
rhythm
|
27
|
1.04e-01
|
1.81e-01
|
2.76e-01
|
GO:0001965 G-protein alpha-subunit
binding
|
10
|
3.23e-01
|
-1.81e-01
|
5.35e-01
|
GO:0001843 neural tube closure
|
48
|
3.05e-02
|
1.81e-01
|
1.22e-01
|
GO:0001947 heart looping
|
23
|
1.34e-01
|
1.80e-01
|
3.22e-01
|
GO:0016922 nuclear receptor binding
|
21
|
1.53e-01
|
1.80e-01
|
3.50e-01
|
GO:0050840 extracellular matrix
binding
|
16
|
2.12e-01
|
-1.80e-01
|
4.23e-01
|
GO:0031623 receptor internalization
|
21
|
1.53e-01
|
-1.80e-01
|
3.50e-01
|
GO:0032212 positive regulation of
telomere maintenance via telomerase
|
17
|
1.99e-01
|
1.80e-01
|
4.09e-01
|
GO:0005516 calmodulin binding
|
66
|
1.15e-02
|
1.80e-01
|
6.08e-02
|
GO:0007030 Golgi organization
|
62
|
1.44e-02
|
-1.80e-01
|
7.24e-02
|
GO:0061351 neural precursor cell
proliferation
|
14
|
2.45e-01
|
1.79e-01
|
4.56e-01
|
GO:0051131 chaperone-mediated
protein complex assembly
|
14
|
2.49e-01
|
-1.78e-01
|
4.60e-01
|
GO:0006633 fatty acid biosynthetic
process
|
21
|
1.59e-01
|
-1.78e-01
|
3.60e-01
|
GO:0097150 neuronal stem cell
population maintenance
|
18
|
1.93e-01
|
1.77e-01
|
4.04e-01
|
GO:0007005 mitochondrion
organization
|
62
|
1.60e-02
|
-1.77e-01
|
7.76e-02
|
GO:0050766 positive regulation of
phagocytosis
|
14
|
2.52e-01
|
-1.77e-01
|
4.61e-01
|
GO:0007389 pattern specification
process
|
14
|
2.52e-01
|
1.77e-01
|
4.61e-01
|
GO:0140297 DNA-binding
transcription factor binding
|
70
|
1.08e-02
|
1.76e-01
|
5.79e-02
|
GO:0030016 myofibril
|
12
|
2.94e-01
|
-1.75e-01
|
5.04e-01
|
GO:0090314 positive regulation of
protein targeting to membrane
|
12
|
2.94e-01
|
-1.75e-01
|
5.05e-01
|
GO:0015031 protein transport
|
173
|
7.73e-05
|
-1.75e-01
|
1.66e-03
|
GO:0010977 negative regulation of
neuron projection development
|
17
|
2.13e-01
|
1.74e-01
|
4.25e-01
|
GO:0005109 frizzled binding
|
18
|
2.01e-01
|
1.74e-01
|
4.10e-01
|
GO:0005164 tumor necrosis factor
receptor binding
|
13
|
2.78e-01
|
1.74e-01
|
4.93e-01
|
GO:0034332 adherens junction
organization
|
12
|
2.97e-01
|
-1.74e-01
|
5.09e-01
|
GO:0004713 protein tyrosine kinase
activity
|
34
|
8.03e-02
|
1.73e-01
|
2.35e-01
|
GO:0016328 lateral plasma membrane
|
24
|
1.42e-01
|
1.73e-01
|
3.36e-01
|
GO:0120009 intermembrane lipid
transfer
|
16
|
2.31e-01
|
-1.73e-01
|
4.43e-01
|
GO:0004497 monooxygenase activity
|
11
|
3.23e-01
|
1.72e-01
|
5.35e-01
|
GO:0030552 cAMP binding
|
10
|
3.46e-01
|
-1.72e-01
|
5.56e-01
|
GO:0019904 protein domain specific
binding
|
104
|
2.51e-03
|
1.72e-01
|
2.18e-02
|
GO:0016301 kinase activity
|
13
|
2.84e-01
|
-1.72e-01
|
4.99e-01
|
GO:0045070 positive regulation of
viral genome replication
|
19
|
1.96e-01
|
1.71e-01
|
4.05e-01
|
GO:0005789 endoplasmic reticulum
membrane
|
402
|
4.32e-09
|
-1.71e-01
|
3.04e-07
|
GO:0008286 insulin receptor
signaling pathway
|
49
|
3.80e-02
|
1.71e-01
|
1.43e-01
|
GO:0060170 ciliary membrane
|
20
|
1.85e-01
|
-1.71e-01
|
3.94e-01
|
GO:0005085 guanyl-nucleotide
exchange factor activity
|
143
|
4.34e-04
|
1.71e-01
|
6.05e-03
|
GO:0009887 animal organ
morphogenesis
|
34
|
8.53e-02
|
1.71e-01
|
2.44e-01
|
GO:0035914 skeletal muscle cell
differentiation
|
24
|
1.48e-01
|
1.71e-01
|
3.46e-01
|
GO:0008021 synaptic vesicle
|
47
|
4.35e-02
|
-1.70e-01
|
1.56e-01
|
GO:0007193 adenylate
cyclase-inhibiting G protein-coupled receptor signaling pathway
|
11
|
3.29e-01
|
1.70e-01
|
5.42e-01
|
GO:0000049 tRNA binding
|
52
|
3.43e-02
|
-1.70e-01
|
1.33e-01
|
GO:0030316 osteoclast
differentiation
|
28
|
1.21e-01
|
1.70e-01
|
3.01e-01
|
GO:0030425 dendrite
|
132
|
7.87e-04
|
1.69e-01
|
9.41e-03
|
GO:0035770 ribonucleoprotein
granule
|
13
|
2.91e-01
|
1.69e-01
|
5.03e-01
|
GO:0005911 cell-cell junction
|
77
|
1.05e-02
|
1.69e-01
|
5.65e-02
|
GO:0043015 gamma-tubulin binding
|
21
|
1.82e-01
|
1.68e-01
|
3.90e-01
|
GO:0019894 kinesin binding
|
21
|
1.83e-01
|
1.68e-01
|
3.92e-01
|
GO:0042733 embryonic digit
morphogenesis
|
30
|
1.12e-01
|
1.68e-01
|
2.89e-01
|
GO:0048513 animal organ development
|
11
|
3.36e-01
|
1.68e-01
|
5.48e-01
|
GO:0001662 behavioral fear response
|
12
|
3.15e-01
|
1.68e-01
|
5.27e-01
|
GO:0043484 regulation of RNA
splicing
|
24
|
1.56e-01
|
1.67e-01
|
3.55e-01
|
GO:0097009 energy homeostasis
|
24
|
1.56e-01
|
1.67e-01
|
3.55e-01
|
GO:0001937 negative regulation of
endothelial cell proliferation
|
12
|
3.16e-01
|
1.67e-01
|
5.29e-01
|
GO:0031941 filamentous actin
|
18
|
2.20e-01
|
1.67e-01
|
4.32e-01
|
GO:0070411 I-SMAD binding
|
11
|
3.38e-01
|
1.67e-01
|
5.48e-01
|
GO:0008333 endosome to lysosome
transport
|
32
|
1.03e-01
|
-1.67e-01
|
2.74e-01
|
GO:0071539 protein localization to
centrosome
|
20
|
1.97e-01
|
1.67e-01
|
4.06e-01
|
GO:0045879 negative regulation of
smoothened signaling pathway
|
15
|
2.64e-01
|
1.66e-01
|
4.78e-01
|
GO:0140861 DNA repair-dependent
chromatin remodeling
|
14
|
2.81e-01
|
1.66e-01
|
4.95e-01
|
GO:0019882 antigen processing and
presentation
|
11
|
3.40e-01
|
-1.66e-01
|
5.52e-01
|
GO:0000278 mitotic cell cycle
|
53
|
3.67e-02
|
1.66e-01
|
1.39e-01
|
GO:0002376 immune system process
|
13
|
3.01e-01
|
-1.66e-01
|
5.13e-01
|
GO:0006397 mRNA processing
|
73
|
1.47e-02
|
1.65e-01
|
7.35e-02
|
GO:0032869 cellular response to
insulin stimulus
|
33
|
1.01e-01
|
1.65e-01
|
2.72e-01
|
GO:0012506 vesicle membrane
|
16
|
2.53e-01
|
-1.65e-01
|
4.62e-01
|
GO:0016525 negative regulation of
angiogenesis
|
35
|
9.25e-02
|
1.64e-01
|
2.59e-01
|
GO:0006612 protein targeting to
membrane
|
24
|
1.64e-01
|
-1.64e-01
|
3.65e-01
|
GO:0019902 phosphatase binding
|
23
|
1.73e-01
|
1.64e-01
|
3.77e-01
|
GO:0004726 non-membrane spanning
protein tyrosine phosphatase activity
|
19
|
2.15e-01
|
1.64e-01
|
4.27e-01
|
GO:0036211 protein modification
process
|
16
|
2.56e-01
|
-1.64e-01
|
4.65e-01
|
GO:2000352 negative regulation of
endothelial cell apoptotic process
|
14
|
2.88e-01
|
1.64e-01
|
5.00e-01
|
GO:0043525 positive regulation of
neuron apoptotic process
|
18
|
2.29e-01
|
1.64e-01
|
4.39e-01
|
GO:0051959 dynein light
intermediate chain binding
|
15
|
2.76e-01
|
1.63e-01
|
4.90e-01
|
GO:0090307 mitotic spindle assembly
|
30
|
1.23e-01
|
1.63e-01
|
3.05e-01
|
GO:0034599 cellular response to
oxidative stress
|
44
|
6.23e-02
|
-1.62e-01
|
2.01e-01
|
GO:0007160 cell-matrix adhesion
|
40
|
7.58e-02
|
-1.62e-01
|
2.30e-01
|
GO:0071233 cellular response to
L-leucine
|
10
|
3.75e-01
|
1.62e-01
|
5.85e-01
|
GO:0001822 kidney development
|
51
|
4.63e-02
|
1.61e-01
|
1.63e-01
|
GO:0048705 skeletal system
morphogenesis
|
15
|
2.80e-01
|
-1.61e-01
|
4.95e-01
|
GO:0001702 gastrulation with mouth
forming second
|
10
|
3.79e-01
|
1.61e-01
|
5.89e-01
|
GO:0033077 T cell differentiation
in thymus
|
18
|
2.38e-01
|
1.61e-01
|
4.49e-01
|
GO:0080025
phosphatidylinositol-3,5-bisphosphate binding
|
15
|
2.81e-01
|
-1.61e-01
|
4.95e-01
|
GO:0007409 axonogenesis
|
40
|
7.98e-02
|
1.60e-01
|
2.35e-01
|
GO:0006986 response to unfolded
protein
|
12
|
3.37e-01
|
-1.60e-01
|
5.48e-01
|
GO:0005793 endoplasmic
reticulum-Golgi intermediate compartment
|
35
|
1.01e-01
|
-1.60e-01
|
2.73e-01
|
GO:0007155 cell adhesion
|
103
|
5.07e-03
|
1.60e-01
|
3.47e-02
|
GO:0000124 SAGA complex
|
15
|
2.85e-01
|
1.60e-01
|
4.99e-01
|
GO:0005879 axonemal microtubule
|
10
|
3.83e-01
|
1.59e-01
|
5.92e-01
|
GO:0007268 chemical synaptic
transmission
|
33
|
1.13e-01
|
1.59e-01
|
2.90e-01
|
GO:0000146 microfilament motor
activity
|
18
|
2.42e-01
|
1.59e-01
|
4.53e-01
|
GO:0008266 poly(U) RNA binding
|
16
|
2.70e-01
|
1.59e-01
|
4.84e-01
|
GO:0090263 positive regulation of
canonical Wnt signaling pathway
|
61
|
3.25e-02
|
1.58e-01
|
1.28e-01
|
GO:0006281 DNA repair
|
95
|
7.88e-03
|
1.58e-01
|
4.80e-02
|
GO:0046034 ATP metabolic process
|
13
|
3.25e-01
|
-1.58e-01
|
5.38e-01
|
GO:0031463 Cul3-RING ubiquitin
ligase complex
|
41
|
8.07e-02
|
-1.58e-01
|
2.36e-01
|
GO:0003727 single-stranded RNA
binding
|
21
|
2.11e-01
|
1.58e-01
|
4.22e-01
|
GO:0007411 axon guidance
|
75
|
1.84e-02
|
1.58e-01
|
8.54e-02
|
GO:0006366 transcription by RNA
polymerase II
|
73
|
2.02e-02
|
1.57e-01
|
9.10e-02
|
GO:0070979 protein K11-linked
ubiquitination
|
22
|
2.02e-01
|
-1.57e-01
|
4.11e-01
|
GO:0005874 microtubule
|
129
|
2.08e-03
|
1.57e-01
|
1.95e-02
|
GO:0005759 mitochondrial matrix
|
119
|
3.17e-03
|
-1.57e-01
|
2.59e-02
|
GO:0048536 spleen development
|
23
|
1.96e-01
|
1.56e-01
|
4.05e-01
|
GO:0008542 visual learning
|
20
|
2.28e-01
|
1.56e-01
|
4.39e-01
|
GO:0090398 cellular senescence
|
19
|
2.43e-01
|
1.55e-01
|
4.54e-01
|
GO:0005021 vascular endothelial
growth factor receptor activity
|
15
|
3.00e-01
|
1.55e-01
|
5.12e-01
|
GO:0051123 RNA polymerase II
preinitiation complex assembly
|
16
|
2.85e-01
|
-1.54e-01
|
4.99e-01
|
GO:0003779 actin binding
|
138
|
1.80e-03
|
1.54e-01
|
1.78e-02
|
GO:0004843 cysteine-type
deubiquitinase activity
|
57
|
4.43e-02
|
1.54e-01
|
1.58e-01
|
GO:0048706 embryonic skeletal
system development
|
16
|
2.86e-01
|
1.54e-01
|
5.00e-01
|
GO:0005245 voltage-gated calcium
channel activity
|
12
|
3.56e-01
|
1.54e-01
|
5.66e-01
|
GO:0000086 G2/M transition of
mitotic cell cycle
|
25
|
1.84e-01
|
1.54e-01
|
3.92e-01
|
GO:0035264 multicellular organism
growth
|
66
|
3.16e-02
|
1.53e-01
|
1.25e-01
|
GO:1904707 positive regulation of
vascular associated smooth muscle cell proliferation
|
14
|
3.22e-01
|
1.53e-01
|
5.35e-01
|
GO:0045332 phospholipid
translocation
|
15
|
3.05e-01
|
-1.53e-01
|
5.18e-01
|
GO:0005902 microvillus
|
28
|
1.62e-01
|
-1.53e-01
|
3.63e-01
|
GO:0017148 negative regulation of
translation
|
43
|
8.37e-02
|
1.53e-01
|
2.41e-01
|
GO:0004896 cytokine receptor
activity
|
20
|
2.40e-01
|
1.52e-01
|
4.52e-01
|
GO:0004860 protein kinase inhibitor
activity
|
19
|
2.52e-01
|
-1.52e-01
|
4.61e-01
|
GO:0032007 negative regulation of
TOR signaling
|
18
|
2.65e-01
|
-1.52e-01
|
4.78e-01
|
GO:0090443 FAR/SIN/STRIPAK complex
|
12
|
3.63e-01
|
-1.52e-01
|
5.74e-01
|
GO:0035904 aorta development
|
15
|
3.10e-01
|
1.51e-01
|
5.25e-01
|
GO:0004674 protein serine/threonine
kinase activity
|
202
|
2.20e-04
|
1.51e-01
|
3.76e-03
|
GO:0005262 calcium channel activity
|
22
|
2.20e-01
|
-1.51e-01
|
4.31e-01
|
GO:0005739 mitochondrion
|
607
|
2.73e-10
|
-1.51e-01
|
2.28e-08
|
GO:0032580 Golgi cisterna membrane
|
26
|
1.83e-01
|
-1.51e-01
|
3.92e-01
|
GO:0086091 regulation of heart rate
by cardiac conduction
|
17
|
2.82e-01
|
1.51e-01
|
4.96e-01
|
GO:0033344 cholesterol efflux
|
11
|
3.89e-01
|
-1.50e-01
|
5.99e-01
|
GO:0042056 chemoattractant activity
|
11
|
3.90e-01
|
1.50e-01
|
6.01e-01
|
GO:0008283 cell population
proliferation
|
65
|
3.71e-02
|
1.50e-01
|
1.40e-01
|
GO:0070006 metalloaminopeptidase
activity
|
15
|
3.16e-01
|
-1.49e-01
|
5.29e-01
|
GO:0050680 negative regulation of
epithelial cell proliferation
|
24
|
2.06e-01
|
1.49e-01
|
4.18e-01
|
GO:0043021 ribonucleoprotein
complex binding
|
23
|
2.16e-01
|
1.49e-01
|
4.28e-01
|
GO:0009966 regulation of signal
transduction
|
37
|
1.17e-01
|
1.49e-01
|
2.96e-01
|
GO:0030155 regulation of cell
adhesion
|
18
|
2.75e-01
|
1.49e-01
|
4.90e-01
|
GO:1990837 sequence-specific
double-stranded DNA binding
|
47
|
7.80e-02
|
1.49e-01
|
2.34e-01
|
GO:0007611 learning or memory
|
15
|
3.19e-01
|
-1.49e-01
|
5.32e-01
|
GO:0060324 face development
|
14
|
3.37e-01
|
1.48e-01
|
5.48e-01
|
GO:0004177 aminopeptidase activity
|
13
|
3.55e-01
|
-1.48e-01
|
5.65e-01
|
GO:1990498 mitotic spindle
microtubule
|
10
|
4.17e-01
|
1.48e-01
|
6.26e-01
|
GO:0070301 cellular response to
hydrogen peroxide
|
23
|
2.19e-01
|
-1.48e-01
|
4.31e-01
|
GO:0030206 chondroitin sulfate
biosynthetic process
|
11
|
3.97e-01
|
1.48e-01
|
6.09e-01
|
GO:0001525 angiogenesis
|
86
|
1.84e-02
|
1.47e-01
|
8.54e-02
|
GO:0001784 phosphotyrosine residue
binding
|
27
|
1.87e-01
|
1.47e-01
|
3.96e-01
|
GO:0016529 sarcoplasmic reticulum
|
13
|
3.60e-01
|
1.47e-01
|
5.71e-01
|
GO:0030878 thyroid gland
development
|
14
|
3.42e-01
|
1.47e-01
|
5.53e-01
|
GO:0005385 zinc ion transmembrane
transporter activity
|
15
|
3.26e-01
|
-1.47e-01
|
5.38e-01
|
GO:0051117 ATPase binding
|
44
|
9.33e-02
|
-1.46e-01
|
2.60e-01
|
GO:0048488 synaptic vesicle
endocytosis
|
20
|
2.58e-01
|
1.46e-01
|
4.67e-01
|
GO:0070372 regulation of ERK1 and
ERK2 cascade
|
12
|
3.81e-01
|
1.46e-01
|
5.92e-01
|
GO:0030183 B cell differentiation
|
27
|
1.89e-01
|
1.46e-01
|
4.00e-01
|
GO:0030140 trans-Golgi network
transport vesicle
|
11
|
4.02e-01
|
-1.46e-01
|
6.16e-01
|
GO:0001968 fibronectin binding
|
10
|
4.24e-01
|
1.46e-01
|
6.33e-01
|
GO:0050681 nuclear androgen
receptor binding
|
16
|
3.13e-01
|
1.46e-01
|
5.26e-01
|
GO:0051216 cartilage development
|
20
|
2.59e-01
|
1.46e-01
|
4.70e-01
|
GO:0007507 heart development
|
78
|
2.63e-02
|
1.46e-01
|
1.09e-01
|
GO:0055085 transmembrane transport
|
82
|
2.29e-02
|
-1.45e-01
|
9.83e-02
|
GO:0060339 negative regulation of
type I interferon-mediated signaling pathway
|
13
|
3.65e-01
|
1.45e-01
|
5.76e-01
|
GO:0001508 action potential
|
11
|
4.05e-01
|
1.45e-01
|
6.18e-01
|
GO:0022008 neurogenesis
|
31
|
1.63e-01
|
1.45e-01
|
3.64e-01
|
GO:0070936 protein K48-linked
ubiquitination
|
68
|
3.94e-02
|
-1.45e-01
|
1.46e-01
|
GO:0042472 inner ear morphogenesis
|
27
|
1.96e-01
|
1.44e-01
|
4.05e-01
|
GO:0035987 endodermal cell
differentiation
|
22
|
2.43e-01
|
1.44e-01
|
4.54e-01
|
GO:1904263 positive regulation of
TORC1 signaling
|
35
|
1.42e-01
|
-1.44e-01
|
3.36e-01
|
GO:1904047 S-adenosyl-L-methionine
binding
|
13
|
3.71e-01
|
-1.43e-01
|
5.82e-01
|
GO:0006644 phospholipid metabolic
process
|
11
|
4.10e-01
|
-1.43e-01
|
6.21e-01
|
GO:0005669 transcription factor
TFIID complex
|
22
|
2.46e-01
|
-1.43e-01
|
4.57e-01
|
GO:0045197 establishment or
maintenance of epithelial cell apical/basal polarity
|
14
|
3.54e-01
|
1.43e-01
|
5.65e-01
|
GO:0015629 actin cytoskeleton
|
111
|
9.41e-03
|
1.43e-01
|
5.34e-02
|
GO:0015908 fatty acid transport
|
11
|
4.12e-01
|
1.43e-01
|
6.23e-01
|
GO:0001222 transcription
corepressor binding
|
27
|
1.99e-01
|
1.43e-01
|
4.09e-01
|
GO:0030163 protein catabolic
process
|
30
|
1.77e-01
|
1.43e-01
|
3.83e-01
|
GO:0043524 negative regulation of
neuron apoptotic process
|
51
|
7.95e-02
|
1.42e-01
|
2.35e-01
|
GO:0050830 defense response to
Gram-positive bacterium
|
15
|
3.41e-01
|
1.42e-01
|
5.52e-01
|
GO:0000724 double-strand break
repair via homologous recombination
|
71
|
3.98e-02
|
1.41e-01
|
1.47e-01
|
GO:0000387 spliceosomal snRNP
assembly
|
17
|
3.14e-01
|
-1.41e-01
|
5.27e-01
|
GO:0045211 postsynaptic membrane
|
57
|
6.61e-02
|
1.41e-01
|
2.09e-01
|
GO:0030659 cytoplasmic vesicle
membrane
|
43
|
1.10e-01
|
1.41e-01
|
2.88e-01
|
GO:0003007 heart morphogenesis
|
15
|
3.46e-01
|
1.41e-01
|
5.55e-01
|
GO:0016251 RNA polymerase II
general transcription initiation factor activity
|
22
|
2.56e-01
|
-1.40e-01
|
4.65e-01
|
GO:0032526 response to retinoic
acid
|
15
|
3.48e-01
|
1.40e-01
|
5.58e-01
|
GO:0070371 ERK1 and ERK2 cascade
|
20
|
2.79e-01
|
1.40e-01
|
4.95e-01
|
GO:0000974 Prp19 complex
|
10
|
4.44e-01
|
1.40e-01
|
6.48e-01
|
GO:0071230 cellular response to
amino acid stimulus
|
29
|
1.94e-01
|
-1.40e-01
|
4.04e-01
|
GO:0030672 synaptic vesicle
membrane
|
43
|
1.14e-01
|
-1.39e-01
|
2.91e-01
|
GO:0031012 extracellular matrix
|
88
|
2.46e-02
|
1.39e-01
|
1.03e-01
|
GO:0006468 protein phosphorylation
|
12
|
4.06e-01
|
1.39e-01
|
6.18e-01
|
GO:0030165 PDZ domain binding
|
29
|
1.98e-01
|
1.38e-01
|
4.08e-01
|
GO:0032924 activin receptor
signaling pathway
|
12
|
4.07e-01
|
1.38e-01
|
6.19e-01
|
GO:0051592 response to calcium ion
|
20
|
2.86e-01
|
-1.38e-01
|
5.00e-01
|
GO:0043113 receptor clustering
|
12
|
4.09e-01
|
-1.38e-01
|
6.20e-01
|
GO:0045453 bone resorption
|
11
|
4.31e-01
|
1.37e-01
|
6.37e-01
|
GO:0006261 DNA-templated DNA
replication
|
18
|
3.14e-01
|
1.37e-01
|
5.27e-01
|
GO:0031965 nuclear membrane
|
121
|
9.33e-03
|
1.37e-01
|
5.33e-02
|
GO:0071711 basement membrane
organization
|
11
|
4.33e-01
|
-1.37e-01
|
6.40e-01
|
GO:0006622 protein targeting to
lysosome
|
15
|
3.61e-01
|
-1.36e-01
|
5.72e-01
|
GO:1902042 negative regulation of
extrinsic apoptotic signaling pathway via death domain receptors
|
13
|
3.95e-01
|
1.36e-01
|
6.07e-01
|
GO:0030036 actin cytoskeleton
organization
|
107
|
1.51e-02
|
1.36e-01
|
7.49e-02
|
GO:0003756 protein disulfide
isomerase activity
|
10
|
4.56e-01
|
-1.36e-01
|
6.55e-01
|
GO:0034707 chloride channel complex
|
10
|
4.56e-01
|
1.36e-01
|
6.55e-01
|
GO:0032722 positive regulation of
chemokine production
|
11
|
4.35e-01
|
-1.36e-01
|
6.41e-01
|
GO:0019901 protein kinase binding
|
235
|
3.41e-04
|
1.36e-01
|
5.13e-03
|
GO:0043679 axon terminus
|
18
|
3.18e-01
|
1.36e-01
|
5.31e-01
|
GO:0016358 dendrite development
|
17
|
3.32e-01
|
1.36e-01
|
5.46e-01
|
GO:0004197 cysteine-type
endopeptidase activity
|
37
|
1.55e-01
|
-1.35e-01
|
3.53e-01
|
GO:0005254 chloride channel
activity
|
19
|
3.08e-01
|
1.35e-01
|
5.22e-01
|
GO:0060395 SMAD protein signal
transduction
|
14
|
3.82e-01
|
1.35e-01
|
5.92e-01
|
GO:0003924 GTPase activity
|
175
|
2.11e-03
|
-1.35e-01
|
1.95e-02
|
GO:0014032 neural crest cell
development
|
11
|
4.39e-01
|
-1.35e-01
|
6.45e-01
|
GO:0006869 lipid transport
|
26
|
2.35e-01
|
-1.35e-01
|
4.46e-01
|
GO:0007264 small GTPase-mediated
signal transduction
|
47
|
1.11e-01
|
1.35e-01
|
2.88e-01
|
GO:0001650 fibrillar center
|
102
|
1.92e-02
|
1.34e-01
|
8.74e-02
|
GO:0016485 protein processing
|
40
|
1.42e-01
|
-1.34e-01
|
3.37e-01
|
GO:0008168 methyltransferase
activity
|
13
|
4.03e-01
|
-1.34e-01
|
6.16e-01
|
GO:0090090 negative regulation of
canonical Wnt signaling pathway
|
70
|
5.33e-02
|
1.34e-01
|
1.80e-01
|
GO:0140311 protein sequestering
activity
|
18
|
3.26e-01
|
1.34e-01
|
5.38e-01
|
GO:0010906 regulation of glucose
metabolic process
|
10
|
4.67e-01
|
-1.33e-01
|
6.64e-01
|
GO:1900087 positive regulation of
G1/S transition of mitotic cell cycle
|
27
|
2.32e-01
|
1.33e-01
|
4.44e-01
|
GO:0000132 establishment of mitotic
spindle orientation
|
26
|
2.43e-01
|
1.32e-01
|
4.54e-01
|
GO:0046983 protein dimerization
activity
|
69
|
5.75e-02
|
1.32e-01
|
1.89e-01
|
GO:0030220 platelet formation
|
11
|
4.48e-01
|
1.32e-01
|
6.51e-01
|
GO:0032735 positive regulation of
interleukin-12 production
|
12
|
4.29e-01
|
1.32e-01
|
6.36e-01
|
GO:0006302 double-strand break
repair
|
45
|
1.26e-01
|
1.32e-01
|
3.10e-01
|
GO:0015813 L-glutamate
transmembrane transport
|
11
|
4.49e-01
|
1.32e-01
|
6.51e-01
|
GO:0030336 negative regulation of
cell migration
|
50
|
1.07e-01
|
1.32e-01
|
2.83e-01
|
GO:0001558 regulation of cell
growth
|
24
|
2.65e-01
|
1.31e-01
|
4.79e-01
|
GO:0001541 ovarian follicle
development
|
19
|
3.22e-01
|
1.31e-01
|
5.35e-01
|
GO:0005686 U2 snRNP
|
16
|
3.65e-01
|
1.31e-01
|
5.76e-01
|
GO:0008180 COP9 signalosome
|
21
|
3.00e-01
|
1.31e-01
|
5.12e-01
|
GO:0008630 intrinsic apoptotic
signaling pathway in response to DNA damage
|
24
|
2.67e-01
|
1.31e-01
|
4.82e-01
|
GO:0098794 postsynapse
|
66
|
6.66e-02
|
1.31e-01
|
2.10e-01
|
GO:0033209 tumor necrosis
factor-mediated signaling pathway
|
15
|
3.82e-01
|
-1.30e-01
|
5.92e-01
|
GO:0005811 lipid droplet
|
42
|
1.45e-01
|
-1.30e-01
|
3.42e-01
|
GO:0030154 cell differentiation
|
141
|
7.83e-03
|
1.30e-01
|
4.79e-02
|
GO:0045880 positive regulation of
smoothened signaling pathway
|
22
|
2.92e-01
|
1.30e-01
|
5.04e-01
|
GO:0006654 phosphatidic acid
biosynthetic process
|
11
|
4.56e-01
|
-1.30e-01
|
6.55e-01
|
GO:0072657 protein localization to
membrane
|
18
|
3.41e-01
|
1.30e-01
|
5.52e-01
|
GO:0008045 motor neuron axon
guidance
|
12
|
4.38e-01
|
1.29e-01
|
6.44e-01
|
GO:0035567 non-canonical Wnt
signaling pathway
|
13
|
4.20e-01
|
1.29e-01
|
6.30e-01
|
GO:0010842 retina layer formation
|
11
|
4.59e-01
|
1.29e-01
|
6.56e-01
|
GO:0048863 stem cell
differentiation
|
21
|
3.07e-01
|
1.29e-01
|
5.21e-01
|
GO:0046854 phosphatidylinositol
phosphate biosynthetic process
|
18
|
3.44e-01
|
1.29e-01
|
5.54e-01
|
GO:0099170 postsynaptic modulation
of chemical synaptic transmission
|
13
|
4.22e-01
|
1.29e-01
|
6.30e-01
|
GO:0051016 barbed-end actin
filament capping
|
15
|
3.89e-01
|
-1.28e-01
|
6.00e-01
|
GO:0070830 bicellular tight
junction assembly
|
19
|
3.33e-01
|
1.28e-01
|
5.46e-01
|
GO:0004198 calcium-dependent
cysteine-type endopeptidase activity
|
10
|
4.83e-01
|
1.28e-01
|
6.81e-01
|
GO:0043491 phosphatidylinositol
3-kinase/protein kinase B signal transduction
|
35
|
1.90e-01
|
1.28e-01
|
4.00e-01
|
GO:0001658 branching involved in
ureteric bud morphogenesis
|
16
|
3.76e-01
|
1.28e-01
|
5.86e-01
|
GO:0006270 DNA replication
initiation
|
19
|
3.35e-01
|
1.28e-01
|
5.48e-01
|
GO:0005905 clathrin-coated pit
|
30
|
2.26e-01
|
1.28e-01
|
4.39e-01
|
GO:0005929 cilium
|
77
|
5.29e-02
|
-1.28e-01
|
1.80e-01
|
GO:0005524 ATP binding
|
888
|
1.84e-10
|
1.27e-01
|
1.62e-08
|
GO:0005930 axoneme
|
48
|
1.28e-01
|
-1.27e-01
|
3.10e-01
|
GO:0005884 actin filament
|
43
|
1.49e-01
|
1.27e-01
|
3.48e-01
|
GO:0015026 coreceptor activity
|
13
|
4.28e-01
|
1.27e-01
|
6.36e-01
|
GO:0045724 positive regulation of
cilium assembly
|
13
|
4.28e-01
|
1.27e-01
|
6.36e-01
|
GO:0042734 presynaptic membrane
|
36
|
1.88e-01
|
1.27e-01
|
3.97e-01
|
GO:0004725 protein tyrosine
phosphatase activity
|
44
|
1.46e-01
|
1.27e-01
|
3.43e-01
|
GO:0003690 double-stranded DNA
binding
|
35
|
1.95e-01
|
1.27e-01
|
4.05e-01
|
GO:0030515 snoRNA binding
|
14
|
4.13e-01
|
1.26e-01
|
6.23e-01
|
GO:0006446 regulation of
translational initiation
|
17
|
3.67e-01
|
1.26e-01
|
5.79e-01
|
GO:0030512 negative regulation of
transforming growth factor beta receptor signaling pathway
|
41
|
1.62e-01
|
1.26e-01
|
3.63e-01
|
GO:0016282 eukaryotic 43S
preinitiation complex
|
14
|
4.14e-01
|
-1.26e-01
|
6.24e-01
|
GO:0008198 ferrous iron binding
|
12
|
4.50e-01
|
-1.26e-01
|
6.51e-01
|
GO:0001516 prostaglandin
biosynthetic process
|
10
|
4.91e-01
|
-1.26e-01
|
6.88e-01
|
GO:0031397 negative regulation of
protein ubiquitination
|
33
|
2.11e-01
|
-1.26e-01
|
4.22e-01
|
GO:0006914 autophagy
|
44
|
1.49e-01
|
-1.26e-01
|
3.47e-01
|
GO:0005634 nucleus
|
2123
|
1.73e-20
|
1.26e-01
|
6.09e-18
|
GO:0140627 ubiquitin-dependent
protein catabolic process via the C-end degron rule pathway
|
10
|
4.92e-01
|
-1.26e-01
|
6.88e-01
|
GO:0031901 early endosome membrane
|
75
|
6.14e-02
|
-1.25e-01
|
1.99e-01
|
GO:0003723 RNA binding
|
372
|
3.83e-05
|
1.25e-01
|
9.35e-04
|
GO:0050804 modulation of chemical
synaptic transmission
|
35
|
2.01e-01
|
1.25e-01
|
4.11e-01
|
GO:0034644 cellular response to UV
|
33
|
2.15e-01
|
1.25e-01
|
4.27e-01
|
GO:0008306 associative learning
|
10
|
4.95e-01
|
1.25e-01
|
6.92e-01
|
GO:0010628 positive regulation of
gene expression
|
147
|
9.26e-03
|
1.25e-01
|
5.30e-02
|
GO:0035331 negative regulation of
hippo signaling
|
18
|
3.62e-01
|
1.24e-01
|
5.72e-01
|
GO:0030544 Hsp70 protein binding
|
29
|
2.48e-01
|
-1.24e-01
|
4.59e-01
|
GO:0004721 phosphoprotein
phosphatase activity
|
21
|
3.26e-01
|
-1.24e-01
|
5.38e-01
|
GO:0045171 intercellular bridge
|
55
|
1.12e-01
|
1.24e-01
|
2.89e-01
|
GO:0030282 bone mineralization
|
22
|
3.15e-01
|
-1.24e-01
|
5.27e-01
|
GO:0098609 cell-cell adhesion
|
80
|
5.59e-02
|
1.24e-01
|
1.85e-01
|
GO:0002931 response to ischemia
|
10
|
4.99e-01
|
-1.23e-01
|
6.96e-01
|
GO:0005154 epidermal growth factor
receptor binding
|
19
|
3.52e-01
|
-1.23e-01
|
5.63e-01
|
GO:0002088 lens development in
camera-type eye
|
13
|
4.42e-01
|
1.23e-01
|
6.46e-01
|
GO:0090201 negative regulation of
release of cytochrome c from mitochondria
|
11
|
4.82e-01
|
-1.22e-01
|
6.81e-01
|
GO:2000773 negative regulation of
cellular senescence
|
12
|
4.65e-01
|
-1.22e-01
|
6.62e-01
|
GO:0032868 response to insulin
|
22
|
3.23e-01
|
1.22e-01
|
5.35e-01
|
GO:2000134 negative regulation of
G1/S transition of mitotic cell cycle
|
23
|
3.12e-01
|
1.22e-01
|
5.26e-01
|
GO:0045931 positive regulation of
mitotic cell cycle
|
14
|
4.31e-01
|
-1.22e-01
|
6.37e-01
|
GO:0048787 presynaptic active zone
membrane
|
11
|
4.86e-01
|
-1.21e-01
|
6.84e-01
|
GO:0071805 potassium ion
transmembrane transport
|
39
|
1.90e-01
|
-1.21e-01
|
4.00e-01
|
GO:0006367 transcription initiation
at RNA polymerase II promoter
|
20
|
3.49e-01
|
-1.21e-01
|
5.58e-01
|
GO:0140801 histone H2AXY142 kinase
activity
|
22
|
3.26e-01
|
1.21e-01
|
5.38e-01
|
GO:1904019 epithelial cell
apoptotic process
|
13
|
4.51e-01
|
1.21e-01
|
6.51e-01
|
GO:0043235 receptor complex
|
79
|
6.42e-02
|
1.21e-01
|
2.04e-01
|
GO:0019005 SCF ubiquitin ligase
complex
|
43
|
1.74e-01
|
-1.20e-01
|
3.80e-01
|
GO:0035249 synaptic transmission,
glutamatergic
|
16
|
4.07e-01
|
1.20e-01
|
6.19e-01
|
GO:0007275 multicellular organism
development
|
26
|
2.92e-01
|
1.19e-01
|
5.04e-01
|
GO:0005856 cytoskeleton
|
173
|
7.01e-03
|
1.19e-01
|
4.42e-02
|
GO:0016477 cell migration
|
135
|
1.72e-02
|
1.19e-01
|
8.17e-02
|
GO:0031514 motile cilium
|
35
|
2.24e-01
|
-1.19e-01
|
4.39e-01
|
GO:0051259 protein complex
oligomerization
|
14
|
4.42e-01
|
-1.19e-01
|
6.46e-01
|
GO:0007064 mitotic sister chromatid
cohesion
|
10
|
5.16e-01
|
1.19e-01
|
7.13e-01
|
GO:0035024 negative regulation of
Rho protein signal transduction
|
14
|
4.43e-01
|
-1.18e-01
|
6.46e-01
|
GO:0098586 cellular response to
virus
|
22
|
3.36e-01
|
1.18e-01
|
5.48e-01
|
GO:0015631 tubulin binding
|
27
|
2.88e-01
|
1.18e-01
|
5.00e-01
|
GO:0070050 neuron cellular
homeostasis
|
15
|
4.29e-01
|
-1.18e-01
|
6.36e-01
|
GO:0042254 ribosome biogenesis
|
16
|
4.15e-01
|
1.18e-01
|
6.24e-01
|
GO:0060326 cell chemotaxis
|
29
|
2.74e-01
|
1.17e-01
|
4.89e-01
|
GO:0004535 poly(A)-specific
ribonuclease activity
|
10
|
5.20e-01
|
-1.17e-01
|
7.17e-01
|
GO:0031072 heat shock protein
binding
|
27
|
2.93e-01
|
1.17e-01
|
5.04e-01
|
GO:0051879 Hsp90 protein binding
|
27
|
2.93e-01
|
1.17e-01
|
5.04e-01
|
GO:0030127 COPII vesicle coat
|
10
|
5.24e-01
|
-1.16e-01
|
7.17e-01
|
GO:0098719 sodium ion import across
plasma membrane
|
10
|
5.24e-01
|
1.16e-01
|
7.17e-01
|
GO:0030073 insulin secretion
|
13
|
4.68e-01
|
1.16e-01
|
6.66e-01
|
GO:0051894 positive regulation of
focal adhesion assembly
|
15
|
4.38e-01
|
1.16e-01
|
6.44e-01
|
GO:0009925 basal plasma membrane
|
12
|
4.89e-01
|
-1.15e-01
|
6.86e-01
|
GO:0048741 skeletal muscle fiber
development
|
16
|
4.26e-01
|
1.15e-01
|
6.34e-01
|
GO:0010971 positive regulation of
G2/M transition of mitotic cell cycle
|
15
|
4.41e-01
|
1.15e-01
|
6.46e-01
|
GO:0030424 axon
|
120
|
2.99e-02
|
1.15e-01
|
1.20e-01
|
GO:0045296 cadherin binding
|
28
|
2.93e-01
|
1.15e-01
|
5.04e-01
|
GO:0000077 DNA damage checkpoint
signaling
|
26
|
3.12e-01
|
1.15e-01
|
5.26e-01
|
GO:1904646 cellular response to
amyloid-beta
|
11
|
5.11e-01
|
-1.14e-01
|
7.08e-01
|
GO:0006611 protein export from
nucleus
|
22
|
3.54e-01
|
1.14e-01
|
5.64e-01
|
GO:0007605 sensory perception of
sound
|
53
|
1.51e-01
|
1.14e-01
|
3.49e-01
|
GO:0007059 chromosome segregation
|
41
|
2.07e-01
|
1.14e-01
|
4.19e-01
|
GO:0050919 negative chemotaxis
|
21
|
3.68e-01
|
-1.14e-01
|
5.79e-01
|
GO:0099560 synaptic membrane
adhesion
|
14
|
4.63e-01
|
1.13e-01
|
6.60e-01
|
GO:0019905 syntaxin binding
|
25
|
3.27e-01
|
-1.13e-01
|
5.39e-01
|
GO:0045727 positive regulation of
translation
|
36
|
2.40e-01
|
1.13e-01
|
4.52e-01
|
GO:0030971 receptor tyrosine kinase
binding
|
32
|
2.69e-01
|
1.13e-01
|
4.84e-01
|
GO:0046716 muscle cell cellular
homeostasis
|
15
|
4.51e-01
|
-1.12e-01
|
6.51e-01
|
GO:0000307 cyclin-dependent protein
kinase holoenzyme complex
|
21
|
3.73e-01
|
-1.12e-01
|
5.85e-01
|
GO:0048384 retinoic acid receptor
signaling pathway
|
11
|
5.20e-01
|
1.12e-01
|
7.17e-01
|
GO:0045814 negative regulation of
gene expression, epigenetic
|
16
|
4.39e-01
|
1.12e-01
|
6.45e-01
|
GO:0048568 embryonic organ
development
|
15
|
4.57e-01
|
1.11e-01
|
6.55e-01
|
GO:0097730 non-motile cilium
|
15
|
4.57e-01
|
-1.11e-01
|
6.55e-01
|
GO:0070847 core mediator complex
|
19
|
4.03e-01
|
-1.11e-01
|
6.16e-01
|
GO:0043588 skin development
|
23
|
3.58e-01
|
1.11e-01
|
5.68e-01
|
GO:0009566 fertilization
|
12
|
5.07e-01
|
1.11e-01
|
7.05e-01
|
GO:0035591 signaling adaptor
activity
|
40
|
2.28e-01
|
1.10e-01
|
4.39e-01
|
GO:0033173 calcineurin-NFAT
signaling cascade
|
10
|
5.46e-01
|
1.10e-01
|
7.36e-01
|
GO:0030521 androgen receptor
signaling pathway
|
12
|
5.09e-01
|
1.10e-01
|
7.06e-01
|
GO:0004879 nuclear receptor
activity
|
39
|
2.35e-01
|
1.10e-01
|
4.46e-01
|
GO:0097550 transcription
preinitiation complex
|
12
|
5.11e-01
|
-1.10e-01
|
7.08e-01
|
GO:0001778 plasma membrane repair
|
16
|
4.50e-01
|
-1.09e-01
|
6.51e-01
|
GO:0005847 mRNA cleavage and
polyadenylation specificity factor complex
|
11
|
5.31e-01
|
1.09e-01
|
7.22e-01
|
GO:0045672 positive regulation of
osteoclast differentiation
|
11
|
5.31e-01
|
1.09e-01
|
7.22e-01
|
GO:0006417 regulation of
translation
|
44
|
2.12e-01
|
1.09e-01
|
4.23e-01
|
GO:0035861 site of double-strand
break
|
58
|
1.54e-01
|
1.08e-01
|
3.53e-01
|
GO:2001243 negative regulation of
intrinsic apoptotic signaling pathway
|
13
|
5.01e-01
|
1.08e-01
|
6.97e-01
|
GO:0045600 positive regulation of
fat cell differentiation
|
21
|
3.94e-01
|
1.07e-01
|
6.06e-01
|
GO:0008270 zinc ion binding
|
398
|
2.61e-04
|
1.07e-01
|
4.25e-03
|
GO:0035401 histone H3Y41 kinase
activity
|
21
|
3.95e-01
|
1.07e-01
|
6.07e-01
|
GO:0005788 endoplasmic reticulum
lumen
|
40
|
2.41e-01
|
-1.07e-01
|
4.52e-01
|
GO:0005938 cell cortex
|
75
|
1.10e-01
|
1.07e-01
|
2.88e-01
|
GO:0045785 positive regulation of
cell adhesion
|
15
|
4.75e-01
|
1.07e-01
|
6.73e-01
|
GO:0051496 positive regulation of
stress fiber assembly
|
31
|
3.05e-01
|
1.07e-01
|
5.18e-01
|
GO:0045177 apical part of cell
|
34
|
2.83e-01
|
1.07e-01
|
4.96e-01
|
GO:0004888 transmembrane signaling
receptor activity
|
23
|
3.77e-01
|
-1.06e-01
|
5.87e-01
|
GO:0097192 extrinsic apoptotic
signaling pathway in absence of ligand
|
12
|
5.24e-01
|
1.06e-01
|
7.17e-01
|
GO:0030018 Z disc
|
49
|
2.00e-01
|
1.06e-01
|
4.09e-01
|
GO:0030218 erythrocyte
differentiation
|
28
|
3.33e-01
|
1.06e-01
|
5.46e-01
|
GO:0019903 protein phosphatase
binding
|
49
|
2.00e-01
|
1.06e-01
|
4.10e-01
|
GO:0003684 damaged DNA binding
|
34
|
2.86e-01
|
1.06e-01
|
5.00e-01
|
GO:0005802 trans-Golgi network
|
99
|
6.97e-02
|
-1.06e-01
|
2.17e-01
|
GO:0032456 endocytic recycling
|
42
|
2.37e-01
|
-1.06e-01
|
4.47e-01
|
GO:0030332 cyclin binding
|
20
|
4.15e-01
|
1.05e-01
|
6.24e-01
|
GO:0001501 skeletal system
development
|
34
|
2.88e-01
|
1.05e-01
|
5.00e-01
|
GO:0036503 ERAD pathway
|
59
|
1.62e-01
|
-1.05e-01
|
3.63e-01
|
GO:0012507 ER to Golgi transport
vesicle membrane
|
11
|
5.46e-01
|
1.05e-01
|
7.36e-01
|
GO:0008023 transcription elongation
factor complex
|
14
|
4.97e-01
|
1.05e-01
|
6.94e-01
|
GO:0071456 cellular response to
hypoxia
|
34
|
2.90e-01
|
1.05e-01
|
5.03e-01
|
GO:0030295 protein kinase activator
activity
|
21
|
4.06e-01
|
1.05e-01
|
6.18e-01
|
GO:0006513 protein
monoubiquitination
|
27
|
3.47e-01
|
-1.05e-01
|
5.56e-01
|
GO:0005525 GTP binding
|
211
|
9.05e-03
|
-1.05e-01
|
5.23e-02
|
GO:0030010 establishment of cell
polarity
|
18
|
4.45e-01
|
1.04e-01
|
6.49e-01
|
GO:0051015 actin filament binding
|
116
|
5.46e-02
|
1.03e-01
|
1.83e-01
|
GO:0045766 positive regulation of
angiogenesis
|
53
|
1.94e-01
|
1.03e-01
|
4.04e-01
|
GO:0055088 lipid homeostasis
|
18
|
4.51e-01
|
-1.03e-01
|
6.51e-01
|
GO:0005643 nuclear pore
|
33
|
3.07e-01
|
1.03e-01
|
5.21e-01
|
GO:0051260 protein
homooligomerization
|
48
|
2.19e-01
|
1.03e-01
|
4.31e-01
|
GO:0050750 low-density lipoprotein
particle receptor binding
|
12
|
5.40e-01
|
1.02e-01
|
7.31e-01
|
GO:0060612 adipose tissue
development
|
23
|
3.97e-01
|
-1.02e-01
|
6.09e-01
|
GO:0043025 neuronal cell body
|
83
|
1.09e-01
|
1.02e-01
|
2.86e-01
|
GO:0003755 peptidyl-prolyl
cis-trans isomerase activity
|
30
|
3.37e-01
|
-1.01e-01
|
5.48e-01
|
GO:1901673 regulation of mitotic
spindle assembly
|
16
|
4.84e-01
|
-1.01e-01
|
6.82e-01
|
GO:0032588 trans-Golgi network
membrane
|
25
|
3.82e-01
|
-1.01e-01
|
5.92e-01
|
GO:0098656 monoatomic anion
transmembrane transport
|
18
|
4.58e-01
|
-1.01e-01
|
6.56e-01
|
GO:0006006 glucose metabolic
process
|
26
|
3.73e-01
|
-1.01e-01
|
5.85e-01
|
GO:0030199 collagen fibril
organization
|
31
|
3.31e-01
|
-1.01e-01
|
5.44e-01
|
GO:0044389 ubiquitin-like protein
ligase binding
|
16
|
4.85e-01
|
1.01e-01
|
6.83e-01
|
GO:0005654 nucleoplasm
|
1531
|
1.35e-10
|
1.00e-01
|
1.25e-08
|
GO:0030496 midbody
|
100
|
8.51e-02
|
9.98e-02
|
2.44e-01
|
GO:0051781 positive regulation of
cell division
|
12
|
5.50e-01
|
-9.97e-02
|
7.38e-01
|
GO:0019915 lipid storage
|
11
|
5.67e-01
|
9.97e-02
|
7.53e-01
|
GO:0008237 metallopeptidase
activity
|
12
|
5.50e-01
|
9.96e-02
|
7.38e-01
|
GO:0010629 negative regulation of
gene expression
|
102
|
8.34e-02
|
9.93e-02
|
2.41e-01
|
GO:0042327 positive regulation of
phosphorylation
|
12
|
5.52e-01
|
-9.92e-02
|
7.39e-01
|
GO:0046580 negative regulation of
Ras protein signal transduction
|
13
|
5.36e-01
|
-9.92e-02
|
7.26e-01
|
GO:0001666 response to hypoxia
|
50
|
2.26e-01
|
9.91e-02
|
4.39e-01
|
GO:0009982 pseudouridine synthase
activity
|
12
|
5.53e-01
|
-9.90e-02
|
7.40e-01
|
GO:0030324 lung development
|
35
|
3.11e-01
|
-9.89e-02
|
5.26e-01
|
GO:0050853 B cell receptor
signaling pathway
|
19
|
4.57e-01
|
9.86e-02
|
6.55e-01
|
GO:0001649 osteoblast
differentiation
|
39
|
2.87e-01
|
9.85e-02
|
5.00e-01
|
GO:0044331 cell-cell adhesion
mediated by cadherin
|
11
|
5.72e-01
|
-9.84e-02
|
7.55e-01
|
GO:0019706 protein-cysteine
S-palmitoyltransferase activity
|
17
|
4.84e-01
|
-9.81e-02
|
6.82e-01
|
GO:0051087 protein-folding
chaperone binding
|
55
|
2.09e-01
|
-9.80e-02
|
4.20e-01
|
GO:0005009 insulin receptor
activity
|
14
|
5.29e-01
|
9.72e-02
|
7.21e-01
|
GO:0005689 U12-type spliceosomal
complex
|
20
|
4.52e-01
|
-9.71e-02
|
6.52e-01
|
GO:0006268 DNA unwinding involved
in DNA replication
|
14
|
5.31e-01
|
9.68e-02
|
7.22e-01
|
GO:0007628 adult walking behavior
|
13
|
5.46e-01
|
9.67e-02
|
7.36e-01
|
GO:0030326 embryonic limb
morphogenesis
|
14
|
5.32e-01
|
9.66e-02
|
7.22e-01
|
GO:0000398 mRNA splicing, via
spliceosome
|
87
|
1.20e-01
|
9.65e-02
|
3.00e-01
|
GO:0090110 COPII-coated vesicle
cargo loading
|
10
|
5.97e-01
|
9.65e-02
|
7.69e-01
|
GO:0048701 embryonic cranial
skeleton morphogenesis
|
13
|
5.48e-01
|
-9.63e-02
|
7.36e-01
|
GO:1990166 protein localization to
site of double-strand break
|
10
|
6.01e-01
|
9.56e-02
|
7.72e-01
|
GO:0005635 nuclear envelope
|
76
|
1.51e-01
|
-9.53e-02
|
3.49e-01
|
GO:0046426 negative regulation of
receptor signaling pathway via JAK-STAT
|
11
|
5.85e-01
|
-9.52e-02
|
7.63e-01
|
GO:0008092 cytoskeletal protein
binding
|
15
|
5.24e-01
|
-9.51e-02
|
7.17e-01
|
GO:0051607 defense response to
virus
|
55
|
2.25e-01
|
9.46e-02
|
4.39e-01
|
GO:0071549 cellular response to
dexamethasone stimulus
|
11
|
5.88e-01
|
9.44e-02
|
7.63e-01
|
GO:0030501 positive regulation of
bone mineralization
|
14
|
5.42e-01
|
-9.41e-02
|
7.33e-01
|
GO:0009617 response to bacterium
|
34
|
3.44e-01
|
-9.38e-02
|
5.54e-01
|
GO:0005685 U1 snRNP
|
12
|
5.74e-01
|
-9.38e-02
|
7.56e-01
|
GO:0030374 nuclear receptor
coactivator activity
|
30
|
3.75e-01
|
9.37e-02
|
5.85e-01
|
GO:0005925 focal adhesion
|
113
|
8.62e-02
|
9.36e-02
|
2.46e-01
|
GO:0006915 apoptotic process
|
135
|
6.10e-02
|
-9.35e-02
|
1.97e-01
|
GO:0001764 neuron migration
|
37
|
3.25e-01
|
9.35e-02
|
5.38e-01
|
GO:0016757 glycosyltransferase
activity
|
13
|
5.60e-01
|
-9.34e-02
|
7.46e-01
|
GO:0006882 intracellular zinc ion
homeostasis
|
12
|
5.76e-01
|
-9.32e-02
|
7.58e-01
|
GO:0019838 growth factor binding
|
11
|
5.94e-01
|
9.29e-02
|
7.67e-01
|
GO:0019955 cytokine binding
|
11
|
5.94e-01
|
9.29e-02
|
7.67e-01
|
GO:0046872 metal ion binding
|
868
|
4.52e-06
|
9.27e-02
|
1.89e-04
|
GO:0048144 fibroblast proliferation
|
22
|
4.53e-01
|
-9.24e-02
|
6.53e-01
|
GO:0048009 insulin-like growth
factor receptor signaling pathway
|
31
|
3.74e-01
|
9.23e-02
|
5.85e-01
|
GO:0007338 single fertilization
|
20
|
4.76e-01
|
-9.22e-02
|
6.74e-01
|
GO:0043596 nuclear replication fork
|
10
|
6.15e-01
|
-9.19e-02
|
7.80e-01
|
GO:0000226 microtubule cytoskeleton
organization
|
68
|
1.92e-01
|
9.16e-02
|
4.03e-01
|
GO:0098978 glutamatergic synapse
|
230
|
1.70e-02
|
9.16e-02
|
8.12e-02
|
GO:0031175 neuron projection
development
|
49
|
2.68e-01
|
9.15e-02
|
4.82e-01
|
GO:0120162 positive regulation of
cold-induced thermogenesis
|
30
|
3.86e-01
|
-9.15e-02
|
5.96e-01
|
GO:0034451 centriolar satellite
|
73
|
1.78e-01
|
9.14e-02
|
3.83e-01
|
GO:0009636 response to toxic
substance
|
15
|
5.40e-01
|
-9.13e-02
|
7.31e-01
|
GO:0006730 one-carbon metabolic
process
|
13
|
5.69e-01
|
-9.11e-02
|
7.54e-01
|
GO:0030308 negative regulation of
cell growth
|
42
|
3.08e-01
|
9.10e-02
|
5.21e-01
|
GO:0034394 protein localization to
cell surface
|
17
|
5.16e-01
|
9.09e-02
|
7.13e-01
|
GO:0061436 establishment of skin
barrier
|
13
|
5.71e-01
|
9.09e-02
|
7.54e-01
|
GO:0005975 carbohydrate metabolic
process
|
49
|
2.74e-01
|
-9.03e-02
|
4.89e-01
|
GO:0042605 peptide antigen binding
|
10
|
6.21e-01
|
9.03e-02
|
7.83e-01
|
GO:0098793 presynapse
|
63
|
2.16e-01
|
9.02e-02
|
4.28e-01
|
GO:0032259 methylation
|
76
|
1.75e-01
|
-9.02e-02
|
3.80e-01
|
GO:0042274 ribosomal small subunit
biogenesis
|
44
|
3.02e-01
|
-9.01e-02
|
5.14e-01
|
GO:0000902 cell morphogenesis
|
54
|
2.53e-01
|
9.00e-02
|
4.62e-01
|
GO:0007265 Ras protein signal
transduction
|
37
|
3.44e-01
|
9.00e-02
|
5.54e-01
|
GO:0051965 positive regulation of
synapse assembly
|
21
|
4.76e-01
|
8.98e-02
|
6.74e-01
|
GO:0005080 protein kinase C binding
|
17
|
5.22e-01
|
8.96e-02
|
7.17e-01
|
GO:0071944 cell periphery
|
12
|
5.91e-01
|
-8.96e-02
|
7.65e-01
|
GO:0001817 regulation of cytokine
production
|
26
|
4.30e-01
|
-8.95e-02
|
6.36e-01
|
GO:0098655 monoatomic cation
transmembrane transport
|
13
|
5.76e-01
|
-8.95e-02
|
7.58e-01
|
GO:0031410 cytoplasmic vesicle
|
105
|
1.14e-01
|
8.93e-02
|
2.91e-01
|
GO:0042593 glucose homeostasis
|
43
|
3.13e-01
|
-8.90e-02
|
5.26e-01
|
GO:0032040 small-subunit processome
|
59
|
2.38e-01
|
-8.90e-02
|
4.49e-01
|
GO:0006457 protein folding
|
81
|
1.68e-01
|
-8.87e-02
|
3.70e-01
|
GO:0007623 circadian rhythm
|
18
|
5.15e-01
|
8.86e-02
|
7.13e-01
|
GO:0098982 GABA-ergic synapse
|
29
|
4.09e-01
|
-8.85e-02
|
6.20e-01
|
GO:0005507 copper ion binding
|
23
|
4.63e-01
|
-8.84e-02
|
6.61e-01
|
GO:0010468 regulation of gene
expression
|
57
|
2.49e-01
|
8.83e-02
|
4.60e-01
|
GO:0007612 learning
|
13
|
5.82e-01
|
8.81e-02
|
7.63e-01
|
GO:0007519 skeletal muscle tissue
development
|
17
|
5.30e-01
|
-8.81e-02
|
7.21e-01
|
GO:0050870 positive regulation of T
cell activation
|
14
|
5.69e-01
|
-8.80e-02
|
7.54e-01
|
GO:0043161 proteasome-mediated
ubiquitin-dependent protein catabolic process
|
155
|
5.93e-02
|
-8.79e-02
|
1.93e-01
|
GO:0060391 positive regulation of
SMAD protein signal transduction
|
11
|
6.14e-01
|
-8.79e-02
|
7.80e-01
|
GO:0098552 side of membrane
|
14
|
5.70e-01
|
-8.76e-02
|
7.54e-01
|
GO:0034976 response to endoplasmic
reticulum stress
|
34
|
3.77e-01
|
-8.75e-02
|
5.87e-01
|
GO:0008361 regulation of cell size
|
13
|
5.85e-01
|
8.75e-02
|
7.63e-01
|
GO:0090543 Flemming body
|
14
|
5.71e-01
|
8.75e-02
|
7.54e-01
|
GO:0050731 positive regulation of
peptidyl-tyrosine phosphorylation
|
29
|
4.16e-01
|
8.73e-02
|
6.25e-01
|
GO:0071346 cellular response to
type II interferon
|
24
|
4.62e-01
|
8.68e-02
|
6.59e-01
|
GO:0071782 endoplasmic reticulum
tubular network
|
12
|
6.03e-01
|
-8.67e-02
|
7.72e-01
|
GO:0050769 positive regulation of
neurogenesis
|
12
|
6.03e-01
|
8.67e-02
|
7.72e-01
|
GO:0000082 G1/S transition of
mitotic cell cycle
|
40
|
3.43e-01
|
8.66e-02
|
5.54e-01
|
GO:0007613 memory
|
28
|
4.28e-01
|
-8.66e-02
|
6.36e-01
|
GO:0007020 microtubule nucleation
|
14
|
5.77e-01
|
8.61e-02
|
7.58e-01
|
GO:2001237 negative regulation of
extrinsic apoptotic signaling pathway
|
19
|
5.17e-01
|
8.60e-02
|
7.13e-01
|
GO:0045668 negative regulation of
osteoblast differentiation
|
27
|
4.40e-01
|
8.59e-02
|
6.45e-01
|
GO:0000151 ubiquitin ligase complex
|
48
|
3.04e-01
|
-8.58e-02
|
5.18e-01
|
GO:0036342 post-anal tail
morphogenesis
|
11
|
6.23e-01
|
8.56e-02
|
7.84e-01
|
GO:0071363 cellular response to
growth factor stimulus
|
19
|
5.21e-01
|
8.52e-02
|
7.17e-01
|
GO:0010975 regulation of neuron
projection development
|
16
|
5.56e-01
|
8.50e-02
|
7.42e-01
|
GO:0007219 Notch signaling pathway
|
40
|
3.53e-01
|
8.50e-02
|
5.63e-01
|
GO:2000378 negative regulation of
reactive oxygen species metabolic process
|
10
|
6.42e-01
|
-8.49e-02
|
7.96e-01
|
GO:0007608 sensory perception of
smell
|
11
|
6.27e-01
|
-8.47e-02
|
7.87e-01
|
GO:1904294 positive regulation of
ERAD pathway
|
10
|
6.44e-01
|
-8.44e-02
|
7.98e-01
|
GO:0000400 four-way junction DNA
binding
|
14
|
5.86e-01
|
8.41e-02
|
7.63e-01
|
GO:0032587 ruffle membrane
|
41
|
3.52e-01
|
8.41e-02
|
5.63e-01
|
GO:0017124 SH3 domain binding
|
43
|
3.41e-01
|
-8.40e-02
|
5.52e-01
|
GO:0048854 brain morphogenesis
|
14
|
5.88e-01
|
-8.37e-02
|
7.63e-01
|
GO:0006486 protein glycosylation
|
44
|
3.38e-01
|
-8.36e-02
|
5.48e-01
|
GO:0001530 lipopolysaccharide
binding
|
13
|
6.02e-01
|
-8.36e-02
|
7.72e-01
|
GO:0050728 negative regulation of
inflammatory response
|
48
|
3.19e-01
|
-8.31e-02
|
5.32e-01
|
GO:0043001 Golgi to plasma membrane
protein transport
|
21
|
5.11e-01
|
-8.28e-02
|
7.08e-01
|
GO:0005178 integrin binding
|
65
|
2.49e-01
|
-8.27e-02
|
4.60e-01
|
GO:0016042 lipid catabolic process
|
28
|
4.49e-01
|
-8.27e-02
|
6.51e-01
|
GO:0007169 cell surface receptor
protein tyrosine kinase signaling pathway
|
42
|
3.57e-01
|
8.22e-02
|
5.67e-01
|
GO:0048147 negative regulation of
fibroblast proliferation
|
14
|
5.96e-01
|
8.18e-02
|
7.69e-01
|
GO:0072542 protein phosphatase
activator activity
|
10
|
6.55e-01
|
8.17e-02
|
8.07e-01
|
GO:0015701 bicarbonate transport
|
11
|
6.40e-01
|
-8.15e-02
|
7.95e-01
|
GO:1990904 ribonucleoprotein
complex
|
105
|
1.50e-01
|
8.14e-02
|
3.49e-01
|
GO:0042391 regulation of membrane
potential
|
11
|
6.41e-01
|
-8.12e-02
|
7.96e-01
|
GO:0038063 collagen-activated
tyrosine kinase receptor signaling pathway
|
15
|
5.87e-01
|
8.10e-02
|
7.63e-01
|
GO:0002250 adaptive immune response
|
21
|
5.21e-01
|
-8.08e-02
|
7.17e-01
|
GO:0031167 rRNA methylation
|
11
|
6.43e-01
|
-8.08e-02
|
7.97e-01
|
GO:0004867 serine-type
endopeptidase inhibitor activity
|
21
|
5.24e-01
|
8.04e-02
|
7.17e-01
|
GO:0070300 phosphatidic acid
binding
|
13
|
6.16e-01
|
8.04e-02
|
7.80e-01
|
GO:0007281 germ cell development
|
14
|
6.03e-01
|
8.02e-02
|
7.72e-01
|
GO:0006623 protein targeting to
vacuole
|
11
|
6.48e-01
|
7.96e-02
|
8.01e-01
|
GO:0046326 positive regulation of
D-glucose import
|
14
|
6.06e-01
|
-7.95e-02
|
7.75e-01
|
GO:0042098 T cell proliferation
|
16
|
5.83e-01
|
7.93e-02
|
7.63e-01
|
GO:0031146 SCF-dependent
proteasomal ubiquitin-dependent protein catabolic process
|
28
|
4.69e-01
|
-7.91e-02
|
6.66e-01
|
GO:0002244 hematopoietic progenitor
cell differentiation
|
35
|
4.20e-01
|
7.88e-02
|
6.30e-01
|
GO:0044322 endoplasmic reticulum
quality control compartment
|
11
|
6.52e-01
|
-7.85e-02
|
8.05e-01
|
GO:0038023 signaling receptor
activity
|
41
|
3.86e-01
|
7.82e-02
|
5.96e-01
|
GO:0006629 lipid metabolic process
|
52
|
3.31e-01
|
-7.79e-02
|
5.44e-01
|
GO:0005901 caveola
|
28
|
4.76e-01
|
-7.79e-02
|
6.74e-01
|
GO:0051649 establishment of
localization in cell
|
38
|
4.08e-01
|
-7.76e-02
|
6.19e-01
|
GO:0030225 macrophage
differentiation
|
11
|
6.57e-01
|
-7.75e-02
|
8.09e-01
|
GO:0097225 sperm midpiece
|
15
|
6.04e-01
|
7.74e-02
|
7.72e-01
|
GO:0031982 vesicle
|
27
|
4.87e-01
|
7.73e-02
|
6.84e-01
|
GO:0004222 metalloendopeptidase
activity
|
50
|
3.45e-01
|
7.72e-02
|
5.55e-01
|
GO:0005615 extracellular space
|
399
|
8.50e-03
|
-7.71e-02
|
5.03e-02
|
GO:0010506 regulation of autophagy
|
26
|
4.98e-01
|
7.68e-02
|
6.95e-01
|
GO:0007080 mitotic metaphase
chromosome alignment
|
23
|
5.27e-01
|
-7.62e-02
|
7.19e-01
|
GO:0004864 protein phosphatase
inhibitor activity
|
13
|
6.34e-01
|
-7.62e-02
|
7.91e-01
|
GO:0009408 response to heat
|
19
|
5.67e-01
|
-7.59e-02
|
7.53e-01
|
GO:0032731 positive regulation of
interleukin-1 beta production
|
12
|
6.49e-01
|
7.58e-02
|
8.02e-01
|
GO:0051301 cell division
|
144
|
1.18e-01
|
7.56e-02
|
2.97e-01
|
GO:0032760 positive regulation of
tumor necrosis factor production
|
34
|
4.47e-01
|
7.54e-02
|
6.51e-01
|
GO:0030593 neutrophil chemotaxis
|
13
|
6.38e-01
|
7.54e-02
|
7.94e-01
|
GO:0000939 inner kinetochore
|
10
|
6.80e-01
|
7.54e-02
|
8.24e-01
|
GO:0016853 isomerase activity
|
19
|
5.70e-01
|
7.52e-02
|
7.54e-01
|
GO:0000287 magnesium ion binding
|
149
|
1.14e-01
|
-7.51e-02
|
2.91e-01
|
GO:0006493 protein O-linked
glycosylation
|
28
|
4.92e-01
|
-7.51e-02
|
6.88e-01
|
GO:0061744 motor behavior
|
16
|
6.03e-01
|
7.50e-02
|
7.72e-01
|
GO:0031398 positive regulation of
protein ubiquitination
|
40
|
4.14e-01
|
-7.46e-02
|
6.24e-01
|
GO:0007166 cell surface receptor
signaling pathway
|
40
|
4.15e-01
|
7.46e-02
|
6.24e-01
|
GO:0030838 positive regulation of
actin filament polymerization
|
27
|
5.03e-01
|
-7.44e-02
|
7.00e-01
|
GO:0000922 spindle pole
|
68
|
2.91e-01
|
7.42e-02
|
5.03e-01
|
GO:0001654 eye development
|
17
|
5.97e-01
|
-7.41e-02
|
7.69e-01
|
GO:0007286 spermatid development
|
25
|
5.21e-01
|
-7.41e-02
|
7.17e-01
|
GO:0001568 blood vessel development
|
18
|
5.86e-01
|
7.41e-02
|
7.63e-01
|
GO:0035025 positive regulation of
Rho protein signal transduction
|
10
|
6.86e-01
|
-7.39e-02
|
8.30e-01
|
GO:0042626 ATPase-coupled
transmembrane transporter activity
|
16
|
6.09e-01
|
7.38e-02
|
7.77e-01
|
GO:0033192 calmodulin-dependent
protein phosphatase activity
|
16
|
6.10e-01
|
-7.36e-02
|
7.78e-01
|
GO:0007165 signal transduction
|
263
|
4.08e-02
|
7.35e-02
|
1.50e-01
|
GO:0016460 myosin II complex
|
12
|
6.60e-01
|
7.33e-02
|
8.12e-01
|
GO:0006352 DNA-templated
transcription initiation
|
11
|
6.74e-01
|
7.32e-02
|
8.20e-01
|
GO:0016740 transferase activity
|
23
|
5.44e-01
|
-7.31e-02
|
7.34e-01
|
GO:0006893 Golgi to plasma membrane
transport
|
19
|
5.81e-01
|
7.31e-02
|
7.62e-01
|
GO:0007229 integrin-mediated
signaling pathway
|
44
|
4.04e-01
|
7.27e-02
|
6.17e-01
|
GO:0070536 protein K63-linked
deubiquitination
|
16
|
6.16e-01
|
7.25e-02
|
7.80e-01
|
GO:0007368 determination of
left/right symmetry
|
28
|
5.07e-01
|
-7.25e-02
|
7.04e-01
|
GO:0010608 post-transcriptional
regulation of gene expression
|
11
|
6.78e-01
|
7.24e-02
|
8.24e-01
|
GO:0097190 apoptotic signaling
pathway
|
20
|
5.77e-01
|
7.21e-02
|
7.58e-01
|
GO:0050714 positive regulation of
protein secretion
|
19
|
5.87e-01
|
7.21e-02
|
7.63e-01
|
GO:0040018 positive regulation of
multicellular organism growth
|
16
|
6.18e-01
|
7.20e-02
|
7.81e-01
|
GO:0032418 lysosome localization
|
23
|
5.50e-01
|
-7.20e-02
|
7.38e-01
|
GO:0000159 protein phosphatase type
2A complex
|
12
|
6.66e-01
|
-7.20e-02
|
8.16e-01
|
GO:0007517 muscle organ development
|
12
|
6.68e-01
|
-7.16e-02
|
8.17e-01
|
GO:0020037 heme binding
|
50
|
3.83e-01
|
-7.13e-02
|
5.93e-01
|
GO:0048786 presynaptic active zone
|
10
|
6.97e-01
|
7.11e-02
|
8.36e-01
|
GO:0003676 nucleic acid binding
|
106
|
2.09e-01
|
7.07e-02
|
4.20e-01
|
GO:0140664 ATP-dependent DNA damage
sensor activity
|
14
|
6.47e-01
|
7.06e-02
|
8.01e-01
|
GO:0048012 hepatocyte growth factor
receptor signaling pathway
|
17
|
6.15e-01
|
7.05e-02
|
7.80e-01
|
GO:0019886 antigen processing and
presentation of exogenous peptide antigen via MHC class II
|
12
|
6.73e-01
|
7.04e-02
|
8.20e-01
|
GO:0006783 heme biosynthetic
process
|
10
|
7.01e-01
|
-7.01e-02
|
8.38e-01
|
GO:0031573 mitotic intra-S DNA
damage checkpoint signaling
|
11
|
6.88e-01
|
-7.00e-02
|
8.30e-01
|
GO:0048008 platelet-derived growth
factor receptor signaling pathway
|
17
|
6.18e-01
|
-6.99e-02
|
7.81e-01
|
GO:0005801 cis-Golgi network
|
28
|
5.24e-01
|
-6.96e-02
|
7.17e-01
|
GO:0047496 vesicle transport along
microtubule
|
11
|
6.91e-01
|
6.91e-02
|
8.31e-01
|
GO:0005814 centriole
|
92
|
2.53e-01
|
6.90e-02
|
4.62e-01
|
GO:0051402 neuron apoptotic process
|
42
|
4.41e-01
|
6.87e-02
|
6.46e-01
|
GO:0097191 extrinsic apoptotic
signaling pathway
|
20
|
5.97e-01
|
6.83e-02
|
7.69e-01
|
GO:0000712 resolution of meiotic
recombination intermediates
|
14
|
6.61e-01
|
6.77e-02
|
8.12e-01
|
GO:0141198 protein branched
polyubiquitination
|
13
|
6.73e-01
|
6.75e-02
|
8.20e-01
|
GO:0034244 negative regulation of
transcription elongation by RNA polymerase II
|
13
|
6.74e-01
|
6.74e-02
|
8.20e-01
|
GO:0035725 sodium ion transmembrane
transport
|
48
|
4.20e-01
|
-6.73e-02
|
6.30e-01
|
GO:0036297 interstrand cross-link
repair
|
24
|
5.69e-01
|
-6.72e-02
|
7.54e-01
|
GO:0004181 metallocarboxypeptidase
activity
|
11
|
7.01e-01
|
6.70e-02
|
8.38e-01
|
GO:0070063 RNA polymerase binding
|
12
|
6.88e-01
|
6.70e-02
|
8.30e-01
|
GO:0032991 protein-containing
complex
|
207
|
9.80e-02
|
6.69e-02
|
2.68e-01
|
GO:0071897 DNA biosynthetic process
|
12
|
6.89e-01
|
6.67e-02
|
8.30e-01
|
GO:0006909 phagocytosis
|
23
|
5.80e-01
|
-6.67e-02
|
7.61e-01
|
GO:0016779 nucleotidyltransferase
activity
|
10
|
7.16e-01
|
-6.65e-02
|
8.49e-01
|
GO:0007254 JNK cascade
|
26
|
5.58e-01
|
6.64e-02
|
7.44e-01
|
GO:0051225 spindle assembly
|
21
|
5.99e-01
|
-6.63e-02
|
7.71e-01
|
GO:0035176 social behavior
|
17
|
6.38e-01
|
6.60e-02
|
7.94e-01
|
GO:0004714 transmembrane receptor
protein tyrosine kinase activity
|
14
|
6.71e-01
|
-6.57e-02
|
8.20e-01
|
GO:0044183 protein folding
chaperone
|
21
|
6.03e-01
|
-6.56e-02
|
7.72e-01
|
GO:0010839 negative regulation of
keratinocyte proliferation
|
14
|
6.71e-01
|
-6.55e-02
|
8.20e-01
|
GO:0008217 regulation of blood
pressure
|
20
|
6.13e-01
|
6.54e-02
|
7.80e-01
|
GO:0046540 U4/U6 x U5 tri-snRNP
complex
|
23
|
5.88e-01
|
6.53e-02
|
7.63e-01
|
GO:0090050 positive regulation of
cell migration involved in sprouting angiogenesis
|
14
|
6.73e-01
|
-6.52e-02
|
8.20e-01
|
GO:0005515 protein binding
|
90
|
2.86e-01
|
6.51e-02
|
5.00e-01
|
GO:0043014 alpha-tubulin binding
|
23
|
5.89e-01
|
6.51e-02
|
7.64e-01
|
GO:0005770 late endosome
|
74
|
3.37e-01
|
-6.46e-02
|
5.48e-01
|
GO:0032435 negative regulation of
proteasomal ubiquitin-dependent protein catabolic process
|
19
|
6.28e-01
|
-6.43e-02
|
7.88e-01
|
GO:2000811 negative regulation of
anoikis
|
10
|
7.25e-01
|
6.42e-02
|
8.54e-01
|
GO:0030970 retrograde protein
transport, ER to cytosol
|
12
|
7.00e-01
|
-6.42e-02
|
8.38e-01
|
GO:0046982 protein
heterodimerization activity
|
131
|
2.05e-01
|
-6.42e-02
|
4.17e-01
|
GO:0042645 mitochondrial nucleoid
|
37
|
5.01e-01
|
6.40e-02
|
6.97e-01
|
GO:0099175 regulation of
postsynapse organization
|
20
|
6.21e-01
|
6.39e-02
|
7.83e-01
|
GO:0050821 protein stabilization
|
109
|
2.51e-01
|
-6.38e-02
|
4.61e-01
|
GO:0031648 protein destabilization
|
32
|
5.33e-01
|
6.37e-02
|
7.23e-01
|
GO:0004722 protein serine/threonine
phosphatase activity
|
33
|
5.27e-01
|
-6.36e-02
|
7.19e-01
|
GO:1904262 negative regulation of
TORC1 signaling
|
28
|
5.60e-01
|
-6.36e-02
|
7.46e-01
|
GO:0014069 postsynaptic density
|
97
|
2.81e-01
|
6.35e-02
|
4.95e-01
|
GO:0007214 gamma-aminobutyric acid
signaling pathway
|
10
|
7.28e-01
|
6.34e-02
|
8.57e-01
|
GO:0030170 pyridoxal phosphate
binding
|
33
|
5.29e-01
|
-6.33e-02
|
7.21e-01
|
GO:0005794 Golgi apparatus
|
464
|
2.04e-02
|
-6.32e-02
|
9.14e-02
|
GO:0002682 regulation of immune
system process
|
11
|
7.17e-01
|
-6.31e-02
|
8.50e-01
|
GO:0007189 adenylate
cyclase-activating G protein-coupled receptor signaling pathway
|
31
|
5.47e-01
|
6.25e-02
|
7.36e-01
|
GO:0045444 fat cell differentiation
|
44
|
4.74e-01
|
6.25e-02
|
6.72e-01
|
GO:0045499 chemorepellent activity
|
17
|
6.57e-01
|
-6.22e-02
|
8.09e-01
|
GO:0010467 gene expression
|
81
|
3.34e-01
|
6.21e-02
|
5.47e-01
|
GO:0045111 intermediate filament
cytoskeleton
|
23
|
6.07e-01
|
6.20e-02
|
7.75e-01
|
GO:0032436 positive regulation of
proteasomal ubiquitin-dependent protein catabolic process
|
43
|
4.82e-01
|
-6.19e-02
|
6.81e-01
|
GO:0045505 dynein intermediate
chain binding
|
16
|
6.68e-01
|
-6.19e-02
|
8.17e-01
|
GO:0043123 positive regulation of
canonical NF-kappaB signal transduction
|
75
|
3.55e-01
|
6.18e-02
|
5.65e-01
|
GO:0005547
phosphatidylinositol-3,4,5-trisphosphate binding
|
21
|
6.24e-01
|
6.18e-02
|
7.85e-01
|
GO:0001958 endochondral
ossification
|
15
|
6.79e-01
|
-6.17e-02
|
8.24e-01
|
GO:2001235 positive regulation of
apoptotic signaling pathway
|
17
|
6.60e-01
|
-6.17e-02
|
8.12e-01
|
GO:0055038 recycling endosome
membrane
|
43
|
4.91e-01
|
6.07e-02
|
6.88e-01
|
GO:0000774 adenyl-nucleotide
exchange factor activity
|
12
|
7.16e-01
|
6.07e-02
|
8.49e-01
|
GO:0035091 phosphatidylinositol
binding
|
74
|
3.68e-01
|
6.06e-02
|
5.79e-01
|
GO:0007098 centrosome cycle
|
17
|
6.66e-01
|
6.04e-02
|
8.16e-01
|
GO:0070588 calcium ion
transmembrane transport
|
46
|
4.79e-01
|
-6.04e-02
|
6.77e-01
|
GO:0051289 protein
homotetramerization
|
35
|
5.37e-01
|
-6.03e-02
|
7.28e-01
|
GO:0051457 maintenance of protein
location in nucleus
|
10
|
7.43e-01
|
5.99e-02
|
8.69e-01
|
GO:0038062 protein tyrosine kinase
collagen receptor activity
|
13
|
7.10e-01
|
5.96e-02
|
8.46e-01
|
GO:0035791 platelet-derived growth
factor receptor-beta signaling pathway
|
15
|
6.90e-01
|
5.94e-02
|
8.31e-01
|
GO:0004252 serine-type
endopeptidase activity
|
52
|
4.59e-01
|
-5.93e-02
|
6.57e-01
|
GO:0045862 positive regulation of
proteolysis
|
12
|
7.22e-01
|
-5.92e-02
|
8.53e-01
|
GO:0030507 spectrin binding
|
12
|
7.23e-01
|
-5.92e-02
|
8.53e-01
|
GO:0050727 regulation of
inflammatory response
|
26
|
6.01e-01
|
-5.92e-02
|
7.72e-01
|
GO:0097194 execution phase of
apoptosis
|
10
|
7.46e-01
|
5.92e-02
|
8.71e-01
|
GO:0048813 dendrite morphogenesis
|
20
|
6.50e-01
|
-5.86e-02
|
8.03e-01
|
GO:0051897 positive regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
77
|
3.75e-01
|
5.86e-02
|
5.85e-01
|
GO:0042177 negative regulation of
protein catabolic process
|
23
|
6.29e-01
|
5.82e-02
|
7.88e-01
|
GO:0045747 positive regulation of
Notch signaling pathway
|
23
|
6.30e-01
|
5.81e-02
|
7.88e-01
|
GO:0030097 hemopoiesis
|
25
|
6.17e-01
|
5.78e-02
|
7.81e-01
|
GO:0006508 proteolysis
|
172
|
1.92e-01
|
5.78e-02
|
4.03e-01
|
GO:0043231 intracellular
membrane-bounded organelle
|
113
|
2.93e-01
|
5.73e-02
|
5.04e-01
|
GO:0005680 anaphase-promoting
complex
|
13
|
7.21e-01
|
-5.73e-02
|
8.53e-01
|
GO:0009986 cell surface
|
182
|
1.87e-01
|
5.69e-02
|
3.96e-01
|
GO:0006874 intracellular calcium
ion homeostasis
|
36
|
5.55e-01
|
5.68e-02
|
7.42e-01
|
GO:0070062 extracellular exosome
|
38
|
5.47e-01
|
5.65e-02
|
7.36e-01
|
GO:0032496 response to
lipopolysaccharide
|
37
|
5.54e-01
|
5.63e-02
|
7.41e-01
|
GO:0008083 growth factor activity
|
37
|
5.57e-01
|
5.59e-02
|
7.42e-01
|
GO:0016925 protein sumoylation
|
19
|
6.74e-01
|
5.57e-02
|
8.20e-01
|
GO:0034605 cellular response to
heat
|
16
|
7.04e-01
|
5.49e-02
|
8.41e-01
|
GO:0004672 protein kinase activity
|
64
|
4.48e-01
|
5.49e-02
|
6.51e-01
|
GO:0007218 neuropeptide signaling
pathway
|
16
|
7.07e-01
|
5.43e-02
|
8.44e-01
|
GO:0001669 acrosomal vesicle
|
26
|
6.32e-01
|
-5.43e-02
|
7.90e-01
|
GO:0009615 response to virus
|
29
|
6.14e-01
|
-5.41e-02
|
7.80e-01
|
GO:0071407 cellular response to
organic cyclic compound
|
11
|
7.57e-01
|
5.39e-02
|
8.75e-01
|
GO:0051642 centrosome localization
|
14
|
7.28e-01
|
-5.37e-02
|
8.57e-01
|
GO:0005791 rough endoplasmic
reticulum
|
12
|
7.48e-01
|
5.36e-02
|
8.72e-01
|
GO:0030246 carbohydrate binding
|
39
|
5.64e-01
|
-5.34e-02
|
7.50e-01
|
GO:0051497 negative regulation of
stress fiber assembly
|
18
|
6.95e-01
|
5.34e-02
|
8.34e-01
|
GO:0043616 keratinocyte
proliferation
|
11
|
7.60e-01
|
-5.32e-02
|
8.78e-01
|
GO:0043687 post-translational
protein modification
|
19
|
6.89e-01
|
5.30e-02
|
8.30e-01
|
GO:0030674 protein-macromolecule
adaptor activity
|
73
|
4.34e-01
|
-5.30e-02
|
6.41e-01
|
GO:0046847 filopodium assembly
|
11
|
7.61e-01
|
5.29e-02
|
8.78e-01
|
GO:0032154 cleavage furrow
|
28
|
6.28e-01
|
5.29e-02
|
7.88e-01
|
GO:0005769 early endosome
|
141
|
2.80e-01
|
-5.28e-02
|
4.95e-01
|
GO:0046627 negative regulation of
insulin receptor signaling pathway
|
16
|
7.15e-01
|
5.27e-02
|
8.49e-01
|
GO:0072583 clathrin-dependent
endocytosis
|
19
|
6.93e-01
|
-5.23e-02
|
8.33e-01
|
GO:0008344 adult locomotory
behavior
|
23
|
6.65e-01
|
5.21e-02
|
8.16e-01
|
GO:0015630 microtubule cytoskeleton
|
69
|
4.55e-01
|
5.21e-02
|
6.55e-01
|
GO:0046513 ceramide biosynthetic
process
|
19
|
6.95e-01
|
-5.20e-02
|
8.34e-01
|
GO:0004521 RNA endonuclease
activity
|
20
|
6.88e-01
|
-5.19e-02
|
8.30e-01
|
GO:0006284 base-excision repair
|
17
|
7.12e-01
|
5.18e-02
|
8.47e-01
|
GO:0006509 membrane protein
ectodomain proteolysis
|
15
|
7.29e-01
|
5.17e-02
|
8.57e-01
|
GO:0006368 transcription elongation
by RNA polymerase II
|
24
|
6.64e-01
|
5.13e-02
|
8.15e-01
|
GO:0016020 membrane
|
942
|
8.44e-03
|
-5.13e-02
|
5.01e-02
|
GO:0045722 positive regulation of
gluconeogenesis
|
10
|
7.80e-01
|
-5.11e-02
|
8.89e-01
|
GO:0060079 excitatory postsynaptic
potential
|
15
|
7.32e-01
|
5.10e-02
|
8.60e-01
|
GO:0090141 positive regulation of
mitochondrial fission
|
16
|
7.24e-01
|
-5.09e-02
|
8.54e-01
|
GO:0000776 kinetochore
|
90
|
4.05e-01
|
5.08e-02
|
6.18e-01
|
GO:0006897 endocytosis
|
91
|
4.09e-01
|
5.01e-02
|
6.20e-01
|
GO:0016055 Wnt signaling pathway
|
77
|
4.49e-01
|
4.99e-02
|
6.51e-01
|
GO:0006310 DNA recombination
|
23
|
6.80e-01
|
4.98e-02
|
8.24e-01
|
GO:0045821 positive regulation of
glycolytic process
|
10
|
7.85e-01
|
4.97e-02
|
8.93e-01
|
GO:0045202 synapse
|
162
|
2.77e-01
|
-4.96e-02
|
4.92e-01
|
GO:0046676 negative regulation of
insulin secretion
|
10
|
7.88e-01
|
4.92e-02
|
8.95e-01
|
GO:0007186 G protein-coupled
receptor signaling pathway
|
90
|
4.23e-01
|
4.90e-02
|
6.31e-01
|
GO:0008285 negative regulation of
cell population proliferation
|
116
|
3.70e-01
|
4.83e-02
|
5.81e-01
|
GO:0034097 response to cytokine
|
12
|
7.72e-01
|
-4.82e-02
|
8.86e-01
|
GO:0050699 WW domain binding
|
11
|
7.83e-01
|
-4.80e-02
|
8.91e-01
|
GO:0031547 brain-derived
neurotrophic factor receptor signaling pathway
|
14
|
7.56e-01
|
4.79e-02
|
8.75e-01
|
GO:0005604 basement membrane
|
43
|
5.88e-01
|
4.78e-02
|
7.63e-01
|
GO:0016239 positive regulation of
macroautophagy
|
17
|
7.34e-01
|
4.77e-02
|
8.60e-01
|
GO:0099523 presynaptic cytosol
|
11
|
7.85e-01
|
-4.75e-02
|
8.93e-01
|
GO:0051898 negative regulation of
phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
35
|
6.33e-01
|
4.67e-02
|
7.90e-01
|
GO:0038109 Kit signaling pathway
|
14
|
7.63e-01
|
-4.65e-02
|
8.80e-01
|
GO:0099072 regulation of
postsynaptic membrane neurotransmitter receptor levels
|
16
|
7.48e-01
|
4.64e-02
|
8.72e-01
|
GO:0019216 regulation of lipid
metabolic process
|
10
|
8.01e-01
|
-4.61e-02
|
9.00e-01
|
GO:0008076 voltage-gated potassium
channel complex
|
18
|
7.36e-01
|
-4.59e-02
|
8.63e-01
|
GO:0044877 protein-containing
complex binding
|
105
|
4.22e-01
|
4.55e-02
|
6.30e-01
|
GO:0042470 melanosome
|
27
|
6.83e-01
|
-4.54e-02
|
8.28e-01
|
GO:0009267 cellular response to
starvation
|
48
|
5.87e-01
|
4.53e-02
|
7.63e-01
|
GO:0061630 ubiquitin protein ligase
activity
|
176
|
3.01e-01
|
4.53e-02
|
5.13e-01
|
GO:0060218 hematopoietic stem cell
differentiation
|
11
|
7.95e-01
|
4.53e-02
|
8.98e-01
|
GO:0019933 cAMP-mediated signaling
|
13
|
7.77e-01
|
4.53e-02
|
8.89e-01
|
GO:0036064 ciliary basal body
|
103
|
4.28e-01
|
-4.52e-02
|
6.36e-01
|
GO:0048471 perinuclear region of
cytoplasm
|
287
|
1.90e-01
|
4.51e-02
|
4.00e-01
|
GO:0061564 axon development
|
13
|
7.80e-01
|
-4.48e-02
|
8.89e-01
|
GO:0045740 positive regulation of
DNA replication
|
11
|
7.97e-01
|
4.48e-02
|
8.99e-01
|
GO:0030317 flagellated sperm
motility
|
27
|
6.89e-01
|
-4.45e-02
|
8.30e-01
|
GO:0005730 nucleolus
|
442
|
1.13e-01
|
4.42e-02
|
2.90e-01
|
GO:2000786 positive regulation of
autophagosome assembly
|
14
|
7.75e-01
|
-4.41e-02
|
8.88e-01
|
GO:0005774 vacuolar membrane
|
10
|
8.09e-01
|
-4.41e-02
|
9.05e-01
|
GO:0005198 structural molecule
activity
|
38
|
6.40e-01
|
-4.39e-02
|
7.95e-01
|
GO:0048487 beta-tubulin binding
|
22
|
7.22e-01
|
4.39e-02
|
8.53e-01
|
GO:0004930 G protein-coupled
receptor activity
|
54
|
5.78e-01
|
4.38e-02
|
7.58e-01
|
GO:0031593 polyubiquitin
modification-dependent protein binding
|
19
|
7.41e-01
|
4.38e-02
|
8.68e-01
|
GO:0007157 heterophilic cell-cell
adhesion via plasma membrane cell adhesion molecules
|
11
|
8.01e-01
|
4.38e-02
|
9.00e-01
|
GO:0051453 regulation of
intracellular pH
|
15
|
7.69e-01
|
-4.38e-02
|
8.84e-01
|
GO:0006935 chemotaxis
|
15
|
7.70e-01
|
-4.37e-02
|
8.84e-01
|
GO:0005903 brush border
|
18
|
7.50e-01
|
-4.34e-02
|
8.72e-01
|
GO:0032481 positive regulation of
type I interferon production
|
18
|
7.50e-01
|
4.34e-02
|
8.72e-01
|
GO:0040014 regulation of
multicellular organism growth
|
12
|
7.95e-01
|
4.32e-02
|
8.98e-01
|
GO:0035925 mRNA 3’-UTR AU-rich
region binding
|
13
|
7.90e-01
|
-4.27e-02
|
8.96e-01
|
GO:0010508 positive regulation of
autophagy
|
39
|
6.44e-01
|
-4.27e-02
|
7.98e-01
|
GO:0007200 phospholipase
C-activating G protein-coupled receptor signaling pathway
|
28
|
6.97e-01
|
-4.25e-02
|
8.36e-01
|
GO:0060041 retina development in
camera-type eye
|
20
|
7.44e-01
|
4.22e-02
|
8.70e-01
|
GO:2001238 positive regulation of
extrinsic apoptotic signaling pathway
|
12
|
8.01e-01
|
-4.21e-02
|
9.00e-01
|
GO:0031464 Cul4A-RING E3 ubiquitin
ligase complex
|
10
|
8.18e-01
|
-4.21e-02
|
9.12e-01
|
GO:0005010 insulin-like growth
factor receptor activity
|
13
|
7.93e-01
|
4.21e-02
|
8.98e-01
|
GO:0043065 positive regulation of
apoptotic process
|
121
|
4.25e-01
|
4.20e-02
|
6.34e-01
|
GO:0046677 response to antibiotic
|
13
|
7.94e-01
|
4.18e-02
|
8.98e-01
|
GO:0072344 rescue of stalled
ribosome
|
26
|
7.14e-01
|
-4.15e-02
|
8.49e-01
|
GO:0043029 T cell homeostasis
|
13
|
7.95e-01
|
4.15e-02
|
8.98e-01
|
GO:0042803 protein homodimerization
activity
|
371
|
1.72e-01
|
-4.15e-02
|
3.76e-01
|
GO:0019221 cytokine-mediated
signaling pathway
|
45
|
6.32e-01
|
-4.13e-02
|
7.90e-01
|
GO:0016324 apical plasma membrane
|
121
|
4.34e-01
|
4.13e-02
|
6.40e-01
|
GO:0005829 cytosol
|
2011
|
3.10e-03
|
4.11e-02
|
2.58e-02
|
GO:0016567 protein ubiquitination
|
155
|
3.81e-01
|
4.09e-02
|
5.92e-01
|
GO:0045721 negative regulation of
gluconeogenesis
|
10
|
8.23e-01
|
-4.07e-02
|
9.16e-01
|
GO:0005019 platelet-derived growth
factor beta-receptor activity
|
13
|
8.00e-01
|
4.07e-02
|
9.00e-01
|
GO:0042147 retrograde transport,
endosome to Golgi
|
50
|
6.20e-01
|
-4.06e-02
|
7.83e-01
|
GO:0060271 cilium assembly
|
124
|
4.36e-01
|
-4.06e-02
|
6.42e-01
|
GO:0048870 cell motility
|
12
|
8.08e-01
|
4.05e-02
|
9.04e-01
|
GO:0007032 endosome organization
|
28
|
7.12e-01
|
4.04e-02
|
8.47e-01
|
GO:0031297 replication fork
processing
|
26
|
7.24e-01
|
4.00e-02
|
8.54e-01
|
GO:0043130 ubiquitin binding
|
61
|
5.90e-01
|
3.99e-02
|
7.64e-01
|
GO:0007224 smoothened signaling
pathway
|
50
|
6.30e-01
|
3.94e-02
|
7.88e-01
|
GO:0030335 positive regulation of
cell migration
|
106
|
4.86e-01
|
3.92e-02
|
6.84e-01
|
GO:1990756 ubiquitin-like
ligase-substrate adaptor activity
|
71
|
5.71e-01
|
-3.89e-02
|
7.54e-01
|
GO:0009411 response to UV
|
23
|
7.50e-01
|
-3.84e-02
|
8.72e-01
|
GO:0019722 calcium-mediated
signaling
|
31
|
7.13e-01
|
3.82e-02
|
8.48e-01
|
GO:0035556 intracellular signal
transduction
|
183
|
3.74e-01
|
3.82e-02
|
5.85e-01
|
GO:0001772 immunological synapse
|
23
|
7.52e-01
|
-3.80e-02
|
8.74e-01
|
GO:0030217 T cell differentiation
|
19
|
7.75e-01
|
3.80e-02
|
8.88e-01
|
GO:0044297 cell body
|
24
|
7.48e-01
|
3.79e-02
|
8.72e-01
|
GO:0003180 aortic valve
morphogenesis
|
11
|
8.30e-01
|
3.74e-02
|
9.18e-01
|
GO:0070527 platelet aggregation
|
15
|
8.03e-01
|
-3.73e-02
|
9.01e-01
|
GO:0010008 endosome membrane
|
86
|
5.56e-01
|
-3.68e-02
|
7.42e-01
|
GO:0044344 cellular response to
fibroblast growth factor stimulus
|
10
|
8.41e-01
|
-3.66e-02
|
9.22e-01
|
GO:0071949 FAD binding
|
27
|
7.43e-01
|
-3.65e-02
|
8.69e-01
|
GO:0045121 membrane raft
|
74
|
5.88e-01
|
-3.64e-02
|
7.64e-01
|
GO:0051017 actin filament bundle
assembly
|
13
|
8.21e-01
|
-3.63e-02
|
9.14e-01
|
GO:0005813 centrosome
|
343
|
2.54e-01
|
3.60e-02
|
4.62e-01
|
GO:0005506 iron ion binding
|
64
|
6.20e-01
|
3.58e-02
|
7.83e-01
|
GO:0007420 brain development
|
76
|
5.90e-01
|
3.58e-02
|
7.64e-01
|
GO:0005006 epidermal growth factor
receptor activity
|
14
|
8.17e-01
|
-3.58e-02
|
9.12e-01
|
GO:0045824 negative regulation of
innate immune response
|
16
|
8.05e-01
|
-3.57e-02
|
9.02e-01
|
GO:0006955 immune response
|
43
|
6.86e-01
|
3.56e-02
|
8.30e-01
|
GO:0045742 positive regulation of
epidermal growth factor receptor signaling pathway
|
13
|
8.24e-01
|
-3.56e-02
|
9.16e-01
|
GO:0006364 rRNA processing
|
65
|
6.22e-01
|
-3.54e-02
|
7.83e-01
|
GO:0008154 actin polymerization or
depolymerization
|
11
|
8.40e-01
|
-3.51e-02
|
9.22e-01
|
GO:0034504 protein localization to
nucleus
|
20
|
7.86e-01
|
3.51e-02
|
8.93e-01
|
GO:0035269 protein O-linked
mannosylation
|
13
|
8.27e-01
|
3.49e-02
|
9.16e-01
|
GO:0062023 collagen-containing
extracellular matrix
|
71
|
6.13e-01
|
-3.47e-02
|
7.80e-01
|
GO:0051059 NF-kappaB binding
|
22
|
7.79e-01
|
3.46e-02
|
8.89e-01
|
GO:0050729 positive regulation of
inflammatory response
|
22
|
7.80e-01
|
-3.44e-02
|
8.89e-01
|
GO:0035102 PRC1 complex
|
12
|
8.38e-01
|
3.40e-02
|
9.22e-01
|
GO:0005657 replication fork
|
20
|
7.94e-01
|
-3.37e-02
|
8.98e-01
|
GO:0043153 entrainment of circadian
clock by photoperiod
|
13
|
8.33e-01
|
-3.37e-02
|
9.20e-01
|
GO:0007173 epidermal growth factor
receptor signaling pathway
|
38
|
7.22e-01
|
3.33e-02
|
8.53e-01
|
GO:0001786 phosphatidylserine
binding
|
25
|
7.76e-01
|
-3.29e-02
|
8.89e-01
|
GO:0000175 3’-5’-RNA exonuclease
activity
|
21
|
7.95e-01
|
3.28e-02
|
8.98e-01
|
GO:1903078 positive regulation of
protein localization to plasma membrane
|
21
|
7.95e-01
|
3.27e-02
|
8.98e-01
|
GO:0000979 RNA polymerase II core
promoter sequence-specific DNA binding
|
12
|
8.45e-01
|
-3.26e-02
|
9.26e-01
|
GO:0001503 ossification
|
25
|
7.79e-01
|
3.24e-02
|
8.89e-01
|
GO:0006400 tRNA modification
|
11
|
8.54e-01
|
3.21e-02
|
9.32e-01
|
GO:0000502 proteasome complex
|
13
|
8.42e-01
|
-3.20e-02
|
9.22e-01
|
GO:0044325 transmembrane
transporter binding
|
54
|
6.87e-01
|
3.18e-02
|
8.30e-01
|
GO:0006096 glycolytic process
|
23
|
7.93e-01
|
3.16e-02
|
8.98e-01
|
GO:0071479 cellular response to
ionizing radiation
|
22
|
7.99e-01
|
3.14e-02
|
9.00e-01
|
GO:0008543 fibroblast growth factor
receptor signaling pathway
|
35
|
7.54e-01
|
-3.06e-02
|
8.74e-01
|
GO:0001974 blood vessel remodeling
|
17
|
8.28e-01
|
3.05e-02
|
9.16e-01
|
GO:0001755 neural crest cell
migration
|
24
|
7.98e-01
|
3.02e-02
|
8.99e-01
|
GO:0019888 protein phosphatase
regulator activity
|
16
|
8.34e-01
|
3.02e-02
|
9.20e-01
|
GO:0007040 lysosome organization
|
33
|
7.66e-01
|
-3.00e-02
|
8.82e-01
|
GO:0005795 Golgi stack
|
18
|
8.26e-01
|
3.00e-02
|
9.16e-01
|
GO:0005007 fibroblast growth factor
receptor activity
|
13
|
8.52e-01
|
-2.99e-02
|
9.30e-01
|
GO:0071260 cellular response to
mechanical stimulus
|
23
|
8.05e-01
|
-2.98e-02
|
9.02e-01
|
GO:1901224 positive regulation of
non-canonical NF-kappaB signal transduction
|
22
|
8.10e-01
|
2.97e-02
|
9.05e-01
|
GO:0030509 BMP signaling pathway
|
37
|
7.57e-01
|
2.94e-02
|
8.75e-01
|
GO:0009968 negative regulation of
signal transduction
|
14
|
8.50e-01
|
-2.93e-02
|
9.28e-01
|
GO:0005576 extracellular region
|
237
|
4.41e-01
|
-2.91e-02
|
6.46e-01
|
GO:0045732 positive regulation of
protein catabolic process
|
46
|
7.34e-01
|
-2.90e-02
|
8.60e-01
|
GO:0005737 cytoplasm
|
2171
|
3.32e-02
|
2.87e-02
|
1.29e-01
|
GO:0043204 perikaryon
|
35
|
7.70e-01
|
2.86e-02
|
8.84e-01
|
GO:0042474 middle ear morphogenesis
|
10
|
8.77e-01
|
-2.84e-02
|
9.47e-01
|
GO:0043005 neuron projection
|
95
|
6.35e-01
|
-2.82e-02
|
7.91e-01
|
GO:0001935 endothelial cell
proliferation
|
12
|
8.67e-01
|
2.79e-02
|
9.42e-01
|
GO:0060828 regulation of canonical
Wnt signaling pathway
|
18
|
8.39e-01
|
2.78e-02
|
9.22e-01
|
GO:0001676 long-chain fatty acid
metabolic process
|
11
|
8.74e-01
|
-2.77e-02
|
9.47e-01
|
GO:0042632 cholesterol homeostasis
|
39
|
7.67e-01
|
-2.75e-02
|
8.82e-01
|
GO:0007288 sperm axoneme assembly
|
18
|
8.41e-01
|
-2.74e-02
|
9.22e-01
|
GO:0007339 binding of sperm to zona
pellucida
|
11
|
8.75e-01
|
2.74e-02
|
9.47e-01
|
GO:2000300 regulation of synaptic
vesicle exocytosis
|
18
|
8.41e-01
|
2.72e-02
|
9.22e-01
|
GO:0031290 retinal ganglion cell
axon guidance
|
11
|
8.77e-01
|
2.70e-02
|
9.47e-01
|
GO:0016538 cyclin-dependent protein
serine/threonine kinase regulator activity
|
20
|
8.35e-01
|
-2.69e-02
|
9.21e-01
|
GO:0009897 external side of plasma
membrane
|
108
|
6.36e-01
|
-2.64e-02
|
7.92e-01
|
GO:0051085 chaperone
cofactor-dependent protein refolding
|
23
|
8.28e-01
|
-2.63e-02
|
9.16e-01
|
GO:0051865 protein
autoubiquitination
|
38
|
7.80e-01
|
-2.63e-02
|
8.89e-01
|
GO:0005637 nuclear inner membrane
|
24
|
8.24e-01
|
2.62e-02
|
9.16e-01
|
GO:0007179 transforming growth
factor beta receptor signaling pathway
|
48
|
7.54e-01
|
-2.61e-02
|
8.74e-01
|
GO:0001819 positive regulation of
cytokine production
|
13
|
8.71e-01
|
-2.61e-02
|
9.45e-01
|
GO:0000775 chromosome, centromeric
region
|
31
|
8.03e-01
|
2.59e-02
|
9.01e-01
|
GO:0043022 ribosome binding
|
46
|
7.62e-01
|
-2.59e-02
|
8.78e-01
|
GO:0048704 embryonic skeletal
system morphogenesis
|
18
|
8.50e-01
|
2.58e-02
|
9.28e-01
|
GO:0030215 semaphorin receptor
binding
|
10
|
8.88e-01
|
-2.58e-02
|
9.51e-01
|
GO:0007015 actin filament
organization
|
70
|
7.09e-01
|
-2.58e-02
|
8.46e-01
|
GO:0072659 protein localization to
plasma membrane
|
75
|
7.05e-01
|
-2.53e-02
|
8.42e-01
|
GO:0099171 presynaptic modulation
of chemical synaptic transmission
|
11
|
8.85e-01
|
2.52e-02
|
9.50e-01
|
GO:0006605 protein targeting
|
18
|
8.54e-01
|
-2.50e-02
|
9.32e-01
|
GO:0007274 neuromuscular synaptic
transmission
|
12
|
8.81e-01
|
-2.50e-02
|
9.49e-01
|
GO:0016323 basolateral plasma
membrane
|
94
|
6.78e-01
|
2.48e-02
|
8.24e-01
|
GO:0008201 heparin binding
|
57
|
7.47e-01
|
-2.47e-02
|
8.72e-01
|
GO:0042802 identical protein
binding
|
659
|
2.89e-01
|
2.44e-02
|
5.01e-01
|
GO:0032024 positive regulation of
insulin secretion
|
21
|
8.47e-01
|
-2.43e-02
|
9.27e-01
|
GO:0007029 endoplasmic reticulum
organization
|
16
|
8.67e-01
|
2.42e-02
|
9.42e-01
|
GO:0030198 extracellular matrix
organization
|
76
|
7.17e-01
|
-2.40e-02
|
8.50e-01
|
GO:0007626 locomotory behavior
|
26
|
8.33e-01
|
2.39e-02
|
9.20e-01
|
GO:0019900 kinase binding
|
47
|
7.77e-01
|
2.39e-02
|
8.89e-01
|
GO:0061608 nuclear import signal
receptor activity
|
14
|
8.77e-01
|
2.38e-02
|
9.47e-01
|
GO:0030234 enzyme regulator
activity
|
14
|
8.78e-01
|
2.37e-02
|
9.47e-01
|
GO:0042552 myelination
|
28
|
8.29e-01
|
-2.35e-02
|
9.18e-01
|
GO:0008284 positive regulation of
cell population proliferation
|
156
|
6.14e-01
|
2.34e-02
|
7.80e-01
|
GO:0140359 ABC-type transporter
activity
|
10
|
8.99e-01
|
2.32e-02
|
9.58e-01
|
GO:0031145 anaphase-promoting
complex-dependent catabolic process
|
14
|
8.81e-01
|
2.31e-02
|
9.49e-01
|
GO:0005008 hepatocyte growth factor
receptor activity
|
13
|
8.86e-01
|
2.29e-02
|
9.50e-01
|
GO:1905515 non-motile cilium
assembly
|
39
|
8.06e-01
|
-2.28e-02
|
9.02e-01
|
GO:0005886 plasma membrane
|
1513
|
1.47e-01
|
2.28e-02
|
3.44e-01
|
GO:0031418 L-ascorbic acid binding
|
14
|
8.85e-01
|
-2.24e-02
|
9.50e-01
|
GO:0008340 determination of adult
lifespan
|
21
|
8.61e-01
|
-2.20e-02
|
9.39e-01
|
GO:0001736 establishment of planar
polarity
|
12
|
8.95e-01
|
-2.19e-02
|
9.57e-01
|
GO:0044782 cilium organization
|
12
|
8.96e-01
|
-2.18e-02
|
9.57e-01
|
GO:0071356 cellular response to
tumor necrosis factor
|
37
|
8.19e-01
|
2.18e-02
|
9.13e-01
|
GO:0031625 ubiquitin protein ligase
binding
|
171
|
6.26e-01
|
-2.17e-02
|
7.86e-01
|
GO:1990830 cellular response to
leukemia inhibitory factor
|
66
|
7.64e-01
|
2.13e-02
|
8.81e-01
|
GO:0030168 platelet activation
|
11
|
9.05e-01
|
-2.08e-02
|
9.60e-01
|
GO:0005834 heterotrimeric G-protein
complex
|
19
|
8.76e-01
|
-2.08e-02
|
9.47e-01
|
GO:0071364 cellular response to
epidermal growth factor stimulus
|
19
|
8.77e-01
|
2.05e-02
|
9.47e-01
|
GO:0030742 GTP-dependent protein
binding
|
13
|
8.99e-01
|
2.04e-02
|
9.58e-01
|
GO:0034450 ubiquitin-ubiquitin
ligase activity
|
12
|
9.03e-01
|
2.03e-02
|
9.59e-01
|
GO:0048018 receptor ligand activity
|
17
|
8.85e-01
|
2.02e-02
|
9.50e-01
|
GO:0071300 cellular response to
retinoic acid
|
17
|
8.85e-01
|
2.02e-02
|
9.50e-01
|
GO:0007283 spermatogenesis
|
100
|
7.33e-01
|
1.98e-02
|
8.60e-01
|
GO:0006954 inflammatory response
|
83
|
7.56e-01
|
1.98e-02
|
8.75e-01
|
GO:0048027 mRNA 5’-UTR binding
|
19
|
8.82e-01
|
1.97e-02
|
9.50e-01
|
GO:1901223 negative regulation of
non-canonical NF-kappaB signal transduction
|
14
|
9.00e-01
|
1.94e-02
|
9.59e-01
|
GO:0046332 SMAD binding
|
23
|
8.73e-01
|
1.93e-02
|
9.47e-01
|
GO:0008289 lipid binding
|
44
|
8.27e-01
|
-1.91e-02
|
9.16e-01
|
GO:0032880 regulation of protein
localization
|
41
|
8.34e-01
|
1.89e-02
|
9.20e-01
|
GO:0031462 Cul2-RING ubiquitin
ligase complex
|
15
|
9.00e-01
|
-1.87e-02
|
9.59e-01
|
GO:1902476 chloride transmembrane
transport
|
38
|
8.49e-01
|
1.78e-02
|
9.28e-01
|
GO:0032755 positive regulation of
interleukin-6 production
|
32
|
8.65e-01
|
1.74e-02
|
9.41e-01
|
GO:0008408 3’-5’ exonuclease
activity
|
10
|
9.24e-01
|
1.74e-02
|
9.64e-01
|
GO:0051604 protein maturation
|
20
|
8.94e-01
|
1.73e-02
|
9.57e-01
|
GO:0019899 enzyme binding
|
112
|
7.54e-01
|
1.72e-02
|
8.74e-01
|
GO:0007346 regulation of mitotic
cell cycle
|
31
|
8.69e-01
|
-1.71e-02
|
9.44e-01
|
GO:0045184 establishment of protein
localization
|
17
|
9.04e-01
|
1.69e-02
|
9.59e-01
|
GO:0055037 recycling endosome
|
56
|
8.27e-01
|
-1.69e-02
|
9.16e-01
|
GO:0006511 ubiquitin-dependent
protein catabolic process
|
117
|
7.54e-01
|
1.68e-02
|
8.74e-01
|
GO:0043539 protein serine/threonine
kinase activator activity
|
34
|
8.67e-01
|
1.66e-02
|
9.42e-01
|
GO:0003774 cytoskeletal motor
activity
|
12
|
9.21e-01
|
-1.66e-02
|
9.64e-01
|
GO:0045739 positive regulation of
DNA repair
|
20
|
9.01e-01
|
-1.61e-02
|
9.59e-01
|
GO:0030665 clathrin-coated vesicle
membrane
|
11
|
9.27e-01
|
-1.61e-02
|
9.64e-01
|
GO:0051020 GTPase binding
|
15
|
9.15e-01
|
1.58e-02
|
9.64e-01
|
GO:0009611 response to wounding
|
19
|
9.07e-01
|
-1.56e-02
|
9.60e-01
|
GO:0007528 neuromuscular junction
development
|
15
|
9.17e-01
|
1.55e-02
|
9.64e-01
|
GO:0002224 toll-like receptor
signaling pathway
|
15
|
9.17e-01
|
1.55e-02
|
9.64e-01
|
GO:0051082 unfolded protein binding
|
56
|
8.42e-01
|
-1.55e-02
|
9.22e-01
|
GO:0071007 U2-type catalytic step 2
spliceosome
|
24
|
8.96e-01
|
1.54e-02
|
9.57e-01
|
GO:0005004 GPI-linked ephrin
receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0005011 macrophage
colony-stimulating factor receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0005018 platelet-derived growth
factor alpha-receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0005020 stem cell factor
receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0008288 boss receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0035790 platelet-derived growth
factor receptor-alpha signaling pathway
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0036323 vascular endothelial
growth factor receptor-1 signaling pathway
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0036332 placental growth factor
receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0038145 macrophage
colony-stimulating factor signaling pathway
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0060175 brain-derived
neurotrophic factor receptor activity
|
12
|
9.26e-01
|
-1.54e-02
|
9.64e-01
|
GO:0042102 positive regulation of T
cell proliferation
|
10
|
9.33e-01
|
1.53e-02
|
9.67e-01
|
GO:0017015 regulation of
transforming growth factor beta receptor signaling pathway
|
11
|
9.31e-01
|
1.51e-02
|
9.67e-01
|
GO:0000145 exocyst
|
11
|
9.31e-01
|
-1.51e-02
|
9.67e-01
|
GO:0006289 nucleotide-excision
repair
|
22
|
9.03e-01
|
1.51e-02
|
9.59e-01
|
GO:0060090 molecular adaptor
activity
|
75
|
8.22e-01
|
1.50e-02
|
9.15e-01
|
GO:0060325 face morphogenesis
|
20
|
9.09e-01
|
-1.48e-02
|
9.60e-01
|
GO:0017134 fibroblast growth factor
binding
|
12
|
9.31e-01
|
-1.44e-02
|
9.67e-01
|
GO:0000993 RNA polymerase II
complex binding
|
23
|
9.08e-01
|
-1.39e-02
|
9.60e-01
|
GO:0017025 TBP-class protein
binding
|
18
|
9.21e-01
|
1.36e-02
|
9.64e-01
|
GO:0003950 NAD+-protein
poly-ADP-ribosyltransferase activity
|
16
|
9.25e-01
|
1.36e-02
|
9.64e-01
|
GO:0046330 positive regulation of
JNK cascade
|
38
|
8.85e-01
|
-1.35e-02
|
9.50e-01
|
GO:0034067 protein localization to
Golgi apparatus
|
12
|
9.37e-01
|
-1.32e-02
|
9.68e-01
|
GO:0060586 multicellular
organismal-level iron ion homeostasis
|
16
|
9.29e-01
|
-1.29e-02
|
9.66e-01
|
GO:0001938 positive regulation of
endothelial cell proliferation
|
23
|
9.16e-01
|
-1.27e-02
|
9.64e-01
|
GO:0007204 positive regulation of
cytosolic calcium ion concentration
|
20
|
9.25e-01
|
-1.22e-02
|
9.64e-01
|
GO:0001540 amyloid-beta binding
|
28
|
9.12e-01
|
1.21e-02
|
9.62e-01
|
GO:0005546
phosphatidylinositol-4,5-bisphosphate binding
|
40
|
8.96e-01
|
1.19e-02
|
9.57e-01
|
GO:0016197 endosomal transport
|
27
|
9.18e-01
|
-1.15e-02
|
9.64e-01
|
GO:0043325
phosphatidylinositol-3,4-bisphosphate binding
|
13
|
9.43e-01
|
-1.14e-02
|
9.73e-01
|
GO:0030136 clathrin-coated vesicle
|
29
|
9.16e-01
|
-1.13e-02
|
9.64e-01
|
GO:0001782 B cell homeostasis
|
12
|
9.46e-01
|
1.13e-02
|
9.73e-01
|
GO:0043410 positive regulation of
MAPK cascade
|
62
|
8.78e-01
|
1.13e-02
|
9.47e-01
|
GO:0000209 protein
polyubiquitination
|
77
|
8.65e-01
|
-1.13e-02
|
9.41e-01
|
GO:0042383 sarcolemma
|
36
|
9.07e-01
|
-1.12e-02
|
9.60e-01
|
GO:0043066 negative regulation of
apoptotic process
|
151
|
8.13e-01
|
1.12e-02
|
9.08e-01
|
GO:0005768 endosome
|
113
|
8.38e-01
|
-1.11e-02
|
9.22e-01
|
GO:0030307 positive regulation of
cell growth
|
36
|
9.09e-01
|
1.11e-02
|
9.60e-01
|
GO:0034113 heterotypic cell-cell
adhesion
|
12
|
9.47e-01
|
-1.10e-02
|
9.73e-01
|
GO:0036464 cytoplasmic
ribonucleoprotein granule
|
36
|
9.09e-01
|
1.10e-02
|
9.60e-01
|
GO:1990573 potassium ion import
across plasma membrane
|
18
|
9.36e-01
|
-1.10e-02
|
9.68e-01
|
GO:0002020 protease binding
|
43
|
9.02e-01
|
1.08e-02
|
9.59e-01
|
GO:0008277 regulation of G
protein-coupled receptor signaling pathway
|
16
|
9.41e-01
|
-1.07e-02
|
9.72e-01
|
GO:0070971 endoplasmic reticulum
exit site
|
19
|
9.36e-01
|
1.06e-02
|
9.68e-01
|
GO:0002062 chondrocyte
differentiation
|
22
|
9.32e-01
|
-1.05e-02
|
9.67e-01
|
GO:0016459 myosin complex
|
22
|
9.34e-01
|
1.02e-02
|
9.67e-01
|
GO:0032743 positive regulation of
interleukin-2 production
|
16
|
9.44e-01
|
1.02e-02
|
9.73e-01
|
GO:0036126 sperm flagellum
|
32
|
9.21e-01
|
1.01e-02
|
9.64e-01
|
GO:0030030 cell projection
organization
|
13
|
9.51e-01
|
-9.88e-03
|
9.75e-01
|
GO:0070374 positive regulation of
ERK1 and ERK2 cascade
|
58
|
8.97e-01
|
-9.82e-03
|
9.58e-01
|
GO:0070273
phosphatidylinositol-4-phosphate binding
|
17
|
9.45e-01
|
9.73e-03
|
9.73e-01
|
GO:0009898 cytoplasmic side of
plasma membrane
|
47
|
9.09e-01
|
-9.67e-03
|
9.60e-01
|
GO:0071277 cellular response to
calcium ion
|
32
|
9.25e-01
|
9.60e-03
|
9.64e-01
|
GO:0006884 cell volume homeostasis
|
14
|
9.51e-01
|
9.49e-03
|
9.75e-01
|
GO:0005102 signaling receptor
binding
|
81
|
8.83e-01
|
9.43e-03
|
9.50e-01
|
GO:0071480 cellular response to
gamma radiation
|
14
|
9.55e-01
|
8.80e-03
|
9.77e-01
|
GO:0090316 positive regulation of
intracellular protein transport
|
14
|
9.55e-01
|
-8.78e-03
|
9.77e-01
|
GO:0051321 meiotic cell cycle
|
21
|
9.46e-01
|
-8.60e-03
|
9.73e-01
|
GO:0030041 actin filament
polymerization
|
15
|
9.55e-01
|
-8.49e-03
|
9.77e-01
|
GO:0046835 carbohydrate
phosphorylation
|
20
|
9.48e-01
|
-8.38e-03
|
9.74e-01
|
GO:0005776 autophagosome
|
41
|
9.33e-01
|
7.59e-03
|
9.67e-01
|
GO:0005681 spliceosomal complex
|
43
|
9.34e-01
|
7.25e-03
|
9.67e-01
|
GO:0030837 negative regulation of
actin filament polymerization
|
14
|
9.63e-01
|
7.09e-03
|
9.83e-01
|
GO:0004438
phosphatidylinositol-3-phosphate phosphatase activity
|
13
|
9.65e-01
|
7.04e-03
|
9.83e-01
|
GO:0005005 transmembrane-ephrin
receptor activity
|
14
|
9.64e-01
|
6.99e-03
|
9.83e-01
|
GO:0006094 gluconeogenesis
|
21
|
9.56e-01
|
6.95e-03
|
9.77e-01
|
GO:0032956 regulation of actin
cytoskeleton organization
|
37
|
9.46e-01
|
-6.38e-03
|
9.73e-01
|
GO:0005249 voltage-gated potassium
channel activity
|
13
|
9.69e-01
|
6.14e-03
|
9.86e-01
|
GO:0030687 preribosome, large
subunit precursor
|
12
|
9.71e-01
|
6.05e-03
|
9.86e-01
|
GO:0016592 mediator complex
|
28
|
9.56e-01
|
-6.00e-03
|
9.77e-01
|
GO:0048666 neuron development
|
26
|
9.59e-01
|
5.86e-03
|
9.79e-01
|
GO:0009410 response to xenobiotic
stimulus
|
46
|
9.47e-01
|
5.65e-03
|
9.73e-01
|
GO:0099149 regulation of
postsynaptic neurotransmitter receptor internalization
|
12
|
9.73e-01
|
5.65e-03
|
9.87e-01
|
GO:0045087 innate immune response
|
79
|
9.33e-01
|
5.46e-03
|
9.67e-01
|
GO:0034198 cellular response to
amino acid starvation
|
31
|
9.58e-01
|
5.45e-03
|
9.79e-01
|
GO:0009953 dorsal/ventral pattern
formation
|
16
|
9.70e-01
|
5.42e-03
|
9.86e-01
|
GO:0048146 positive regulation of
fibroblast proliferation
|
19
|
9.68e-01
|
-5.38e-03
|
9.85e-01
|
GO:0007099 centriole replication
|
13
|
9.74e-01
|
5.30e-03
|
9.87e-01
|
GO:0030145 manganese ion binding
|
45
|
9.55e-01
|
-4.91e-03
|
9.77e-01
|
GO:0071011 precatalytic spliceosome
|
12
|
9.77e-01
|
4.90e-03
|
9.89e-01
|
GO:0006303 double-strand break
repair via nonhomologous end joining
|
20
|
9.71e-01
|
-4.70e-03
|
9.86e-01
|
GO:0140326 ATPase-coupled
intramembrane lipid transporter activity
|
11
|
9.79e-01
|
4.60e-03
|
9.90e-01
|
GO:0097060 synaptic membrane
|
11
|
9.79e-01
|
-4.56e-03
|
9.90e-01
|
GO:0070534 protein K63-linked
ubiquitination
|
31
|
9.70e-01
|
3.86e-03
|
9.86e-01
|
GO:0048013 ephrin receptor
signaling pathway
|
24
|
9.78e-01
|
3.18e-03
|
9.90e-01
|
GO:0031369 translation initiation
factor binding
|
12
|
9.85e-01
|
-3.17e-03
|
9.95e-01
|
GO:0070628 proteasome binding
|
13
|
9.84e-01
|
-3.16e-03
|
9.95e-01
|
GO:0030522 intracellular receptor
signaling pathway
|
18
|
9.86e-01
|
2.40e-03
|
9.96e-01
|
GO:0045022 early endosome to late
endosome transport
|
19
|
9.88e-01
|
-2.06e-03
|
9.97e-01
|
GO:0050796 regulation of insulin
secretion
|
12
|
9.91e-01
|
-1.84e-03
|
9.99e-01
|
GO:0000176 nuclear exosome (RNase
complex)
|
12
|
9.91e-01
|
1.79e-03
|
9.99e-01
|
GO:0070098 chemokine-mediated
signaling pathway
|
11
|
9.93e-01
|
-1.61e-03
|
9.99e-01
|
GO:0005509 calcium ion binding
|
256
|
9.66e-01
|
1.55e-03
|
9.84e-01
|
GO:0030178 negative regulation of
Wnt signaling pathway
|
17
|
9.92e-01
|
1.43e-03
|
9.99e-01
|
GO:0032715 negative regulation of
interleukin-6 production
|
14
|
9.93e-01
|
1.43e-03
|
9.99e-01
|
GO:0061136 regulation of
proteasomal protein catabolic process
|
11
|
9.94e-01
|
1.31e-03
|
9.99e-01
|
GO:0004683
calcium/calmodulin-dependent protein kinase activity
|
11
|
9.95e-01
|
-1.12e-03
|
9.99e-01
|
GO:0005666 RNA polymerase III
complex
|
12
|
9.96e-01
|
-8.33e-04
|
9.99e-01
|
GO:0004622 lysophospholipase
activity
|
10
|
9.97e-01
|
6.47e-04
|
9.99e-01
|
GO:0005543 phospholipid binding
|
38
|
9.95e-01
|
5.82e-04
|
9.99e-01
|
GO:0101031 protein folding
chaperone complex
|
18
|
9.97e-01
|
5.47e-04
|
9.99e-01
|
GO:0035869 ciliary transition zone
|
22
|
9.97e-01
|
5.25e-04
|
9.99e-01
|
GO:0006816 calcium ion transport
|
19
|
9.98e-01
|
3.00e-04
|
1.00e+00
|
GO:0000266 mitochondrial fission
|
10
|
9.99e-01
|
1.41e-04
|
1.00e+00
|
GO:0071353 cellular response to
interleukin-4
|
10
|
1.00e+00
|
1.13e-04
|
1.00e+00
|
GO:0030658 transport vesicle
membrane
|
13
|
1.00e+00
|
5.41e-06
|
1.00e+00
|